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Introduction: Inflammatory bowel disease (IBD) is a chronic condition affecting over 
300,000 people in the UK. Despite a high level of comorbid mental disorders, most 
patients do not receive psychological help. As a result of scarce healthcare resources in 
IBD, technology is increasingly being recognised as a useful tool to manage anxiety and 
depression associated with IBD. However, there is no online psychotherapy 
programme for patients with IBD and comorbid anxiety and/or depression available in 
the UK. 
Aim: The aim of this thesis was to develop a prototype online psychological 
intervention for patients with IBD and comorbid anxiety and/or depression. 
Methods: The development of the prototype followed the Medical Research Council 
(MRC) framework for complex interventions (the development phase). Firstly, 
theoretical evidence on the effectiveness of online psychological therapy in 
gastrointestinal diseases was gathered in a systematic review. Secondly, a qualitative 
study investigated patients' with IBD and comorbid anxiety and/or depression and 
their service providers' views about lived experiences with IBD and about an online 
psychological intervention. Finally, the recommendation for the online psychological 
intervention for this population was provided.   
Results: The evidence on the usefulness of online psychological interventions in 
gastroenterology, and IBD specifically, is scarce. There is a need for more robust trials 
of psychotherapy in IBD, particularly in patients with IBD and anxiety and/or 
depression. Patients had positive attitude towards online psychological intervention, 
while health professionals were unsure about patients' participation in the 
intervention. Based on the theoretical evidence and the qualitative study findings the 
recommendations for the future interventions were developed. 
Conclusions: This PhD project demonstrated the need for an online psychological 
intervention for patients with IBD and comorbid anxiety and/or depression. The 
intervention based on the prototype could be tested in a future trial. The productive 
collaborations between patients, stakeholders and researchers in co-designing of an 
online psychological intervention are essential during the development, evaluation and 
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1 Chapter 1: Introduction  
This chapter provides an introduction to, the rationale for, and the overview of the 
thesis.  
1.1 Background 
Gastrointestinal (GI) diseases are a substantial burden for the health service providers 
and society as a whole across Europe and the UK (Farthing et al., 2014; Williams et al., 
2007). Patients affected by the symptoms of these diseases have reduced health-
related quality of life (HQOL) (Williams et al., 2007). Despite individual and population 
impact caused by GI disorders, they receive small financial and policy support (Farthing 
et al., 2014).  
 
Disorders of brain-gut interaction (DBGI), formerly known as functional GI disorders 
(the terms will be used interchangeably) (Drossman and Hasler, 2016), and organic GI 
diseases such as inflammatory bowel disease (IBD) are the most common forms of GI 
disease (Langshaw et al., 2018), although the pathophysiological mechanisms of these 
disorders are still poorly understood (Farthing et al., 2014). Nevertheless, the gut-
brain-microbiota links are important in pathogenesis and pathophysiology of GI 
disorders (Martin et al., 2018).  
 
IBD is a GI illness with an incidence increasing globally (Ng et al., 2017). There is a high 
rate of comorbid anxiety and depression in patients with IBD (Mikocka-Walus et al., 
2016b). Despite the evidence of bidirectional links between the gut and brain in IBD 
(Gracie et al., 2018), there  is a lack of clear evidence on the effectiveness of 
psychotherapy for IBD (Timmer et al., 2011). There is some tentative evidence of 
higher effectiveness in selected subgroups of IBD patients (e.g. patients who have a 
high baseline IBD activity; have been recently diagnosed; are young; and with 
comorbid psychological distress) than in unselected IBD cohorts (Mikocka-Walus, 2015; 
Gracie et al., 2017; Timmer et al., 2011).  
 
This thesis explores psychotherapy in the targeted population of IBD patients with 
comorbid anxiety and/or depression by analysing the existing literature and 
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developing and evaluating a prototype of an online psychotherapy programme. This 
has involved identification/development of the appropriate theory and consultation 
with the end-users to adapt the online intervention to their needs regarding its 
content and design, with the aim of improving the acceptability of the intervention 
during the implementation. 
1.2 IBD definition  
IBD is a chronic idiopathic condition, which involves inflammation of the 
gastrointestinal tract (Fusunyan and Sanderson, 1998). IBD is used as a combined term 
for three disease subtypes: ulcerative colitis (UC), Crohn's disease (CD) and 
indeterminate colitis (IC). Predominantly, CD affects the ileocecal area of the GI tract 
(Mills and Stamos, 2007). However, it can affect any segment of the GI tract from the 
mouth to the anus, in contrast to UC, which affects the rectum and colon mucosa 
(Mills and Stamos, 2007). IC is an IBD subtype that, based on diagnostic tests, has both 
CD and UC characteristics (Malaty et al., 2013; Burakoff, 2004; Satsangi et al., 2006). 
The strong similarity in pathophysiology and treatment approaches of these 
autoimmune inflammatory heterogeneous diseases had led to the development of the 
integrated classification system and the common name of IBD (Silverberg et al., 2005; 
Spekhorst et al., 2014). 
 
The definition of IBD only became widely used at the end of the last and the beginning 
of the present century, whereas the term ulcerative colitis was first used in the middle 
of the 19th century (Mulder et al., 2014) and the term Crohn’s disease was initially 
used in 1932 (Crohn, Ginzburg and Oppenheimer, 1932). Nevertheless, IBD has 
affected humans for thousands of years (Mulder et al., 2014).    
1.3 Incidence and prevalence  
IBD is highly prevalent, affecting 2.5 to 3 million people in Europe (Burisch et al., 
2013b). The numbers of those affected by IBD people in the UK differ according to 
different sources but it is likely that over 300,000 people live with this disease in the 
country (The IBD Standards Group, 2013; NICE, 2014; The IBD UK, 2019). The 
distribution of IBD types among different age and sex groups and in different countries 
varies greatly (Cosnes et al., 2011). The highest incidence of CD is in those 20 to 30 
years old and of UC, in those 30 to 40 years old (Cosnes et al., 2011), with occurrence 
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of CD 20% to 30% more frequent in females and occurrence of UC 10% more frequent 
in males (Cosnes et al., 2011). However, this distribution is different for children, 
where CD is more prevalent in boys and UC in girls, with the trend changing during the 
teenage years (Cosnes et al., 2011). Approximately a fifth of all IBD cases are 
paediatric, with more frequent occurrence of the CD subtype in this population and 
across most countries (Cosnes et al., 2011).   
 
The prevalence of IC is higher in children compared to adults (Carvalho et al., 2006). 
The majority of IBD cases that were initially considered as IC ultimately will be 
diagnosed with UC or CD, however between one and 10% of IBD patients will retain 
the IC diagnosis (Burakoff, 2004; Meucci et al., 1999; Nuij et al., 2013; Ng et al., 2013; 
Buderus et al., 2015).  
 
It has been shown that IBD is more likely to affect urban populations compared to rural 
populations and individuals of higher rather than lower socioeconomic status 
(M’Koma, 2013). There is evidence that migration to urban and developed areas from 
the low IBD incidence regions before adolescence considerably increases the risk of 
IBD (M’Koma, 2013). The incidence of IBD is increasing significantly in developing 
countries and countries where it was traditionally low, for instance, Japan (Ng et al., 
2017; Cosnes et al., 2011).  
1.4 Aetiology and epidemiology of IBD 
Although IBD’s aetiology is unknown, microbial, dietary, genetic, infectious and other 
environmental factors influence the occurrence of the diseases (Molodecky and 
Kaplan, 2010; Asakura et al., 2008; Luther et al., 2010; Jostins et al., 2012; Loftus, 2004; 
Jess et al., 2005; Karlinger et al., 2000), with only a few systematic reviews conducted 
on the aetiology of IBD to date (Penagini et al., 2016; Klement et al., 2004).  
1.4.1 Gut-brain-microbiota axis 
The interaction between the brain and the digestive system was explored by the 
Russian scientist Pavlov in the nineteenth century. Pavlov demonstrated that the brain 
affects the functioning of the gut (Tansey, 2006). Since then, this area of research has 
been developing rapidly, particularly in the last few decades as a result of the 
breakthrough in: microbial gut-brain bidirectional signalling (Rhee, Pothoulakis and 
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Mayer, 2009; Mayer, 2011), neuroimaging (Tillisch and Labus, 2014), intestinal 
microbiology and host-microbial interactions (Bron, de Vos and Kleerebezem, 2006; 
Collins and Bercik, 2009; Martin et al., 2007), and enteric neuroscience (Gershon, 
1999; Furness, 2006; Mayer, 2007). Increasing evidence suggests that the gut also 
influences the brain functions (Heijtz et al., 2011; Neufeld et al., 2011; Gareau et al., 
2011), predominantly its behaviour and emotional processing (Burokas et al., 2016; 
Borre et al., 2014; Al Omran and Aziz, 2014; Clarke et al., 2014).  
 
The interactions between the digestive tract and the central nervous system occur 
through various pathways Figure 1) (Petra et al., 2015), including the enteric nervous 
system (ENS), the neuroendocrine system and the humoral immune system (Carabotti 
et al., 2015; Powell, Walker and Talley, 2017; Evrensel and Ceylan, 2015; Mayer and 
Tillisch, 2011; Petra et al., 2015). This bidirectional communication between the brain 
and the gut forms the gut-brain axis (GBA) (Burokas et al., 2016; Carabotti et al., 2015; 
Powell et al., 2017). This well-known term is now being redefined as a gut-brain-
microbiota axis as a result of the discovery that microbiota also influences brain 
functioning (Montiel-Castro et al., 2013; Carabotti et al., 2015; Cryan and O'Mahony, 
2011). Furthermore, the gut microbiome influences the outcomes and the effect of 




"Gut microbiota can release 
molecules that may activate the 
neuroenteric plexus and stimulate 
brain production of 
neuropeptides, as well as increase 
gut–blood barrier and blood–brain 
barrier (BBB) permeability. The 
brain releases molecules that 
stimulate the neuroenteric plexus 
and gut function. The vagus nerve 
sends orthodromic and 
antidromic. CRH = corticotropin-
releasing hormone; NT = 
neurotensin; SP = substance P; Ach 
= acetylcholine; IL-6 = interleukin 
6; TNF = tumor necrosis factor; VIP 
= vasoactive intestinal peptide; 5-
HT = 5-hydroxytryptamine"(Petra 
et al., 2015) 
Figure 1 from (Petra et al., 2015): "Diagrammatic representation of the microbiota–gut–
brain (MGB) axis highlighting the proposed bidirectional communications." (Petra et al., 2015). 
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The gut-brain-microbiota axis provides new insights into treatment directions of 
gastrointestinal diseases (Martin et al., 2018). Emerging from this insight, it has been 
found that modifying stress and mood with the assistance of psychological 
interventions may lead to better management of GI disease (Tabibian, 2013; Roditi and 
Robinson, 2011).  
1.5 Symptoms of IBD 
The symptoms of IBD vary depending on the severity and localisation of inflammation 
but most commonly include: diarrhoea, tiredness and fatigue, unintended weight loss, 
abdominal pain, blood in stool, minor fever, reduced appetite, mouth ulcers and 
anaemia (The IBD Standards Group, 2013; Waljee et al., 2009; Baumgart and 
Sandborn, 2007). Despite having common symptoms, CD and UC also have some 
distinguishing symptomatic features.  
 
Depending on the localisation of inflammation and ulceration of the inner lining of 
rectum and colon, UC’s subtypes include: 
 Proctitis characterised by rectal bleeding, mucus in the stools, tenesmus (an 
urge to pass a stool without being able to due to empty bowel), occasional 
severe constipation.  
 Proctosigmoiditis whose symptoms are similar to that of proctitis, but 
constipation is less likely. 
 Left-sided (distal) colitis characterised by bloody diarrhoea with mucus, left-
hand side abdomen pain, and tenesmus. 
 Extensive pancolitis characterised by frequent bloody diarrhoea with mucus; 
sometimes fever, lethargy, tenesmus, abdominal discomfort and abdominal 
pain, cramps. 
Rarely, gases trapped in the bowel due to severe inflammation could cause toxic 
megacolon with a high temperature and abdominal pain (Waugh et al., 2013; 
Panaccione, 2013). 
 
Symptoms of CD depend on the localisation of the lesions. The most common are 
crampy severe pain, diarrhoea, nausea, vomiting and weight loss. Less common, CD 
can affect the upper gastrointestinal tract such as oesophagus, stomach or duodenum, 
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causing pain, nausea with/without vomiting, loss of appetite, weight loss and anaemia. 
CD occasionally affects the mouth, causing swollen lips and mouth fissures or mouth 
ulcers due to nutrition deficiency during flare-ups. There are specific types of CD 
present in distinct ways: 
 Patients with ileal CD have abdominal pain in the right side, with possible 
intestinal obstruction and watery diarrhoea without blood or mucous, and 
weight loss.  
 In Crohn's disease with colonic localisation, patients have UC-like symptoms 
(bloody diarrhoea with mucus, tenesmus) often with perianal symptoms. 
However, many patients have symptoms of ileocolic CD, and a small number of 
CD patients have isolated perianal disease (Waugh et al., 2013; Panaccione, 
2013). 
 Perianal symptoms manifest in: skin tags (small fleshy growths around the 
anus); haemorrhoids (swollen blood vessels in or around the anus and rectum); 
fissures (tears or splits in the lining of the anal canal); abscesses around the 
anus causing a fever or leading to a fistula; fistulas (narrow passages or tunnels 
between the anal canal and the skin surface around the anus, leaking pus or 
sometimes faecal matter from skin openings); anal fissures, anal ulcers, 
anorectal carcinoma (de Zoeten et al., 2013; Ingle and Loftus, 2007).  
 
During the healing process in CD, the scars (strictures) form in the bowel tissue, 
causing obstruction with cramping abdominal pain, nausea, vomiting and 
constipation (Turnage and Bergen, 1998). Other complications include perforations 
of the bowel, causing severe abdominal pain, fever, nausea, vomiting and 
occasional a passage of the faecal matter through that perforation (Lahat and 
Chowers, 2007). At times an abnormal tunnel between a different internal organ or 
opening to the skin surface (particularly around the anus) called a fistula can be 
formed (Marzo et al., 2015). 
 
Symptoms that affect the entire body, for instance, tachycardia, weight loss, 
anorexia and high body temperature are more common in CD, however, could be 
present in severe cases of UC as well (Tontini et al., 2015; Waugh et al., 2013). 
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1.5.1 Extra-intestinal symptoms (EISs) 
EISs are a manifestation of IBD in the systems other than the gastrointestinal tract. The 
EISs can occur prior to the IBD diagnosis and in some cases could impair patient’s 
health more than the IBD itself (Jang, Kang and Choe, 2019). The chance of EISs 
increases with the disease duration and is higher in CD compared to UC (between 24%-
40% and 26%-31%, respectively) and even higher (47%) for colonic localisation of CD 
(Tontini et al., 2015). The most commonly manifested EISs are in the dermatological 
(most often erythema nodosum and pyoderma gangrenosum) and musculoskeletal 
(most often enteropathic arthritis) systems (Levine and Burakoff, 2011). However, the 
consequences for the hepatobiliary system in the form of primary sclerosing 
cholangitis (PSC) are the most serious (Levine and Burakoff, 2011). PSC is a long-term 
progressive precancerous disease of the liver and gallbladder with the incidence in 
men double that of women (Tontini et al., 2015). Patients with IBD also report eye 
problems in the form of episcleritis, have thinning bones, kidney stones and gallstones, 
thrombosis of deep veins and anaemia (Levine and Burakoff, 2011). The probability of 
EISs is higher in CD, with the exception of PSC whose probability is twice as high in UC 
and which occurs in 2 to 4% of patients with UC (Tontini et al., 2015).  
1.6 Psychological burden 
In addition to the presence of the aforementioned symptoms, many patients have a 
high level of comorbid anxiety and depression (Mikocka-Walus et al., 2016b).  
1.6.1 Anxiety 
1.6.1.1 Epidemiology of anxiety 
Anxiety is the most prevalent mental health disorder affecting approximately 264 
million (3.6%) people globally (WHO, 2017). This disorder can affect people of any age 
with lower prevalence amongst the older population (Ritchie and Roser, 2019; WHO, 
2017). Anxiety affects 4.2% of the UK population and accounts for over 200 thousand 
Total Years Lived with Disability (YLD) (WHO, 2017).  
1.6.1.2 Diagnosis and symptoms of anxiety 
According to DSM-5, anxiety disorders are a combined term used for disorders with 
typical features of excessive fear and anxiety (American Psychiatric Association, 2013). 
Anxiety is an anticipation of the future internal or external danger without evident 
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object or cause, while fear is an emotional reaction to a real or perceived danger 
(American Psychiatric Association, 2013). Short-term stress is not considered as a 
mental health problem, while long-term anxiety that interferes with everyday life 
indicating the severity of the symptoms (American Psychiatric Association, 2013).  
According to the WHO (ICD-10), there are two classes of anxiety disorders: 
 phobic anxiety disorders, which include social phobia, agoraphobia, specific 
(isolated) phobias, which are restricted to very particular situations, other 
phobic anxiety disorders and unspecified phobic anxiety disorder that often 
coexist with depression;  
 other anxiety disorders (generalized anxiety disorder, depressive disorder and 
mixed anxiety, panic disorder, other specified and mixed anxiety disorders, 
anxiety disorder and unspecified disorders) (WHO, 2004). 
The most common types of anxiety disorders are Generalized Anxiety Disorder, 
Panic Disorder, Post-Traumatic Stress Disorder (PTSD) and Social Phobia (or Social 
Anxiety Disorder) (American Psychiatric Association, 2013). 
 
Often anxiety is accompanied by somatic symptoms, the most typical of them include 
feelings of nervousness, rapid breathing or struggling to breathe, pain in the chest, 
sweating, hand tremor, trembling, muscular tension, sweating, tachycardia, light-
headedness, feelings of unreality (depersonalisation or derealisation), blushing, nausea 
and choking sensations (American Psychiatric Association, 2013).  
1.6.1.3 Risk factors for the development of anxiety 
Anxiety is more common among females (63%) compared to males (Ritchie and Roser, 
2019; WHO, 2017). Genetic predisposition, childhood trauma and environmental 
factors play a role in the development of anxiety (Dabkowska and Dabkowska-Mika, 
2015; Hettema, Neale and Kendler, 2001). People with disabilities, with physical illness, 
who are smokers, who are from lower socioeconomic groups and young offenders are 
also predisposed to anxiety (Department of Health, 2011b). A recent systematic review 
and meta-analysis concluded that anxiety and depression are not merely highly 
comorbid but are the risk factors for each other, with anxiety predisposing more to 





1.6.2.1 Epidemiology of depression 
Depression affects around 300 to 350 million (4.4%) people globally and is the leading 
cause of disability worldwide relating to YLD (WHO, 2017). It is estimated that in two 
decades, depression will be the primary source of disease burden globally (WHO, 
2012). The prevalence rates of depressive disorders vary by age with a peak in the 
older populations (WHO, 2017). Depression affects 4.5% of the UK population and 
accounts for 454 789 YLD (WHO, 2017) contributing to the vast economic productivity 
loss (Trautmann, Rehm and Wittchen, 2016; Bloom et al., 2012).  
1.6.2.2 Diagnosis and symptoms of depression 
Depression (depressive disorders) include disruptive mood dysregulation disorder, 
major depressive disorder (including major depressive episode), persistent depressive 
disorder (dysthymia), premenstrual dysphoric disorder, substance/medication-induced 
depressive disorder, depressive disorder due to another medical condition, other 
specified depressive disorder, and unspecified depressive disorder (American 
Psychiatric Association, 2013). 
 
The most commonly reported symptoms of depression are decreased energy levels, 
considerable tiredness, sadness, low mood, loss of interest and ability to enjoy, 
disrupted sleep, loss of interest in sex, lessened self-esteem and self-confidence, 
feeling of guilt/worthlessness (American Psychiatric Association, 2013). These 
symptoms are persistent and often interfere with normal functioning and capacity of 
the person and, in some severe cases, they could lead to suicidal thoughts and acts 
(American Psychiatric Association, 2013). Besides the presence of those symptoms, 
depression frequently has negative impacts on QOL, social, family, sexual and 
professional life of sufferers (Holubova et al., 2016; González-Blanch et al., 2018). 
  
Depression severity is categorised into mild, moderate or severe. Patients with mild 
and moderate depression, despite considerable suffering, are capable of continuing 
with normal functions, whereas severe depression has marked, persistent (at least six 
months) and distressing symptoms of low self-esteem, guilt, and worthlessness with 
somatic symptoms and potentially suicidal thoughts and acts (WHO, 2004). 
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1.6.2.3 Risk factors for the development of depression 
Genetic and environmental factors play a role in the development of depression 
(Sullivan, Neale and Kendler, 2000). The prevalence of depression among females is 
higher (5.1%) than in males (3.6%) (WHO, 2017). The risk of developing depression is 
increased by several factors including female gender, low socioeconomic status, 
unemployment, low social support, several traumatic life events, somatic illness and 
substance misuse, childhood adversities, family history of depression, pregnancy 
(WHO, 2017; Kessler et al., 2010; Bennett et al., 2004). A systematic review and meta-
analysis (n=20,678 participants at follow-up) concluded that female gender, disability, 
bereavement, disturbance in sleep, and previous depression are the risk factors for 
developing depression in older populations (Cole and Dendukuri, 2003). Whereas for 
adolescents, according to longitudinal data (n=1322), the risk factors are female 
gender, increases in smoking and decreases in social support (Galambos, Leadbeater 
and Barker, 2004). 
 
Depression and anxiety have a great financial impact on society and individuals 
(McCrone et al., 2008). However, the WHO survey (n=51,547 participants) from 21 
countries highlighted that fewer than half of those who suffer from major depression 
receive effective treatment (Thornicroft et al., 2017).  
1.6.3 Coping 
To deal with anxiety and depression, people develop coping mechanisms — thoughts 
and behaviours employed to deal with stressful situations, called coping (Folkman and 
Moskowitz, 2004). There are several ways to classify coping strategies described by 
different authors depending on the methods of assessment (Riera-López de Aguileta et 
al.). The most frequently used categories are: emotion‐oriented, task‐oriented, and 
avoidance‐oriented coping (Endler and Parker, 1990). Lazarus and Folkman (1984) 
distinguished two types of coping: coping directed at managing or changing the 
problem that is the source of the distress called problem-focused, and coping directed 
at managing the emotional response to the problem known as emotion-focused 
(Lazarus and Folkman, 1984). However, Skinner et al. (2003) highlighted the 
importance of distinguishing healthy coping from harmful coping and considered the 
following typologies of coping: adaptive against maladaptive, or healthy against 
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unhealthy, or constructive against harmful, or challenge against the threat (Skinner et 
al., 2003).  
1.7 Quality of life in IBD 
In addition to the presence of physical and psychological symptoms, IBD often has 
substantial negative impacts on the person's quality of life (QoL), physical, social, 
educational, occupational, and other functioning (Gay et al., 2011). Evidence from a 
series of systematic reviews and meta-analyses highlighted that people suffering from 
IBD have poorer QOL compared to healthy people (Knowles et al., 2018a) and QoL is 
poorer during disease relapses and possibly is poorer for individuals with CD compared 
to UC (Knowles et al., 2018a; Knowles et al., 2018b). 
 
According to the World Health Organization (WHO), QOL "assesses individuals' 
perceptions of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns" 
(WHO, 1995, p. 1403). Health-related quality of life (HRQoL) is considered a 
subcategory of QOL (Torrance, 1987). HRQoL examines a perceived physical and 
mental health state of individuals and its impact on QOL (Yin et al., 2016). As stated by 
the constitution of the WHO, "health is a state of complete physical, mental and social 
well-being and not merely the absence of disease or infirmity" (WHO, 1947, p. 13). 
These three terms (QOL, HRQoL and health) are often used interchangeably by the 
health professionals and researchers (Post, 2014). In this thesis, both terms QOL and 
HRQoL have been used, as studies discussed here used them both and both are 
applicable to the experience of living with IBD.  
1.8 Cost of IBD 
IBD is costly, this is a chronic condition with an early onset which requires lifelong 
treatment, including medication, hospitalisation and surgery, leading to substantial 
direct medical cost (Petryszyn and Witczak, 2016). However, these account for only 
part of the healthcare costs on a societal level, namely reduced productivity in the 
workplace, sickness absence rates, decreased employment and possibly retiring before 
the pension age due to a disability, resulting in high indirect cost (Petryszyn and 




Although the costs of IBD are vast, at both the individual and societal levels, there are 
significant challenges in the assessment, monitoring and treatment of IBD patients 
(M’Koma, 2013). Even in developed countries, there is a considerable socio-economic 
impact of IBD, about a fifth of individuals affected by IBD in Europe are accessing their 
disability pension, up to a quarter have problems with employment, and about half go 
on sick leave (Burisch et al., 2013a).  
 
IBD patients themselves sustain large out-of-pocket costs (Sin et al., 2015; Park, 
Bhattacharya and Park, 2014; Campbell et al., 2017). In the UK, 33% of patients aged 
40 and above with long-term chronic conditions, including IBD, do not collect 
medications due to the cost of charged prescriptions (Crohn's and Colitis UK, 2018b). 
This factor contributes to medication non-adherence and, as a consequence, lower 
QoL, reduced functional abilities, increased use of medical resources such as 
hospitalisation risk, increased health services use and spending on health care (Crohn's 
and Colitis UK, 2018b). York Health Economics Consortium (YHEC) has found that over 
£200 million might be saved over the next decade if the prescription charges for IBD 
patients were to be cancelled (YHEC, 2018). Therefore, this study recommended 
looking for other possible options of care and optimal treatment strategies to reduce 
IBD healthcare costs.  
1.9 Diagnosis of IBD 
Diagnosis of IBD is established on clinical examination and diagnostic tests (endoscopy, 
colonoscopy, histological criteria, radiology, and MRI type imaging and laboratory 
analysis) (Plevy et al., 2013; Gee and Harisinghani, 2011). The gold standard for 
diagnosing IBD is ileocolonoscopy with biopsy and histological analysis of the tissue 
(Passos, Chaves and Chaves-Junior, 2018).  
 
As an additional diagnostic instrument, the disease activity could be tested with widely 
used non-invasive inflammatory biomarkers (Tontini et al., 2015). However, they could 
not be used to forecast the course of the disease, differentiate IBD subtypes or 
response to treatment. C-reactive protein (CRP), faecal calprotectin (FC), stool 
lactoferrin (SL), ferritin, platelets ESR, albumin and fibrinogen, are universally used 
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markers (Tontini et al., 2015; Rokkas, Portincasa and Koutroubakis, 2018; Mosli et al., 
2015).  
 
Late diagnosis dramatically increases the risk of disease complications and surgical 
procedures for IBD patients (Lee et al., 2017). Increased awareness about IBD is likely 
to translate into more patient self-referrals to primary care and earlier diagnosis of IBD 
by health professionals (Angelberger et al., 2009).  
1.9.1 Current approaches to IBD treatment  
The World Health Organisation (WHO) has recommended the integrated model of 
patient care as the current best practice and provided a process-based definition of 
health care integration: “Integration is a coherent set of methods and models on the 
funding, administrative, organisational, service delivery and clinical levels designed to 
create connectivity, alignment and collaboration within and between the cure and care 
sectors. The goal of these methods and models is to enhance the quality of care and 
quality of life, consumer satisfaction and system efficiency for people by cutting across 
multiple services, providers and settings. Where the result of such multi-pronged 
efforts to promote integration leads to benefits for people, the outcome can be called 
integrated care” (WHO, 2016, p. 3; Kodner and Spreeuwenberg, 2002).  
 
Holistic care is a part of integrated care and is described as a model of care that 
considers and treats the person as a whole: mind, body, and spirit, considers a 
person's environmental circumstances and encourages the patient's participation in 
the treatment process (Zamanzadeh et al., 2015; Papadimitriou, 2017). A recent 
systematic review (n=50 papers, of them: 5 qualitative studies, 40 theoretical articles, 
4 book chapters and 1 thesis) found that three, often interchangeably used but not 
synonymous terms, "whole person", “biopsychosocial” and “holistic care” stress the 
importance of a complex integrated care approach (Thomas et al., 2018). 
Nevertheless, the holistic care term has a broader meaning than the biopsychosocial 
care (Thomas et al., 2018). An interaction between psychological (stress, thoughts, 
emotions, behaviours), biological (genes) and social (family relationships, social 
support, cultural impact) factors influence health and disease (Wade and Halligan, 
2017). They underlie the principles of a biopsychosocial model (Papadimitriou, 2017) 
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which often has been applied to understand gastrointestinal diseases, IBD in particular, 
because of the bidirectional link between the brain and gut through the gut-brain-
microbiota axis (Grover, Herfarth and Drossman, 2009; Long and Drossman, 2010). 
Thus, IBD treatment approaches should be based on the consideration of the 
biopsychosocial model (Rakovec-Felser, 2011; Lee et al., 2018; Casati and Toner, 2000; 
Mikocka-Walus et al., 2012b). However, to date the biomedical approach to IBD 
treatment is still used at times instead of the biopsychosocial, as current treatment 
models in IBD do not involve regular allied health input or psychological care (Mikocka-
Walus et al., 2014), with the accessibility of psychological help for IBD patients limited 
(Bennebroek Evertsz et al., 2012). 
  
The concept of QOL is increasingly being recognised for its importance within IBD, 
consequently achieving remission, maintaining remission, and improving HRQoL are 
becoming key goals of IBD treatment (Orlando et al., 2013; Dubinsky, 2017). 
 
The treatment approach to IBD has recently focused not only on managing flares 
(Orlando et al., 2013; Dubinsky, 2017; Loftus, 2011; Kemp et al., 2018) but on early 
intervention and preventing permanent damage to the bowel structure (Pariente et 
al., 2011). An early IBD treatment is vital in the prevention of this damage (Peyrin-
Biroulet et al., 2010).  
 
IBD treatment consists of long ongoing pharmacological (drug) therapy, surgical 
treatment, dietary, and psychological support (psychotherapy) (Wilhelm and Love, 
2017; RCP, 2014; Kaenkumchorn and Kesavan, 2019; Green et al., 2019). Many 
patients become unresponsive to drug therapy, which is the fundamental therapy in 
IBD and require surgery (Wilhelm and Love, 2017). Establishing the IBD subtype is 
essential for the choice of treatment tactics, especially when choosing a surgical 
intervention (Mills and Stamos, 2007). 
1.9.1.1 Specialist care 
Despite an increase in the number of IBD nurses in the UK, according to the UK IBD 
audit, only 4 in 10 services met the required number of IBD nurses to deliver the 
appropriate level of care and approximately 1 in 10 services did not have IBD nurses in 
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the care team (RCP, 2014). IBD nurses work overtime and struggle meeting service 
requirements (Crohn's and Colitis UK, 2018a).  
 
Almost a quarter of IBD services have no provision of a dietitian (RCP, 2014). Some IBD 
service providers also do not have routing support or comprehensive pathways to 
other services, for example to, pharmacology (just under three quarters have a 
referral) or rheumatology (over quarter patients have a referral) (RCP, 2014). 
Nevertheless, over 90% of services had some multidisciplinary team of the clinician 
involved in managing complicated cases of IBD (RCP, 2014). However, only 40% of 
them were formalised with regular meetings (RCP, 2014). Patients with a relapse of 
IBD were not able to be seen within the required time (5 days) (RCP, 2014). Only 
around half of the providers had a clear transition from paediatric to adult clinics, and 
even fewer of them had an explicit transition policy (RCP, 2014).  
1.9.2 Pharmacological treatment  
The pharmacotherapy selection depends on the localisation of inflammation, the 
course of the disease, complications, side effects and other factors (Kemp et al., 2018). 
Predominantly, treatment is directed at the reduction of inflammation or to manage 
infection (abscesses, fistulas, post-surgery) (Nitzan et al., 2016; Matsuoka et al., 2018). 
There are five main classes of drugs used for the treatment of IBD: Aminosalicylates, 
Corticosteroids, Immunosuppressants, Biological therapies and Antibiotics (Matsuoka 
et al., 2018). Recently, there is an increased interest in antidepressants in the 
treatment of comorbid psychological disorders as well as IBD itself, which have a 
possible positive effect on disease course (Hall et al., 2018; Daghaghzadeh et al., 2015; 
Macer, Prady and Mikocka-Walus, 2017).  
1.9.3 Psychological treatment in IBD 
While a significant proportion of IBD patients suffer from depression and/or anxiety, 
(Byrne et al., 2017), the standard IBD care in the UK does not include screening for 
anxiety and depression. This is important as these mental disorders are associated 
with the clinical recurrence of IBD (Mikocka-Walus et al., 2016c). Only 53% of services 
could refer IBD patients for psychological support when needed, and only 12% of 
services could refer them to a psychologist or counsellor with particular IBD knowledge 




Presently, psychological care in IBD includes psychotherapeutic (psychotherapies) and 
psychopharmacological (central neuromodulators which include antipsychotics, 
antidepressants, and other central nervous system−targeted medications) treatments 
(Van Assche et al., 2013; Van Assche et al., 2010; Drossman et al., 2018).  
 
As part of pharmacological treatment, antidepressants have been used effectively for 
some gastroenterological diseases (Ford et al., 2014; Xiong et al., 2018) and used as 
adjuvant therapy in IBD (Mikocka-Walus et al., 2007b), with positive outcomes (Macer 
et al., 2017). A systematic review also suggested that gastrointestinal symptoms, 
disease activity, anxiety and depression in IBD could be reduced using psychotherapy 
and antidepressants (Tarricone et al., 2017). Furthermore, IBD patients appear to have 
a positive attitude toward antidepressants (Mikocka-Walus et al., 2012a) and express 
desire to have access to psychological support (Fourie, Jackson and Aveyard, 2018). 
Moreover, certain groups of antidepressants are protective against the development 
of IBD, as concluded in a retrospective cohort study of 6 million patients followed over 
an average of 6.7 years (Gracie and Ford, 2019). However, a systematic review and 
meta-analysis (n=188 participants) concluded that the efficacy and safety of 
antidepressants in IBD are unclear and needs further investigation (Mikocka‐Walus et 
al., 2019). 
 
Psychological therapies (also referred to as psychotherapy or talk therapy or talking 
therapy) have different mechanisms of action depending on its type and can improve 
coping, help dealing with the trauma, bereavement, somatic illness and some mental 
disorders and as a result improve well-being (American Psychiatric Association, 2019; 
Zimbardo, 1995). Psychotherapy can be used in combination with medication or on its 
own (American Psychiatric Association, 2019). Psychotherapy is used in individual, 
family, couple or group format for people of various ages, including children (American 
Psychiatric Association, 2019). The length and duration of sessions vary, from weeks to 
months or years, but is determined by agreement between the patient and therapist 
and the type of psychotherapy. Usually, sessions take place once a week between 30 
and 50 minutes and between 12 to 16 sessions to achieve considerable clinical 
improvement (American Psychiatric Association, 2019). The typical duration of the 
39 
 
most commonly used psychotherapies, such as CBTs being between 2 and 4 months of 
one per week session (Beck and Beck, 2011). 
 
There are several different types of psychotherapies with some appearing more 
effective than others for specific problems or disorders (American Psychiatric 
Association, 2019). According to NICE (2011), evidence-based psychological 
interventions for the treatment of mental disorders are: Cognitive Behaviour Therapy 
(CBT), Interpersonal Psychotherapy (IPT), Narrative therapy, Family therapy and family-
based interventions, Mindfulness-Based Cognitive Therapy (MBCT), Acceptance and 
Commitment Therapy (ACT), Solution-Focused Brief Therapy (SFBT), Dialectical 
Behaviour Therapy (DBT), Schema-focused therapy, Psychodynamic psychotherapy, 
Emotion-focused therapy, Hypnotherapy, Self-help, and Psychoeducation (Australian 
Psychological Society, 2010; NICE, 2011). The trained mental health care professionals, 
such as psychiatrists, mental health nurses and psychologists can deliver these 
therapies (Zimbardo, 1995). 
 
CBT is a therapy directed towards changing dysfunctional (unhelpful or inaccurate) 
thoughts or behaviours (Beck and Beck, 2011). Results of a systematic review and 
meta-analysis, highlight that CBT is very effective in treating social anxiety (Powers, 
Sigmarsson and Emmelkamp, 2008; Mayo-Wilson et al., 2014) and reduces symptoms 
of generalised anxiety disorder and depression (Tyrer et al., 2014). Moreover, 
psychotherapies, particularly CBT, seem to be effective in the short-term for treating 
depression and QOL in IBD (Gracie et al., 2017). Considering that CBT is the most 
studied psychotherapy to date and shown to be more effective in treating depression 
and anxiety and in improving these symptoms and QOL in IBD patients compared to 
the other psychological interventions, this thesis focused on CBT but looked for the 
evidence of the effectiveness of psychotherapy in general.  
 
A qualitative study on patients' views about psychotherapy in IBD conducted in 
Australia concluded that psychotherapy in patients with IBD with mental health 
problems is underutilised, even though patients have good access to psychological 
services in this country (Mikocka-Walus, 2013). The author suggested this could be due 
to the lack of direct referral pathways between gastroenterologists and mental health 
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providers and lack of in-house psychology services within gastroenterology clinics 
(Mikocka-Walus, 2013). There is an inadequate level of psychological support for 
patients with IBD, particularly from psychologists specialising in IBD (NICE, 2014). Thus, 
the implementation of the integrated care model could improve the provision of 
psychological services for IBD patients. 
 
Psychological therapies can be delivered through different modes, in-person, 
telephone-assisted, or online assisted (Mozer, Franklin and Rose, 2008; Backhaus et al., 
2012; Jackson, 2016; Beck and Beck, 2011).  
1.9.4 Online psychological interventions (PI) in mental and physical health 
In recent years, the use of online interventions in health has increased rapidly, 
including mental health applications (e-therapy, computerised CBT (cCBT), internet 
CBT, virtual reality-based interventions) (Hill et al., 2017; Maples-Keller et al., 2017; 
Fodor et al., 2018).  Implementation of the digital tools into healthcare is a response to 
high demand for services and to provide cost-effective interventions that are 
accessible and flexible (Hollis et al., 2015). Online interventions include a self-
management/self-directed component, involving activities that patients use 
themselves without guidance from clinicians (Grady and Gough, 2014) to empower 
them to manage their own disease (Hollis et al., 2015).  
 
Online interventions are widely implemented in the US and Australia due to the size of 
the countries and distances that need to be overcome by some patients to access the 
services (Hill et al., 2017). The UK falls behind despite recent government projects 
directed on the promotion of online interventions in mental health (Hunt, Koteyko and 
Gunter, 2015a; Department of Health, 2011a; Department of Health, 2017). 
Implementation of online interventions in mental health is essential in the UK where 
the demand for mental health services is higher than the National Health Service (NHS) 
can provide (Hill et al., 2017). There is an urgent need to find novel approaches in the 
provision of value for money services (Hill et al., 2017).  
 
Online PIs are accessible and cost-effective (Hill et al., 2017). There is good evidence 
that psychotherapy delivered online (therapist-assisted) is effective in the treatment of 
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anxiety/depression (Andersson et al., 2014; Beiwinkel et al., 2017; Johansson et al., 
2019) and considered to have the same cost-effectiveness as treatment as usual for 
depression in primary care settings (Holst et al., 2018). However, there is modest use 
of online interventions for depression in primary care according to an online survey 
(n=1044) (Breedvelt et al., 2019). Over 90% of responders (general practitioners (GPs)) 
in this study were unaware about recent online interventions for mental health or did 
not have any training on how to implement them in primary care (Breedvelt et al., 
2019). Introducing training about the online interventions into a clinical curriculum 
could ease the decision on the choice and recommendation of the intervention and 
improve the effectiveness of the intervention delivery (Breedvelt et al., 2019).  
 
Online psychotherapy offers a new, accessible mode of delivery and may be a solution 
to the lack of psychotherapeutic resources in gastroenterological services (Mikocka-
Walus, 2013). 
1.9.5 Rationale: Previous research, gaps in the literature and future direction 
Psychotherapies are effective in the management of mild to moderate levels of anxiety 
and depression in patients with long-term physical conditions, as suggested in a recent 
systematic review (Thabrew et al., 2018). To date, studies have mainly focused on the 
efficacy of psychotherapy in unselected patients with IBD (i.e. anyone with IBD), but a 
recent trial  showed that cognitive behavioural therapy (CBT) could significantly 
improve QOL in specific groups of participants: who have poor mental health, have 
been recently diagnosed, are young and have high baseline IBD activity (Mikocka-
Walus et al., 2015). A recent systematic review and meta-analysis demonstrated only a 
short-term beneficial effect of psychological interventions, CBT in particular, on 
depression scores and quality of life and no beneficial effect on disease activity or 
other mental health outcomes in unselected patients with IBD (Gracie et al., 2017). 
However, the authors recommended further investigation of the efficacy of these 
interventions in specific subgroups of patients with IBD.  PIs are possibly beneficial for 
subgroups of these patients including patients with IBD with comorbid psychological 
distress (Gracie et al., 2017), where PIs could be effective for the management of 
anxiety and/or depression in this population in addition to the influence on IBD 
through the gut-brain-microbiota axis. Furthermore, psychological interventions are 
42 
 
effective in managing other gastrointestinal conditions such as irritable bowel 
syndrome (IBS) (Ford et al., 2014; Lackner et al., 2018). Given that the link between 
brain and gut in patients with IBD via the gut-brain axis is comparable to patients with 
IBS (Gracie et al., 2018); psychological interventions are also promising in IBD. 
However, to date, there is no online psychological intervention available for patients 
with IBD in the UK, and there is no study assessing this population’s views on online 
psychological interventions for patients with IBD and comorbid anxiety and/or 
depression.  Thus, the focus of this thesis is the population of patients with IBD and 
comorbid anxiety and/or depression. 
1.9.6 Aims 
1.9.6.1 Overall project aim 
This PhD project’s aim was to develop a prototype of an online psychological 
intervention for patients with IBD and comorbid anxiety and/or depression applicable 
to the UK environment. 
 
The Medical Research Council (MRC) framework for complex interventions (Figure 2) 
was used as a guide for the development phase of the current online PI intervention 
(Craig et al., 2013).  
 
The MRC framework recommends identifying an evidence base, developing theory and 
modelling process and outcomes during the development phase prior to the feasibility 






Medical Research Council (MRC) framework corresponds with Pagliari's framework 
(Figure 3). Some of the elements of the concept evaluation and the prototype stage of 
Pagliari's framework were also considered during the development of the current 
online psychological intervention.  
 
Figure 3 An idealised framework for evaluating emergent e-Health resources at 
different stages of development and implementation (Pagliari, 2007). 
Feasibility/piloting 
1 Testing procedures 
2 Estimating recruitment/retention 
3 Determining sample size 
Implementation 
1 Dissemination 
2 Surveillance and monitoring 
3 Long term follow-up 
Evaluation 
1 Assessing effectiveness 
2 Understanding change process 
3 Assessing cost-effectiveness 
Development 
1 Identifying evidence base 
2 Identifying/developing theory 
3 Modelling process and outcomes 
Figure 2 MRC framework of complex interventions (Craig et al., 2013). 
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The specific aims and sections of the thesis presented below reflect the MRC 
framework informing the present work.  
1.9.6.2 Specific aims 
To achieve the overall aim, the project has three specific aims:   
1. To gather theoretical evidence on the effectiveness of the online psychological 
therapy in gastrointestinal diseases.  
2. To investigate patients' with IBD and comorbid anxiety and/or depression and 
their service providers' views about the lived experiences with IBD. 
3. To investigate participants' views about online psychological intervention and 
provide the recommendation for the online psychological intervention for 
patients with IBD and comorbid anxiety and/or depression.   
1.9.7 Thesis sections 
To address the study aims, informed by the MRC framework, the dissertation has the 
following chapters: 
1) Chapter 1 provides an overview of the literature on current IBD aetiology, 
epidemiology and treatment concepts to clarify previous research in the field and 
identify gaps in the literature; 
2) Chapter 2 presents a systematic review and meta-analysis to demonstrate how 
online psychological interventions affect mental and physical outcomes in 
gastrointestinal diseases. Since little data on the effectiveness of online psychological 
interventions for IBD only were available, a broader gastrointestinal context was used.  
3) Chapter 3 supports the theoretical evidence discussed in Chapter 2 by reporting 
on a primary qualitative exploratory study to investigate patients' and health 
professionals' views about the lived experience of patients with IBD and comorbid 
anxiety and/or depression; 
4) Chapter 4 presented the main qualitative data on online psychological 
interventions for IBD. Chapter 4 also presents the modelling prototype of the online 
psychological intervention for patients with IBD and comorbid anxiety and/or 
depression based on evidence gathered throughout the whole PhD project; 
5) Chapter 5 summarises the work accomplished during this project, its outcomes 
and limitations and discusses its implications for future research, practice and policy.  
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2 Chapter 2: Systematic review: Do online psychological interventions 
improve mental and physical outcomes in gastrointestinal disorders, 
including irritable bowel syndrome and inflammatory bowel disease?  
This chapter intends to provide a detailed background to understanding the role of 
psychological therapy in gastrointestinal conditions. There was little data available on 
the online psychological intervention in IBD only. Therefore, taking into account a 
similar mechanism of bidirectional communication between brain and gut through 
brain-gut-biota axis (Gracie et al., 2018), it was decided to investigate the effectiveness 
of the online PI from the general GI diseases context.  
2.1 Introduction 
GI diseases affect any part of the digestive tract, the liver, biliary tract, and the 
pancreas (Martin, 2016). International Statistical Classification of Diseases and Related 
Health Problems (10th revision) classifies the diseases of the digestive system as 
diseases of oral cavity; salivary glands and jaws, diseases of oesophagus; stomach and 
duodenum; hernia; diseases of appendix; noninfective enteritis and colitis; other 
diseases of intestines; diseases of liver; disorders of gallbladder; biliary tract and 
pancreas; diseases of peritoneum; other diseases of the digestive system (World 
Health Organization, 2006). For this systematic review, the terms gastrointestinal 
diseases or gastrointestinal disorders will predominantly be used and will refer only to 
the chronic organic and functional diseases of the gastrointestinal tract, excluding 
neoplasm, acute and infectious diseases.  
 
Diseases of the gastrointestinal tract, liver, and pancreas are a significant social, 
healthcare and financial burden for the society (Peery et al., 2015; Peery et al., 2012; 
Russo et al., 2004; Pinho et al., 2015; Guarner et al., 2008; NIH, 2017). The prevalence 
of depression and anxiety has been found to be high in patients with GI disorders at 
over 30% (Kabra and Nadkarni, 2013; Zhang et al., 2016), but this has been found to 
vary amongst different GI diseases between around 10 - 40% (Xiao-Jing et al., 2012; 
Tribbick et al., 2015; Mikocka-Walus et al., 2007a; Fuller-Thomson and Sulman, 2006; 
Goodwin and Stein, 2002; Mussell et al., 2008; Walker et al., 1992). It has been 
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estimated that during disease relapses the rate of symptoms of anxiety and depression 
can be as high as 80% (Whitehead, Palsson and Jones, 2002; Nahon et al., 2012). 
Despite the high prevalence, psychological symptoms accompanying GI conditions 
often remain undiagnosed (Xiao-Jing et al., 2012; Bennebroek Evertsz et al., 2012). 
Studies show that certain stressful life events can worsen the symptoms of digestive 
system disorders, such as peptic ulcer, functional GI disorders (FGiDs), IBD and gastro-
oesophageal reflux disease (Mayer, 2000; Drossman et al., 1990; Blanchard et al., 
2008; Folks and Kinney, 1992). At the same time, the aggravation of the symptoms of 
the GI disease can be attributed to the worsening of co-morbid psychological disorders 
(Graff, Walker and Bernstein, 2009; Mu, Yang and Zhu, 2016; Mikocka-Walus et al., 
2007a). An internet survey (n = 1,181) showed that the majority of patients with IBD 
were stressed and reported symptoms of depression and over half of the patients 
admitted that their social life was affected by the disease (Viazis, 2013). Another cross-
sectional study (n = 136) showed that relapsing IBD patients with higher levels of stress 
had lower HRQoL than IBD patients without high perceived stress (Tabibian, 2013). The 
study also documented an association between higher levels of stress and lower 
adherence to medication and work productivity. A higher rate of absence from school 
or work, lower HRQoL, and high healthcare costs were also noted in the population 
suffering from functional gastrointestinal disorders (FGiDs) (Drossman et al., 1993).  
 
Evidence suggests that the management of GI disease can be achieved by decreasing 
stress with support from psychological interventions (Tabibian, 2013; Roditi and 
Robinson, 2011), which in turn improves HRQoL and medication adherence.  
 
Psychological interventions (psychotherapy) have been used with good effects in 
chronic diseases (McCombie et al., 2015; Bennett et al., 2015; Kew et al., 2016; Klainin-
Yobas et al., 2016) and they have shown promising results in patients with GI diseases 
(Lackner et al., 2004; Rutten et al., 2013; Knowles, Monshat and Castle, 2013; 
Goodhand, Wahed and Rampton, 2009; McCombie, Mulder and Gearry, 2013; von 
Wietersheim and Kessler, 2006; Zijdenbos, 2009; Ford et al., 2014; Timmer et al., 
2011). The use of psychotherapy is limited for GI conditions, and one of the reasons 
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suggested for this are the limited resources available in these populations (Mikocka-
Walus et al., 2013; Bennebroek Evertsz et al., 2012).  
 
To overcome this barrier and to increase the accessibility of the psychotherapies, 
distant or remote self-management directed at the psychological aspects of the 
disease has been the focus of research over recent years. Self-treatment, self-
management or self-help supported by a clinician or another health professional (i.e. 
guided self-help) have been found useful in treatment of phobias, panic disorder, 
anxiety, obsessive-compulsive disorder and subclinical levels of depression (Newman 
et al., 2011) and have better outcomes and higher completion rates compared to non-
assisted, pure self-help (Ghosh, Marks and Carr, 1988; Klein, Richards and Austin, 
2006).  
 
A systematic review shows that most self-management programmes, including self-
management interventions to reduce anxiety or depression, have beneficial effects on 
HRQoL in patients with IBD (Tu, 2015). Self-management interventions can be 
delivered with the assistance of printed materials, such as manuals, guides, and books. 
In two recent studies, patients with FGiDs and Crohn's disease found cognitive 
behavioural self-help workbooks helpful, which was demonstrated in the improvement 
of HRQoL, visceral sensitivity, GI symptom severity, and the reduction in the use of the 
medical services (Hunt, 2014; Hunt et al., 2015b).   
 
In recent years the communication between patients and clinicians increasingly occur 
via electronic devices, which help to provide distant clinical health care, a 
phenomenon called telemedicine (Marks, Shaw and Parkin, 1998). Some authors use 
the term telemedicine, telehealth, e-health, internet-based, computerised, online 
interchangeably, and others think that e-health is a broad term including all others 
(Kabene, 2010). In the European Union, the term e-health is widely accepted and has 
been defined as "[…] the application of information and communications technologies 
(ICT) across the whole range of functions that affect healthcare, from diagnosis to 
follow-up" (Silber, 2003, p. 7). The term online refers to the use of a computer or other 
electronic devices connected to the Internet, such as a smartphone, iPad or tablet, but 
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internet-based, internet-delivered, e-health, and computerised terms are often used 
as synonyms.   
 
In general, there is a controversy on the effectiveness of online CBT to manage mental 
disorders, with the two recent systematic reviews presenting contradictory findings 
(Hedman, Ljotsson and Lindefors, 2012; Kaltenthaler, 2002). In the first systematic 
review, the quality of the included studies varied from poor to moderate and included 
studies up to 2001 (Kaltenthaler, 2002). In the systematic review by Hedman et al., 
(2012) studies up to 2012 were included, with higher quality studies and a greater 
number of included studies. This systematic review has not formally pooled studies 
into a meta-analysis or done a between-group analysis, a within-group analysis, which 
they provided is not an optimal approach, and the valid conclusion cannot be drawn 
based on this (Bland and Altman, 2011). A subsequent large trial (n=691), which 
compared two types of computerised CBT with usual general practitioner (GP) care, 
showed that online CBT does not significantly improve depression outcomes (Gilbody 
et al., 2015). However, a subsequent trial by the same team found that the addition of 
telephone support can enhance the short-term effectiveness of online CBT in 
depression and other psychological symptoms (Brabyn et al., 2016). 
 
In the last few years, several studies have been conducted on the effectiveness of ICBT 
in physical illness (Sharp, Holly and Broomfield, 2013; McCombie et al., 2015). A 
systematic review demonstrated that online self-help interventions could decrease 
distress and improve the management of chronic diseases (Beatty, 2013). A more 
recent systematic review shows only a moderate effect of online CBT in the treatment 
of psychological distress in patients with physical illness (McCombie et al., 2015). This 
evidence led to the conclusion that more robust and well-performed RCTs are needed 
to conclude on the effectiveness of online psychological interventions in chronic 
diseases. 
 
The use of e-health in gastroenterology is increasing due to the rising demand, limited 
healthcare resources (Knowles and Mikocka-Walus, 2014) and its cost-effectiveness 
(Jackson et al., 2016; Hedman et al., 2012). This mode of intervention delivery is also 
well received by patients (Con et al., 2016; Tonkin-Crine, 2013). A cross-sectional 
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(n=102) survey of IBD patients shows that they prefer to take part in online rather than 
face-to-face (F2F) interventions (McCombie, Gearry and Mulder, 2014), though the 
generalisability of this study is questionable, as it included populations recruited from 
outpatient clinics only. Despite all these advantages, online interventions are 
associated with high attrition rates (Jackson et al., 2016) and thus blended designs 
such as therapist-assisted therapies have been proposed to improve the retention of 
participants (Mikocka-Walus et al., 2016a). 
 
In summary, a systematic review by Knowles and Mikocka-Walus (2014) on e-health 
interventions in gastroenterology shows that online disease management improves 
quality of life (QoL) up to one year of follow up, enhances adherence to medications, 
improves knowledge about the disease and reduces bowel symptoms and healthcare 
costs. This systematic review was the first of its kind, but despite being well-performed 
and discussing the strengths and limitations of the included studies, it did not use a 
formal critical appraisal tool. A more recent systematic review by Jackson et al. (2016) 
confirmed the results of the previous review by Knowles and Mikocka-Walus (2014). 
Both reviews searched a limited number of databases (three by Jackson et al., and 
three by Knowles and Mikocka-Walus), looked at the whole range of e-health 
interventions and included studies that did not consider psychological aspects of the 
disease. Jackson et al. (2016) reviewed e-health use in IBD only. Therefore, given the 
increasing popularity of online psychotherapies and their potential to offer accessible 
and cheap psychotherapy, and the lack of recent systematic reviews on online 
psychological interventions in gastrointestinal diseases (the last conducted by Knowles 
and Mikocka-Walus (2014) with searches conducted in EBSCOhost Medline, CINAHL, 
and PsycINFO), this systematic review was proposed. The current review was adapted 
from the previous reviews in a number of ways: 1) it offered a comprehensive search 
strategy, with a broad definition of the search terms, 2) it used a wider range of 
databases, 3) it applied a formal risk of bias tool for randomised controlled trials, 4) it 
formally pooled studies in a meta-analysis; and 5) it included studies up to February 
2017. 
Aims of this review: 
This review aimed to establish whether online psychological interventions improve 




PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
checklist was used for the reporting of this systematic review and meta-analyses (see 
Appendix 10) (Moher et al., 2009). The protocol of this systematic review was 
registered in PROSPERO (CRD 42016052321).  
2.2.1 Inclusion and exclusion criteria 
2.2.1.1 Types of studies 
2.2.1.1.1 Inclusion criteria: 
Randomised, quasi-randomised and non-randomised controlled trials of psychological 
interventions in children and adults with gastrointestinal diseases  
2.2.1.1.2 Exclusion criteria:  
Conference abstracts  
Observational studies, including all non-controlled experimental designs  
Secondary studies (e.g. reviews, guidelines, commentaries) 
Studies that did not have a comparison group 
Studies for which a full text was not available  
Studies that were not published in English that could not be translated 
2.2.1.2 Types of participants 
2.2.1.2.1 Inclusion criteria 
Studies referring to adult and/or paediatric populations with gastrointestinal diseases 
diagnosed using any well-established criteria (e.g. ROME criteria for FGiDs, Montreal 
classification for Crohn's disease) and where disease course is monitored using well-
established scales or tests (e.g. CDAI, faecal calprotectin, colonoscopy, gastroscopy, 
endoscopy, sigmoidoscopy, enteroscopy, sigmoidoscopy, enteroscopy, abdominal 
ultrasound,  esophagogastroduodenoscopy, surgery, Percutaneous Endoscopic 
Gastrostomy (PEG), CT enterography, barium enema, surgery; blood parameters (C-




Studies examining rates of anxiety, depression, stress and coping in patients with 
gastrointestinal diseases (based on validated screening scales such as the Hospital 
Anxiety and Depression Scale (HADS), the Perceived Stress Scale (PSS) or COPE). 
Studies examining health-related quality of life (based on validated screening scales 
such as the IBDQ or WHO-QOL). 
2.2.1.2.2 Exclusion criteria 
Studies examining tumour, infectious and acute diseases of the gastrointestinal tract. 
2.2.1.3 Types of exposure  
2.2.1.3.1 Inclusion criteria 
Studies investigating all types of online psychological interventions in GI diseases 
patients. 
No restriction on the type of medication used for gastrointestinal symptoms. 
2.2.1.3.2 Exclusion criteria 
Studies focusing on other psychological variables such as personality. 
2.2.1.4 Types of comparator 
Any comparison group (e.g. patients receiving standard care or on the waiting list, or 
receiving alternative therapies).  
2.2.1.5 Types of outcomes 
2.2.1.5.1 Inclusion criteria 
Primary outcomes 
The remission rate (or only mild symptoms) in patients with gastrointestinal diseases. 
For the FGiDs, for instance, IBS, the severity of symptoms. 
Secondary outcomes  
Rates of anxiety and depression and/or mean levels of anxiety and depression 
(symptoms or diagnosis, reported separately) co-existent with gastrointestinal 
diseases; 
Levels of stress;  
Levels of coping; 
Levels of HRQoL;  
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Any related outcomes (e.g. reduced time off work or school, sick leave, hospitalisation 
(frequency and length), pain, adverse events, trial withdrawal and attrition). 
2.2.1.5.2 Exclusion criteria 
Studies that did not report the outcomes of interest 
Studies using mood scales with no independent anxiety or depression scale/dimension 
Studies with non-validated outcome measures  
2.2.2 Data sources 
A systematic and comprehensive literature search of the following databases was 
conducted: 
CINAHL Plus (EBSCO),  
Ovid MEDLINE(R) Epub Ahead of Print 
In-Process & Other Non-Indexed Citations 
Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to Present 
EMBASE (Ovid) 
Health Management Information Consortium (HMIC) (Ovid) 
PsycINFO (Ovid) 
British Nursing Index (BNI) (ProQuest) 
Cochrane Library (Wiley) including a specialised register of the IBD/FBD Group 
MEDLINE (PubMed) 
WHO International Clinical Trial Registry, ClinicalTrials.gov  
Reference lists of all papers included in the review on the 19th of February 2017. 
The search strategy was extensive with no restrictions on publication date or language 
to avoid language bias and to identify all available relevant papers. 
2.2.3 Search strategy 
The search was developed in MEDLINE using population and intervention terms to 
broaden the search. To make it more precise, the terms of the mode of delivery of the 
intervention were used, for instance, online, e-health, and telemedicine. Then, it was 
adapted to the other databases. The full search strategy can be found in Appendix 1-8.  
 
To adapt the search to the other databases, the headings from MEDLINE were 
replaced with alternative terms. If a substitute heading could not be found, they were 
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searched as a term in the title and/or abstract. If the exploded heading in the other 
databases included some of the subheadings, which were searched as a heading in 
MEDLINE, then this term was not used as a separate heading in the other database to 
avoid repetition and vice versa. If the exploded term in Medline had more 
subheadings, then they were searched additionally, for example, "Color therapy/ or 
Crisis intervention/ or Horticultural therapy/ or Psychoanalysis/ or Sleep therapy/" 
headings were added into the Embase search, i.e. they were included in the exp. term 
‘Psychotherapy’ in MEDLINE, but they were not included in the exp. term 
‘psychotherapy’ in Embase.  This was also tested with the assistance of the function 
"OR" and "NOT", to make sure that there were no additional articles missed. Another 
example of how the search was adapted is that in Embase the heading ‘patient-
centred care’ did not exist, but the heading ‘patient care’ was too broad to explore. 
Therefore this term was used only to search in the title and/or abstract. 
 
In some databases, the search was more difficult to adapt. For example, in PubMed 
the attempt to apply a similar approach as to the search in MEDLINE produced a large 
number of unrelated articles as there are no adjacency/proximity operators in 
PubMed; therefore, it was decided to search only the MeSH Major Topic field. The list 
of all the papers (n = 1457) in the IBD/ FGiDs Group Specialized Register (Non Medline 
Records) were examined and double-checked if none of the related articles was 
missing, using the search capabilities of PDF Reader (Ctrl + F), which is limited to the 
search for one key term. Then, the titles of prospective studies were extracted, and 
their abstracts were assessed for inclusion.  
2.2.4 Study selection 
All electronically identified papers were transferred to EndNote referencing software. 
For the ease of management of the data and sharing the data with the second 
reviewer, all the papers were transferred to Excel. This process required some changes 
to the formatting of the citation in EndNote. After the formatting was complete, it 
allowed identification of additional duplicates. The remaining duplicates were 




Additionally, the reference lists of included studies were searched applying the same 
principles and inclusion and exclusion criteria as above.  
2.2.5 Data extraction and management 
The systematic review was based on the recommended PRISMA statement guidelines 
(Moher et al., 2009). The selection process was performed independently by two 
reviewers to reduce the potential risk of bias. Disagreements were resolved by 
consensus or through discussion with a third reviewer. Extracted data included: 
authors, year of publication, country of origin, design, setting, participant 
characteristics (disease type, age, gender and disease activity status), sample size, 
intervention (type and duration), outcome measures, results for the main outcome 
measures and attrition.  
2.2.6 Risk of bias assessment  
The included studies were assessed for internal validity using The Cochrane Risk of Bias 
Tool for randomised controlled trials (Higgins et al., 2011) and ROBINS-I (a tool for 
assessing the risk of bias in non-randomised studies of interventions) (Sterne et al., 
2016) for quasi-experimental and controlled non-randomised trials.    
2.2.7 Data synthesis  
2.2.7.1 Narrative synthesis 
A structured narrative synthesis of the findings from the included studies was carried 
out to summarise, integrate and explain the findings. A systematic approach to 
synthesis was adopted to understand the results, regarding similarities and differences 
between and within the studies and develop a theory of how, why and for whom the 
intervention works (Centre for Reviews and Dissemination, 2008). The robustness of 
the evidence was assessed by considering the risk of bias, suitability of study design to 
the research objective, choice of outcome measure, statistical analysis, quality of 
reporting, and generalisability of findings (Ryan and Cochrane Consumers and 
Communication Review Group, 2013; Centre for Reviews and Dissemination, 2008).  
2.2.7.2 Meta-analysis 
The meta-analysis of the included studies (with the same type of outcome measures, 
similar methodologies, and homogenous samples) was performed using the random-
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effects model using Review Manager (RevMan-5) software. The analysis was 
completed according to the Cochrane Handbook statistical guidelines (Higgins and 
Green, 2011).  
 
As the population in one of the studies differed in age from the rest of the sample (the 
sample of adolescents (Bonnert et al., 2017)), this study was not included in the meta-
analysis, despite providing the same outcome measures as other studies.  
 
If the study used more than one tool to measure the outcome of interest, the 
assessment by clinician rather than self-reported questionnaires were prioritised. Self-
report questionnaires were used where assessment by a clinician was not available. To 
combine continuous data, weighted mean differences (MD) with 95% confidence 
intervals (CI) were used for the same validated rating scales and standardised mean 
differences (SMD) with 95% confidence intervals (CI) for different validated rating 
scales for measuring the outcomes. To combine in the meta-analysis the data often 
needed to be converted. If a study provided a standard error (SE) instead of standard 
deviation (SD), SE was converted into SD, using formula SD = SE x square root (sample 
size), if study provided mean and CI, SD were calculated from CI, using formula SD = 
square root (sample size) x (upper limit - lower limit)/3.92. If there were multiple 
interventions being explored then the results from all arms that received the 
intervention of interest were combined and treated as an intervention group, and all 
participants without online CBT intervention were regarded as a control group. The 
data from the arms receiving intervention were combined:  
  Group 1 
(e.g. males) 
Group 2  
(e.g. females) 
Combined groups 
Sample size N1 N2 N1 + N2 
Mean M1 M2 
 
SD SD1 SD2 
 
 
The calculated total mean and SD for the intervention group and SD for the control 
group presented in Table 1. 
 
The studies were pooled together in the meta-analyses at four points of follow up: 
post-intervention assessment, 3-month follow-up, 6-month follow-up, and 12 and over 
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month follow-up for each outcome measure if the data was available. Studies with an 
adult population were combined separately to that of the adolescent or child 
populations. Data from waitlist design studies were only included until the point at 
which the control group received the intervention as after this point they no longer 
retained a comparator arm meeting the inclusion criteria. 
 
To combine a mixture of change from the baseline and raw outcome scores in the 
same meta-analysis, the mean difference was used as an effect measure. At the same 
time, if these studies used different scales to measure outcome, the meta-analysis was 
not performed, since a standardised mean difference would be the most appropriate 
measure of effect. 
  
Study heterogeneity was assessed with Cochran’s Q (chi-square) and measured with 
the I-squared (I2) statistics (Bland, 2015). The Cochran's Q usually stands for the 
weighted sum of the squared differences between observed effects for the studies and 
the pooled effect estimate, each divided by the variance of the study effect. This 
statistic gives a chi-squared test with degrees of freedom equals a number of studies – 
1. However, Cochran Q test has low power to detect the heterogeneity with a small 
number of studies or, on the other hand, too much power with a large number of 
studies included in the meta-analysis. This test gives a test of significance for 
heterogeneity, but it does not measure it (Higgins et al., 2003). Conversely, an index of 
heterogeneity I2 does not essentially determined by the number of studies included in 
the meta-analysis and represents the percentage of the total variation across studies 
due to variation between studies rather than chance, I² = 100% x (Q-df)/Q (Higgins et 
al., 2002; Higgins et al., 2003). Therefore, both the Cochran’s Q (chi-square) and the I-
squared (I2) were used to measure the heterogeneity. The level of significance for 
heterogeneity was p< 0.10. An I-squared value of 25% was considered as low, 50% as 




2.3.1 Results of the search 
A total 2,627 references were identified, of them: 284 were from CINAHL Plus (EBSCO), 
387 Ovid MEDLINE(R), 1,206 EMBASE (Ovid), 2 HMIC (Ovid), 56 PsycINFO (Ovid), 166 
British Nursing Index (BNI) (ProQuest), 91 (80 trials, 6 Cochrane SR, 1 other Reviews, 1 
Technology Assessments, 2 Economic Evaluations, 1 Methods Study) Cochrane Library 
(Wiley), 435 PubMed, 0 from the register of the IBD and functional bowel disorders 
(FBD) group, WHO International Clinical Trial Registry, ClinicalTrials.gov and from 
reference lists of all included in the review papers. 
 
Overall, 567 duplicates were identified, 400 with the assistance of EndNote and an 
additional 36 after the changes to the styles of the references in the EndNote library 
were made. Further, 131 duplicates were found manually during the process of 
screening titles and abstracts. 
 
 The majority of the retrieved papers were excluded during the stage of screening titles 
and abstracts based on the irrelevance of the material to the research question or 
duplication, retaining only possibly relevant studies. Then, the full texts of these 
papers were accessed and only the articles that met the inclusion criteria retained. 
There were 22 full-text articles assessed for eligibility, and 11 were included in the 








































Citation identified through searching electronic 
databases (n=2,627): 
MEDLINE (n=387)  
Cochrane (n=91)  
PsycINFO (n=56)  
PubMED (n=435)  
EMBASE (n=1,206) 
CINAHL Plus (n=284) 
HMIC (n=2) 
ProQuest (n=166) 
Search of the references of the included articles (n=0) 
IBD/FBD Group Specialized Register 
(Non Medline Records) (n=0) 
ClinicalTrials.gov (n=0) 
WHO International Clinical Trial (n=0)  
Titles /abstracts of citations screened (n=2,627) 
Citation excluded (n=2,605): 
Duplicates (n=567),  
Not relevant topic (n=1,565) 
Conferences and congress 
abstracts, poster presentations, 
letter, interview (n=15)  
Inappropriate intervention (n=33) 
Inappropriate study design (n=107) 
Studies excluded on more than one 
criterion (n=318) 
Full-text articles assessed for eligibility (n=22) 
Trial protocols  (n=2) 
Data overlapping with another 
paper in the review (n=1)  
Inappropriate intervention (n=2)  
Inappropriate study design (n=2) 
Identifying mediators of already 
included study (n=1) 
Assessed predictors of treatment 
outcome in 2 other studies 
already included (n=1) 
Inappropriate comparator (n=2) 
(Appendix 9) 
 
Publications meeting inclusion criteria (n=11)  
(studies (n=9)) 
 
Publications included in the 
meta-analysis (n=10) 
Studies included in the meta-































Figure 4 - PRISMA diagram for selection of studies included in the systematic review. 
59 
 
2.3.2 Excluded Studies 
The electronic search identified 2,627 studies of which 2,605 were excluded (Figure 4). 
Most studies (n=1,565) were not relevant to the topic (the intervention of interest was 
broadly used for patients with cystic fibrosis and cancer). Other reasons for exclusion 
were: duplicates (n=567), conferences and congress abstracts, poster presentations, 
letter, interview (n=15), inappropriate intervention (II) (n=33), inappropriate study 
design (ISD) (n=107), studies excluded on more than one criterion (n=318). Of the 
twenty-two articles that full-text was accessed, eleven were excluded. The table in 
Appendix 9 presents these excluded studies and reasons for exclusion.  
2.3.3 Included Studies 
All nine of the included studies (11 articles) were randomised controlled trials (RCT) 
and conducted between 2009 and 2017 (Andersson et al., 2011; Bonnert et al., 2017; 
Ljotsson et al., 2011a; Ljotsson et al., 2011b; McCombie et al., 2016; Mikocka-Walus et 
al., 2015; Oerlemans et al., 2011; Mikocka-Walus et al., 2016a; Ljotsson et al., 2010; 
Hunt, Moshier and Milonova, 2009). One of the studies was a feasibility trial 
(Oerlemans et al., 2011); one was a pilot trial (Mikocka-Walus et al., 2015); and one an 
exploratory factorial trial (Everitt et al., 2013). The majority of included studies were 
conducted in Sweden (Bonnert et al., 2017; Ljotsson et al., 2011a; Ljotsson et al., 2010; 
Ljotsson et al., 2011b; Andersson et al., 2011), one study in Australia (Mikocka-Walus 
et al., 2015; Mikocka-Walus et al., 2016a) and one study was from each of the 
following countries: Netherlands (Oerlemans et al., 2011), New Zealand (McCombie et 
al., 2016), the USA (Hunt et al., 2009) and the UK (Everitt et al., 2013).  
 
Sample sizes ranged from 54 (Hunt et al., 2009) to 199 (McCombie et al., 2016). The 
total sample size across these studies was 1080; this excludes data from the two 
studies that were associated papers of two already included studies using the same 
patient cohort (Andersson et al., 2011; Mikocka-Walus et al., 2016a). 
  
With regards to the type of GI disease, eight papers (including seven studies) examined 
irritable bowel syndrome (IBS) (Hunt et al., 2009; Andersson et al., 2011; Bonnert et 
al., 2017; Everitt et al., 2013; Ljotsson et al., 2011a; Ljotsson et al., 2010; Ljotsson et al., 
2011b; Oerlemans et al., 2011) and three papers (including two studies) IBD 
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(McCombie et al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a). The 
follow-up time varied in the studies, the majority of studies had a just post-
intervention assessment with the longest follow up being 24 months (Mikocka-Walus 
et al., 2016a). The characteristics of the extracted studies are presented in Table 1. 
Because many studies provided several outcomes and some of them were collected at 
a few different points of follow up, the results of the outcome measures were 
presented in separate tables (see Table 4 -Table 9).  
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Table 1 Characteristics of studies 
Study ID Country of origin 
and Setting 
Design Participants 
(diagnosis, age, gender 
and disease activity 
status) 
Sample size Interventions 
(type and 
duration) 






et al., 2011) 
 
(Ljotsson et 
al., 2010)  
Sweden, 
self-referred IBS 
patients from the 
general adult 
population  
RCT IBS, Rome III criteria;  
male/female 13/72, 
Age mean years (SD): 
total = 34.6 (9.4), Years 
since diagnosis mean 











TIC-P; The GI 
symptom diary; 
GSRS-IBS; Total 






IG 9.5% (n=4) 
CG (n=0) 





wait-list with a 
discussion 
forum, after 10 
weeks 










tertiary care clinics 
RCT IBS, Rome III criteria; 
subtype: constipation 
30%, diarrhoea 15%, 
mixed 55%. 
Age mean years (SD): 
total =15.54 (1.56); 











absence; VSI; PSS; 





















crossed over to 
the online CBT 
(Everitt et 




The UK, recruited 
via GP practices in 
Southampton 
RCT IBS, Rome III criteria; 
moderate severity of IBS  
Age years (16 - 60)  
Age mean years (SD): 
total = 44.39 (10.33), 
females = 78%. The 
mean length of 
Total 
(n=135) 








(Regul8) or online 
CBT + telephone 
support. 
IBS SSS score;  
IBS-QOL; HADS; 
PEQ; SGA of Relief. 
post-
intervention  
IG 25% (n=7)  
CG 31% (n=8) 
12 weeks 9% 









Study ID Country of origin 
and Setting 
Design Participants 
(diagnosis, age, gender 
and disease activity 
status) 
Sample size Interventions 
(type and 
duration) 

















The USA recruited 
via various IBS 
relevant websites 
RCT IBS, self-selected cohort, 
(44 female, 10 male).  
Age mean years(SD): 
total = 38.52 (10.91) 
  
Total (n=54) 
IG (n=28)  
CG (n=26) 
5 weeks online 
CBT 








CG 31% (n=8)  
3 months: 




6 weeks IG 
and CG; 
3 months 






crossed over to 
online CBT. 
(Ljotsson et 




clinic, referral or 
self-referral 
RCT IBS, Rome III criteria,  
74% females. Age mean 
years (SD): total = 34.9 
(11.3); subtype 21% 
constipation, 30% 
diarrhoea, 49% mixed). 
Total (n=61) 
IG (n =30) 
CG (n = 31) 




IG 23% (n=7) 
CG 12.9% 
(n=4) 





crossed over to 
online CBT. 
(Ljotsson et 
al., 2011b)  
Sweden, internet-
recruited  




10 weeks online 









Study ID Country of origin 
and Setting 
Design Participants 
(diagnosis, age, gender 
and disease activity 
status) 
Sample size Interventions 
(type and 
duration) 







with a psychologist 
skilled with IBS and 
reviewed by a 
gastroenterologist. Age 
mean years (SD): total = 
38.9 (11.1), years with 
IBS (SD) 14.9 (11.2). 79% 
female. 
IG (n=98)  
CG (n=97) 
closed discussion 




VSI; PSS; HADS 
anxiety and 
depression; 
IG 1%; CG 3%  
6-months  






















to this RCT  
RCT IBD clinically established. 
Age mean years (SD): 
total = 38.86 (12.36) 
IBD CG group Crohn's 
disease 62 (72.1), 







8 weeks online 
CBT 
IBDQ; HRQOL (SF); 
HADS anxiety and 
depression; SCCAI 
(UC and IBD-U); 
HBI (CD); Brief 
COPE; PSS-10; 
SFQ; EPQ. 
12 weeks,  
IG 42.5%  
CG 9.3%.  
6 months  
IG 53.1%  
CG 17.2%  










RCT IBD clinically established. 
Age mean years (SD): 
total = 49.11 (16.47); 
male= 54%, Years since 






10 weeks CBT 
+CBT arm had 
two subgroups: 
F2F CBT and 
online CBT  
HRQOL (SF) IBDQ  
HADS anxiety and 
depression; Brief 
COPE; RSRRS; 
STAI; CDAI; SCCAI 
















Study ID Country of origin 
and Setting 
Design Participants 
(diagnosis, age, gender 
and disease activity 
status) 
Sample size Interventions 
(type and 
duration) 





al., 2016a)  
 
 IG = 11.8 (10.4) 
CG = 11.7 (11.8)  
 Years with IBD 
symptoms mean (SD): 
IG 16.1 (12.1);  
CG=14.3 (11.7) 













GPs and through 
advertisements by 
the Dutch IBS 
patient 
association.  
RCT  IBS, Rome III criteria  
Age mean years (SD): 
total = 38.31(13.89) 
Female 85 % 
 
Total (n=76) 
IG (n=37)   
CG (n=39)  







IG 2.7% (n=1)  
CG 5.1% (n=2) 
3 months  
IG 29%  
CG 7.7%  





Note: 1- (IG) intervention group, 2 - (CG) control group; CBT - cognitive behaviour therapy; F2F - face to face; GSRS-IBS - Gastrointestinal Symptom Rating Scale; (IBS SSS score) - 
Irritable Bowel Symptom Severity Scale; SCCAI (UC and IBD-U) - Simple Clinical Colitis Activity Index (ulcerative colitis); CDAI - Crohn’s Disease Activity Index; (HBI) (CD) - Harvey-
Bradshaw Index; HADS - Hospital Anxiety and Depression Scale; VSI - Visceral sensitivity index; (MADRS-S) - The Montgomery Åsberg Depression Rating Scale-- Self report;  STAI - 
the State-Trait Anxiety Inventory; SCAS - Spence Childhood Anxiety Scale; ASI  = Anxiety Sensitivity Index; PSS-10 - perceived stress questionnaire; RSRRS - Revised Social 
Readjustment Rating Scale;  IBS–QOL - IBS Quality of Life Impairment; PedsQL - Paediatric Quality of Life Inventory; IBDQ - Inflammatory Bowel Disease Questionnaire; HRQOL (SF) 
- health-related quality of life short form; TIC-P - Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry; CSI-24 - Children’s Somatisation 
Inventory- parents version; CSQ - Client Satisfaction Questionnaire; PEQ - Patient Enablement Questionnaire; IBS - BRQ - behavioural responses questionnaire; SGA of Relief - Subjects 
Global Assessment of Relief; CPSQ - The Consequences of Physical Sensations Questionnaire; SFQ - Social Functioning Questionnaire, EPQ - Eysenck Personality Questionnaire 
(Brief Version) for measuring neuroticism; PCS - Pain Catastrophising Scale; CSFBD - The Cognitive Scale for Functional Bowel Disorders.   
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2.3.3.1  Interventions  
The psychological intervention explored in all included studies was online CBT; hence, 
the planned analysis of the effect of each individual psychological intervention on the 
physical and mental outcomes was not feasible. The duration of the intervention 
varied, the majority of participants received a ten-week internet-delivered CBT course 
(Andersson et al., 2011; Ljotsson et al., 2010; Ljotsson et al., 2011b; Mikocka-Walus et 
al., 2015; Bonnert et al., 2017; Ljotsson et al., 2011a), though some received eight-
week (McCombie et al., 2016), six-week (Everitt et al., 2013), five-week (Hunt et al., 
2009) and four-week (Oerlemans et al., 2011) online therapy. Along with CBT the 
participants in the intervention groups received limited therapist support via e-mail or 
text messages (Andersson et al., 2011; Ljotsson et al., 2010; Hunt et al., 2009; Ljotsson 
et al., 2011a; Bonnert et al., 2017; Oerlemans et al., 2011; Ljotsson et al., 2011b; 
Everitt et al., 2013), and the participants in two other studies could contact a 
psychologist if they needed (McCombie et al., 2016; Mikocka-Walus et al., 2015; 
Mikocka-Walus et al., 2016a). Additionally, during the online CBT treatment, 
participants of some studies had access to a group online treatment discussion forum 
(Ljotsson et al., 2011a; Ljotsson et al., 2010). For one study (Mikocka-Walus et al., 
2015) the patients in the intervention arm could choose the mode of delivery of CBT, 
face-to-face (n=22) or online (n=68). For this systematic review, since 75% of patients 
selected online delivery, we did not disaggregate the results by mode of delivery and 
included all those allocated to receive CBT as the intervention group. 
 
The participants in the control group in most studies were on a wait-list (Bonnert et al., 
2017; Andersson et al., 2011; Ljotsson et al., 2010; Ljotsson et al., 2011a; Hunt et al., 
2009). The participants in the other studies received usual standard care (Mikocka-
Walus et al., 2015; McCombie et al., 2016; Oerlemans et al., 2011; Mikocka-Walus et 
al., 2016a). In the study by Everitt et al., (2013) participants were randomised to the 
following 9 groups: groups: 1) website only CBT + Mebeverine, 2) website only CBT + 
Methylcellulose, 3) website only CBT + placebo, 4) website CBT + support + 
Mebeverine, 5) website CBT + support + Methylcellulose, 6) website CBT + support + 
placebo, 7) no website + Mebeverine, 8) no website + Methylcellulose, 9) no website + 
placebo. Therefore, for this systematic review, the control group of this study was all 
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those participants who did not receive online CBT. In the study by Ljotsson et al., 
(2011b), the participants in the control group received internet-delivered stress 
management (ISM) intervention. 
2.3.3.2  Included studies outcomes measures  
The summaries of the outcome measures reported in the included studies are 
presented in Table 2.  
Table 2 The outcome measures of the included studies 
Outcomes (Andersso
















n et al., 
2011a) 
(Ljotsso














 GSRS-IBS x x  x x x    
IBS SSS score    x       
SCCAI (UC and 
IBD-U) 
      x x  
CDAI        X  
HBI (CD)       X   
The GI symptom 
diary 




  x   x x x  
MADRS-S x         
STAI        x  
SCAS   x        
PSS-10  x    x x   
RSRRS        x  
the Brief COPE       x x  
IBS-QOL x  x x x x   x 
PedsQL   x        
IBDQ       x   
HRQOL (SF)        x x  
TIC-P, Cost 
assessment  
x    x     
School absence  x        
VSI   x x   x x    
ASI    x      
Pain frequency  x        
Abdominal pain         x 
Total pain x         
Faces Pain Scale-
Revised 
 x        
Sheehan Disability 
Scales 
x    x     
CSI-24  x        
CSQ  x        
IBS - BRQ  x        
PEQ   x       
SGA of Relief   x       
CPSQ    x      
SFQ       x   
PCS         x 
CSFBD         x 
EPQ       x   
Note: GSRS-IBS - Gastrointestinal Symptom Rating Scale; (IBS SSS score) - Irritable Bowel Symptom Severity Scale ; SCCAI (UC and 
IBD-U) - Simple Clinical Colitis Activity Index (ulcerative colitis); CDAI - Crohn’s Disease Activity Index; (HBI) (CD) - Harvey-Bradshaw 
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Index; HADS - Hospital Anxiety and Depression Scale; VSI - Visceral sensitivity index; (MADRS-S) - The Montgomery Åsberg 
Depression Rating Scale-- Self report;  STAI - the State-Trait Anxiety Inventory; SCAS - Spence Childhood Anxiety Scale; ASI 
 = Anxiety Sensitivity Index; PSS-10 - perceived stress questionnaire; RSRRS - Revised Social Readjustment Rating Scale;  IBS–QOL -
 IBS Quality of Life Impairment; PedsQL - Paediatric Quality of Life Inventory; IBDQ - Inflammatory Bowel Disease Questionnaire; 
HRQOL (SF) - health-related quality of life short form; TIC-P - Trimbos and Institute of Medical Technology Assessment Cost 
Questionnaire for Psychiatry; CSI-24 - Children’s Somatisation Inventory- parents version; CSQ - Client Satisfaction Questionnaire; PEQ - 
Patient Enablement Questionnaire; IBS - BRQ - behavioural responses questionnaire; SGA of Relief - Subjects Global Assessment of 
Relief; CPSQ - The Consequences of Physical Sensations Questionnaire; SFQ - Social Functioning Questionnaire; PCS - Pain 
Catastrophizing Scale; CSFBD - The Cognitive Scale for Functional Bowel Disorders; EPQ - Eysenck Personality Questionnaire-Brief 
Version for measuring neuroticism. 
 
2.3.3.2.1 Studies reporting the IBD disease activity and the IBS severity of symptoms 
Only one study reported a remission rate for IBD (Mikocka-Walus et al., 2015). All 
studies, except for one (Oerlemans et al., 2011), reported disease activity or severity of 
symptoms and used six different scales: Gastrointestinal Symptom Rating Scale-IBS 
(GSRS-IBS) (Andersson et al., 2011; Bonnert et al., 2017; Hunt et al., 2009; Ljotsson et 
al., 2011a; Ljotsson et al., 2010; Ljotsson et al., 2011b), Irritable Bowel Symptom 
Severity Scale (IBS SSS score) (Everitt et al., 2013), the GI symptom diary (Ljotsson et 
al., 2010), Simple Clinical Colitis Activity Index (SCCAI) (UC and IBD-U) (McCombie et 
al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a), Crohn’s Disease 
Activity Index (CDAI) (Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a) and 
Harvey-Bradshaw Index (HBI) (CD) (McCombie et al., 2016). Therefore, in this 
systematic review, we analysed the mean score for IBD disease activity, but not the 
IBD remission rates as was anticipated initially. 
2.3.3.2.2 Studies reporting anxiety and depression  
Seven papers reported on the level of anxiety and/or depression and used various 
outcome measures (Bonnert et al., 2017; Ljotsson et al., 2010; Ljotsson et al., 2011b; 
Everitt et al., 2013; McCombie et al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus 
et al., 2016a). Two of these articles (the same cohort) used two different scales to 
assess the level of anxiety: the State-Trait Anxiety Inventory (STAI) and the Hospital 
Anxiety and Depression Scale (HADS) (Mikocka-Walus et al., 2015; Mikocka-Walus et 
al., 2016a). Five papers used the HADS score for depression and anxiety (Everitt et al., 
2013; Ljotsson et al., 2011b; McCombie et al., 2016; Mikocka-Walus et al., 2015; 
Mikocka-Walus et al., 2016a). One study used the Montgomery–Asberg Depression 
Rating Scale (MADRS)-S (Ljotsson et al., 2010). One additional scale was used to assess 




2.3.3.2.3 Studies reporting on stress 
Four studies reported the level of stress (Bonnert et al., 2017; Ljotsson et al., 2011b; 
McCombie et al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a). 
Three of these studies assessed the level of stress using the Perceived Stress Scale 
(PSS) (Bonnert et al., 2017; Ljotsson et al., 2011b; McCombie et al., 2016) and one the 
Social Readjustment Rating Scale (RSRRS) (Mikocka-Walus et al., 2015; Mikocka-Walus 
et al., 2016a).  
2.3.3.2.4 Studies reporting the levels of coping 
Two studies explored levels of coping, and both used the Brief Coping Operations 
Preference Enquiry scale (Mikocka-Walus et al., 2015; McCombie et al., 2016; Mikocka-
Walus et al., 2016a).  
2.3.3.2.5 Studies reporting the levels of HRQoL 
Eleven of the included articles reported on HRQoL. Only one paper did not report on 
HRQoL (Andersson et al., 2011), but this outcome was reported in a separate article 
included in the current review (Ljotsson et al., 2010). The majority of studies used the 
IBS Quality of Life Questionnaire (IBS-QOL) (Everitt et al., 2013; Hunt et al., 2009; 
Ljotsson et al., 2011a; Ljotsson et al., 2010; Ljotsson et al., 2011b; Oerlemans et al., 
2011). Other studies used PedsQL (Pediatric Quality of Life Inventory) (Bonnert et al., 
2017), IBD-specific HRQOL (IBDQ), and Generic HRQOL (SF-12 and SF-36) (McCombie et 
al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a).  
2.3.3.2.6 Studies reporting related outcomes 
Nine articles reported related outcomes, with three examining pain (Bonnert et al., 
2017; Oerlemans et al., 2011; Ljotsson et al., 2010). Two studies looked into the cost-
effectiveness (Andersson et al., 2011; Ljotsson et al., 2011a) of online therapy and both 
used the same scale, The Trimbos and Institute of Medical Technology Assessment 
Cost Questionnaire for Psychiatry (TIC-P). Two studies assessed disability using the 
Sheehan disability scale (Ljotsson et al., 2011a; Ljotsson et al., 2010).  
 
Three studies by the same author used the VSI (Visceral sensitivity index), a measure of 
gastrointestinal symptom-specific anxiety (Ljotsson et al., 2011a; Ljotsson et al., 2011b; 
Ljotsson et al., 2010). One study used the Anxiety Sensitivity Index (ASI) for measuring 
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fear of anxiety-related symptoms (Hunt et al., 2009).  One study used three additional 
scales: Children’s Somatisation Inventory - parent's version (CSI-24) to assess other 
somatic symptoms, Client Satisfaction Questionnaire (CSQ) to assess satisfaction with 
treatment and Behavioural Responses Questionnaire IBS - BRQ to measure IBS-specific 
pattern of avoidance behaviour (Bonnert et al., 2017). Bonnert et al., (2017) also 
reported school absence and medication use. Another study measured participants’ 
enablement as an indicator of GP consultation quality using the Patient Enablement 
Questionnaire (PEQ) and their rate of relief from IBS symptoms using the Subjects 
Global Assessment of Relief (SGA of Relief) (Everitt et al., 2013). One study measured 
the tendency to catastrophise the social and functional implications of different 
physical sensations and symptoms using the Consequences of Physical Sensations 
Questionnaire (CPSQ) (Hunt et al., 2009). Two further related outcomes were 
measured in another study, social functioning using the Social Functioning 
Questionnaire (SFQ) and neuroticism using the brief version of the Eysenck Personality 
Questionnaire (McCombie et al., 2016). Finally, another study used the Pain 
Catastrophizing Scale (PCS) scale to measure the degree of pain catastrophising 
thoughts and the Cognitive Scale for Functional Bowel Disorders (CSFBD) to measure 
GI symptom-related dysfunctional cognitions (Oerlemans et al., 2011). 
2.3.3.3 Characteristics of included participants 
The majority of the included studies were in adults. Only one study (n=101) examined 
an adolescent (age 13–17 years) population (Bonnert et al., 2017) (hence were not 
included in the meta-analyses), and another study included participants from the age 
of 16 years and upwards (Everitt et al., 2013). In the studies with adult populations, the 
mean age varied from 34.6 (9.4) to 49.11 (16.47). In the majority of studies, there were 
more females than males, except for the study by Mikocka-Walus et al., (2015), where 
the male population was slightly bigger at 54%. Also, this study had the highest 
average age of participants (mean age of 46.5 (SD=15.7) years in the intervention 
group and 51.9 (SD=16.9) years in the control group). The lowest mean age (in the 
studies with adult populations) was in the two articles representing one cohort (in the 
intervention group 36.4 (SD=10.1) years and 32.8 (SD=8.6) years in the control group) 
and the participants in this study had the shortest mean duration of symptoms of 6.3 
years (Andersson et al., 2011; Ljotsson et al., 2010). The population in three other 
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studies had the longest average duration of symptoms over 14 years (Mikocka-Walus 
et al., 2015; Ljotsson et al., 2011b; Mikocka-Walus et al., 2016a). In the study with the 
adolescent population, the parent-reported mean duration of symptoms was 5.12 
(SD=4.11) years (Bonnert et al., 2014). Three studies did not report on the length of 
symptoms or years since diagnosis (Hunt et al., 2009; McCombie et al., 2016; 
Oerlemans et al., 2011).     
2.3.3.4  The severity of anxiety and/or depression 
Of the six studies reporting severity of anxiety and depression as an outcome measure, 
patients in two studies (n=373) had low anxiety, and depression scores means at 
baseline (Mikocka-Walus et al., 2015; McCombie et al., 2016; Mikocka-Walus et al., 
2016a), in three studies patients (n=330 adults; n=101 adolescents) had mild anxiety 
scores (Everitt et al., 2013; Ljotsson et al., 2011b; Bonnert et al., 2017) and in one 
study patients (n=85) had mild scores for depression MADRS-S Mean (SD) = 12.19 (7.8) 
(Ljotsson et al., 2010).  
 
Four studies by design excluded participants with severe depressive symptoms 
(Ljotsson et al., 2010; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a; 
McCombie et al., 2016; Ljotsson et al., 2011b), one with severe psychosocial or 
psychiatric distress (Bonnert et al., 2017) and two due to psychological disorders but 
did not specify which disorders (Oerlemans et al., 2011; Ljotsson et al., 2011a). The 
final study did not provide the patients' baseline level of anxiety or depression or 






2.3.4 Risk of bias assessment  
Different sources of bias in the included studies are presented in Table 3 and Figure 5. 
 
 
Figure 5 Risk of bias graph: methodological items presented as a percentage across all 
included studies.  
 
Table 3 Risk of bias assessment. Methodological quality: review author's judgment 
about each methodological quality item for each included study. 
 















































+ + - -9 + + + 
0% 20% 40% 60% 80% 100% 
Random sequence generation (selection bias) 
Allocation concealment (selection bias) 
Blinding of participants and personnel 
(performance bias) 
Blinding of outcome assessment (detection bias) 
Incomplete outcome data (attrition bias) 
Selective reporting (reporting bias) 
Validated measure of outcome used 
Low risk of bias Unclear risk of bias High risk of bias 
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Support for judgment:  
1 "participants were randomly assigned to a condition based on order of enrolment" Comment: 
probably done. 
2 "Allocation concealment was not  used, but participants were present when they were randomized; 
therefore, they could see how they were allocated." 
3 "The participants were informed that they would be randomized to one of two different psychological 
treatments, but they were not aware of the differences between the treatments". Comment: partial 
concealment for patients. "... therapists in the study were not blinded and were likely to be biased 
toward the ICBT  protocol". Comment. Not blinding of personnel. 
4  "patients (in the control group) were told that we were examining how psychological health 
influenced IBD behaviour and was unaware of the +CBT arm of the study". Comment: Partial 
concealment, for the control group.  
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5 "Since all outcomes that were waiting list controlled were self-assessed, there was no concealment of 
allocation". Comment: Done. The author describes the procedure of allocation. Probably, the author 
confused blinding of allocated interventions with concealment of allocation.  
6 "To ensure double-blinding, all participants took three over-encapsulated identical tablets ". 
Comment: partial blinding for tablets intake and single-blinding for the website (participants were not 
able to be blind to website access). 
7 Outcome data was "patient self-completed away from the study team, thus avoiding any influence of 
the study team on the responses". Comment: Patients were not blind.  
8 Independently "Two of the authors, who remained blind to symptom severity and treatment 
condition, served as raters". Comment: Partial for the personal, but patients' self-reported outcomes.  
9 "self-report measurements", "all outcomes that were waiting list controlled were self-assessed" 
Comment: not done. 
10 "All measures were administered online" Comment: does not mention how. 
11 Restricted maximum likelihood mixed models used that included all randomised participants and 
took any missing data into account. 
12 Outcomes reported for completers only   
13 There was a slight discrepancy in the number of participants in the CONSORT diagram and the text, 
and the number of participants per arm for some of the outcomes was unclear 
a - Blinding the experimental group is often impossible in psychotherapy trials. In addition, the waiting 
list controls in the majority of studies were transferred to active intervention after post-intervention 
assessment. 
b - Missing data have been imputed. 
2.3.4.1  Selection bias   
The majority of studies met the Cochrane Risk of Bias Tool for randomised controlled 
trials criteria for low risk of selection bias (Table 3). All of them used a random method 
of sequence generation describing the procedure and methods of allocation 
concealment. One study was at a higher risk of bias, namely, it indicated that allocation 
concealment was not used (McCombie et al., 2016). In one study the author described 
the procedure of allocation but saying that it was not done (Ljotsson et al., 2011a). It 
appears that the author confused blinding of allocated interventions with concealment 
of allocation (Higgins and Green, 2011).  
2.3.4.2  Blinding 
All studies were considered to have a high risk of performance and detection bias. It 
has to be taken into account that blinding the experimental group is often difficult in 
psychotherapy trials. The patients and the personnel are subject to bias due to the 
knowledge of the intervention status, but this does not imply low quality (Higgins and 
Green, 2011). Some authors attempted to partially blind the participants (Mikocka-
Walus et al., 2015; Ljotsson et al., 2011b) or the researchers who rated the scales to 
the symptom severity (Hunt et al., 2009) (Table 3). In fact, in trials where the outcome 
measure involves subjectivity, blinding the assessor of the outcome can be more 
essential than blinding the implementation of the intervention (Day and Altman, 
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2000). Those clinicians and participants who are not blinded are more likely to have 
predetermined attitudes during the assessments of the effectiveness of the 
intervention compared to those who are blinded (Karanicolas, Farrokhyar and 
Bhandari, 2010; Hróbjartsson et al., 2012; Hrobjartsson et al., 2014). The level of 
discrepancies between the self-reports scales and clinician ratings varies greatly 
(Dunlop et al., 2010; Domken, Scott and Kelly, 1994; Enns, Larsen and Cox, 2000; 
Corruble et al., 1999). Generally, clinician-rated scales have greater validity and are 
preferred over the self-reports (Rush et al., 2005; Schatzberg and Nemeroff, 2009; 
Prusoff, Klerman and Paykel, 1972). However, to comprehensively assess certain 
outcomes, for instance, the severity of depression, both clinician-rated and self-report 
measures should be incorporated (Cuijpers et al., 2010; Uher et al., 2012).  
2.3.4.3  Incomplete outcome data  
The attrition rates varied amongst the studies and the points of follow-up. The study 
with the largest sample size (n=199) had the highest dropout rate of 53.1% in the 
intervention group at six months, but only 17.2% in control (McCombie et al., 2016). 
The smallest study (n=54) had the highest dropout rate of 92% from the enrol numbers 
in the control group at three months, but only 64% in the intervention (Hunt et al., 
2009). Despite the high attrition rates in some studies, missing data in all studies, 
except for one (Oerlemans, 2011), have been managed using intent-to-treat analysis 
where missing data were imputed using the last observation carried forward method 
(Everitt et al., 2013; Ljotsson et al., 2010; Hunt et al., 2009), full information maximum 
likelihood estimation under the assumption of data missing at random in a linear 
mixed-effects model (Ljotsson et al., 2011a; Ljotsson et al., 2011b), multivariate 
analyses using linear mixed-effects models (Mikocka-Walus et al., 2015; Mikocka-
Walus et al., 2016a; McCombie et al., 2016), and restricted maximum likelihood mixed 
models (Bonnert et al., 2017). Only one study did not use the intention-to-treat 
analysis, and it is unclear how missing data was dealt with (Oerlemans, 2011).  
2.3.4.4  Selective reporting 
2.3.4.4.1 Publication/small study bias 
Publication bias was not explored for each type of outcome due to the low number of 
studies included in each meta-analysis. 
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2.3.4.4.2 Outcome reporting bias 
Outcome reporting bias was defined as the discrepancy between the listed outcomes 
in the methods section and the reported outcomes in the results. Also, where the 
protocols of the studies were available, the intended outcomes in the methods of the 
protocol were compared with the reported outcomes of the actual trials to assess 
reporting bias. All studies met the Cochrane Risk of Bias Tool for randomised 
controlled trials criteria for low risk of outcome reporting bias (Table 3). 
2.3.4.4.3 Other types of reporting bias 
One study had an unclear risk of reporting bias (Everitt et al., 2013). There was a slight 
discrepancy in the number of participants in the CONSORT diagram and the text, and 
the number of participants per arm for some of the outcomes was unclear. We 
contacted the author, who however, no longer had access to the trial data. Two 
studies by Hunt et al., (2009) and McCombie et al., (2016) reported the results for the 
completers of the intervention programme only, hence the reporting bias is unclear. 
We could not obtain the score for the whole intervention group from the authors. 
2.3.5 Data synthesis and meta-analysis 
2.3.5.1  Data synthesis and meta-analysis of the IBD disease activity and IBS 
severity of symptoms 
The IBS severity of symptoms were reported in six studies (Table 4), involving a total of 
631 people (Andersson et al., 2011; Ljotsson et al., 2010; Ljotsson et al., 2011a; 
Ljotsson et al., 2011b; Bonnert et al., 2017; Hunt et al., 2009; Everitt et al., 2013) and 
two studies reported the disease activity for IBD (n=373) (McCombie et al., 2016; 
Mikocka-Walus et al., 2016a; Mikocka-Walus et al., 2015). Two papers reported on the 
same cohort but used different units to report the outcome hence were not included 
in the total number and data only from one of them were combined in the meta-
analysis (Andersson et al., 2011; Ljotsson et al., 2010). One study assessed an 
adolescent population (n=101) (Bonnert et al., 2017). All these studies have reported 
the outcome of the post-intervention assessment. After that, patients were not 
followed-up or were crossed-over into the treatment. Only one study had three 
months follow-up (Everitt et al., 2013) and one six months (Ljotsson et al., 2011b). The 
results from all, except one (Everitt et al., 2013), of the studies reporting the level of 
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severity of IBS symptoms demonstrated that online CBT improved gastrointestinal 
symptoms in the adolescent and adult populations with IBS at the point of post-
intervention assessment. There was no difference in the IBD disease activity reported 
in one study (Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a) and an 
improvement in the IBD disease activity in the online CBT group only for the 
completers of the online programme, compared to the control group in the other 
study (McCombie et al., 2016). The meta-analysis was performed for IBS severity and 
IBD remission rate separately (Figure 6, Figure 7, Figure 8). 
 
Table 4 Results of studies reporting the IBD disease activity and the severity of 
symptoms for IBS. 
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83.2 (92.2)  
88.4 (105.9)   
53.1 (70.6) 
Note: GSRS-IBS - Gastrointestinal Symptom Rating Scale; (IBS SSS score) - Irritable Bowel Symptom Severity Scale; SCCAI (UC and 
IBD-U) - Simple Clinical Colitis Activity Index (ulcerative colitis); CDAI - Crohn’s Disease Activity Index; (HBI) (CD) - Harvey-Bradshaw 
Index.  * - after assessment, they were offered the active treatment phase; a- outcome measures with estimated means, SE 
(analysed intention to treat); a - the number of completers, such as data provided for completers only. 
2.3.5.1.1 A meta-analysis of data on the severity of symptoms for IBS 
The random-effects model (Figure 6) was used to perform the meta-analysis at post-
intervention assessment due to the studies substantial statistical (Tau² = 0.44; Chi² = 
37.59, df = 4 (P < 0.00001); I² = 89%) and clinical heterogeneity. Patients varied in age, 
disease duration, treatment alongside intervention or control conditions.  
 
 
Figure 6 Meta-analysis of studies reporting IBS symptoms severity at post-intervention 
assessment 1. 
 
The standardised mean difference varied from 0.48 (0.10, 0.85) to -1.25 (-2.04, -0.47) 
in the studies. Four out of five studies show statistical significance in favour of the 
intervention (Hunt et al., 2009; Ljotsson et al., 2010; Ljotsson et al., 2011a; Ljotsson et 
al., 2011b). Only one study showed a significant statistical evidence in favour of the 
control condition (Everitt et al., 2013) although this difference disappeared by three 
months of follow-up (Table 4). 
Study or Subgroup 
(Everitt et al., 2013) 
(Hunt et al., 2009) 
(Ljotsson et al., 2010) 
(Ljotsson et al., 2011a) 
(Ljotsson et al., 2011b) 
Total (95% CI) 
Heterogeneity: Tau² = 0.44; Chi² = 37.57, df = 4 (P < 0.00001); I² = 89% 














































IV, Random, 95% CI 
0.48 [0.10, 0.85] 
-1.25 [-2.04, -0.47] 
-1.19 [-1.67, -0.72] 
-0.77 [-1.34, -0.19] 
-0.38 [-0.67, -0.09] 
-0.59 [-1.21, 0.04] 
Intervention Control Std. Mean Difference Std. Mean Difference 
IV, Random, 95% CI 
-2 -1 0 1 2 




The pooled standardised mean difference shows a positive effect of online CBT 
compared to control, but this difference was not statistically significant (-0.59 (-1.21, 
0.04), p=0.07).  
 
Despite the fact that the study by Everitt et al., (2013) (n=135) carried the second 
biggest weight in the meta-analysis, there was a slight discrepancy between the 
number of patients in the CONSORT diagram and the text of this study. A study by 
Hunt et al. (2009) also reported only data for completers only, thus also introduces 
bias in the analysis. Therefore, the meta-analysis was repeated this time excluding the 
two studies (Figure 7). 
  
 
Figure 7 Meta-analysis on the level of IBS symptom severity at post-intervention 
assessment 2. 
 
All three studies favour the intervention concerning the post-intervention effect on 
symptom severity (Ljotsson et al., 2010; Ljotsson et al., 2011a; Ljotsson et al., 2011b). 
The pooled mean difference was -9.63 (-16.18, -3.08) in favour of the intervention and 
this difference was statistically significant (p=0.004).  
2.3.5.1.2 A meta-analysis of data on the IBD disease activity  
A meta-analysis of data on the disease activity in UC 
There were a total of 373 people in the studies which reported IBD disease activity 
(Mikocka-Walus, 2015; Mikocka-Walus et al., 2016a; McCombie et al., 2016). One 
study reported this outcome at three and six months (McCombie et al., 2016) and 
another study at six, twelve and 24 months (Mikocka-Walus et al., 2015; Mikocka-
Walus et al., 2016a).  The meta-analysis was conducted using the 6 months follow-up 
data.  
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(Ljotsson et al., 2010) 
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(Ljotsson et al., 2011b) 
Total (95% CI) 
Heterogeneity: Tau² = 26.17; Chi² = 9.59, df = 2 (P = 0.008); I² = 79% 
































IV, Random, 95% CI 
-14.90 [-20.28, -9.52] 
-9.90 [-16.78, -3.02] 
-4.80 [-8.41, -1.19] 
-9.63 [-16.18, -3.08] 
Intervention Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-20 -10 0 10 20 
Favours [intervention] Favours [control] 
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The random-effects model was used to perform the meta-analysis (Figure 8) at post-
intervention assessment due to the studies substantial statistical (Tau² = 0.50; Chi² = 
3.48, df = 1 (P = 0.06); I² = 71%) and clinical heterogeneity. Patients varied in age and 
length since the onset of symptoms.  
 
Both studies included in the meta-analysis used the SCCAI (UC and IBD-U) to assess the 
IBD disease activity. A study by McCombie et al., (2016) used the change score from 
baseline for completers of the CBT intervention, rather than a raw score. Hence the 
mean difference was used as a measure of effect. 
 
 
Figure 8 Meta-analysis on IBD remission rates at 6 months of follow-up. 
 
One study showed a significant change in disease activity in favour of the intervention 
(McCombie et al., 2016), while another (Mikocka-Walus et al., 2015) showed no 
significant difference with the confidence intervals crossing 0.  
 
The disease activity as measured on the SCCAI (UC and IBD-U) for the patients who 
received online CBT intervention was higher than for patients in the control group but 
was not statistically significant (MD: -0.71, 95% CI: -1.85 to 0.44, p=0.23). 
 
This meta-analysis combined one study that had a high attrition rate and provided data 
for completers only (McCombie et al., 2016), hence the results could have been 
different if the intention-to-treat (ITT) analysis was reported.   
  
Meta-analysis of data on the disease activity in CD 
Only two studies reported disease activity for the CD group alone. McCombie et al., 
(2016) reported the change from baseline score on the HBI (CD) scale, while another 
study reported a final outcome score and used the CDAI to assess the disease activity 
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(Mikocka-Walus et al., 2015) 
Total (95% CI) 
Heterogeneity: Tau² = 0.50; Chi² = 3.48, df = 1 (P = 0.06); I² = 71% 

























IV, Random, 95% CI 
-1.38 [-2.45, -0.31] 
-0.20 [-0.83, 0.43] 
-0.71 [-1.85, 0.44] 
Intervention Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-4 -2 0 2 4 
Favours [intervention] Favours [control] 
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(Mikocka-Walus et al., 2015), making the meta-analysis using the common effect 
measure impossible to perform. 
2.3.5.2  Data synthesis and meta-analysis of the mean levels of anxiety and 
depression 
Not all studies that reported on the level of anxiety reported also the level of 
depression. The total population of individuals in the studies that reported the mean 
level of anxiety was 804, of which 101 were adolescents, and sample in the studies 
that reported the mean level of depression was 788 (Mikocka-Walus et al., 2015; 
Mikocka-Walus et al., 2016a; McCombie et al., 2016; Everitt et al., 2013; Ljotsson et al., 
2010; Ljotsson et al., 2011b; Bonnert et al., 2017). There was no statistically significant 
difference on anxiety or depression between online CBT and control groups reported 
in the individual studies (Table 5).  
 
Table 5 Results of studies reporting the rates of anxiety and depression and/or mean 
levels of anxiety and depression 
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Note:  HADS - Hospital Anxiety and Depression Scale; (MADRS-S) - The Montgomery Åsberg Depression Rating Scale-- Self report; 
STAI - the State-Trait Anxiety Inventory; SCAS - Spence Childhood Anxiety Scale; a- outcome measures with estimated means, SE 
(analysed intention to treat); b - the number of completers, such as data provided for completers only. 
. 
2.3.5.2.1 A meta-analysis of data reporting the mean levels of anxiety and 
depression  
A meta-analysis of data reporting the mean levels of anxiety 
Two studies reported anxiety at post-intervention (Everitt et al., 2013; Ljotsson et al., 
2011b), two studies at 3 months follow-up (Everitt et al., 2013; McCombie et al., 2016), 
three studies at 6 months follow-up (Mikocka-Walus et al., 2015; Ljotsson et al., 
2011b; McCombie et al., 2016) and only one author reported anxiety at 12 and 24 
months follow-up (Mikocka-Walus et al., 2016a). All of these studies used the HADS 
anxiety scale to measure anxiety and only one study presented data as a change score 
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on this scale (McCombie et al., 2016). Therefore, a mean difference was used as a 
measure of effect in the meta-analyses where the change score was combined.  
 
 A meta-analysis of data reporting the mean levels of anxiety at post-intervention 
assessment 
 
Figure 9 Meta-analysis assessing the level of anxiety at post-intervention assessment. 
 
As shown in Figure 9, there was moderate levels of heterogeneity (Tau² = 0.25; Chi² = 
1.68, df = 1 (P = 0.19); I² = 40%). The pooled mean difference was 0.47 (95% CI: -0.62, 
1.55). The level of anxiety at post-intervention was slightly lower in the control group 
compared to those individuals who received online CBT but was not statistically 
significant (p=0.40).  
A meta-analysis of data reporting the mean levels of anxiety at 3 months of follow-
up 
 
Figure 10 Meta-analysis assessing the level of anxiety at 3 months of follow-up. 
 
A similar result was found for the level of anxiety at three months of follow-up (Figure 
10). There was a moderate level of heterogeneity (Tau² = 0.20; Chi² = 1.66, df = 1 (P = 
0.20); I² = 40%). The pooled mean difference for the level of anxiety in the online CBT 
group versus control was 0.51 (95% CI: -0.46, 1.48). This suggests that the level of 
anxiety was slightly lower in the controls compared to the intervention group, but the 
difference was not significant (p=0.30). 
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 A meta-analysis of data reporting the mean levels of anxiety at 6 months of follow-
up 
Despite the fact that there was little evidence for heterogeneity found across these 
three studies (Tau² = 0.00; Chi² = 0.89, df = 2 (P = 0.64); I² = 0%; all CIs overlapped), a 
random effect model was used due to clinical heterogeneity (the sample included IBD 
and IBS patients, with a different disease duration, a different medication regime 
alongside the intervention, and a different standard care in the control condition).  
 
 
Figure 11 Meta-analysis assessing the level of anxiety at 6 months of follow-up. 
 
At 6 months follow-up, the result changed in favour of the CBT intervention group, 
although this difference was not statistically significant (p=0.19), a pooled mean 
difference was -0.54 (95% CI: -1.34, 0.26) (Figure 11).  
 
A meta-analysis of data reporting the mean levels of depression 
The level of depression was reported at post-intervention assessment in two studies 
(Ljotsson et al., 2010; Ljotsson et al., 2011b), at three months follow-up in one 
(McCombie et al., 2016), and at six months follow-up in two studies (Mikocka-Walus et 
al., 2015; Mikocka-Walus et al., 2016a; Ljotsson et al., 2011b) and only one author 
presented data at 12 and 24 months follow-up  (Mikocka-Walus et al., 2015; Mikocka-
Walus et al., 2016a). All studies, except one (Ljotsson et al., 2010), which used MADRS-
S, used the HADS to assess the level of depression. One study presented data as a 
change score on this scale (McCombie et al., 2016). Therefore, a mean difference was 
used as a measure of effect in the first meta-analysis where the change score was 
combined and the same outcome measures were used (Figure 13) and standardised 
mean difference in the second meta-analysis where two different scales were used 
combining a raw data (Figure 12). A random-effects model was used in meta-analyses 
assessing the level of depression. 
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A meta-analysis of data reporting the mean levels of depression at post-intervention 
assessment 
 
Figure 12 Meta-analysis assessing the level of depression at post-intervention 
assessment. 
 
The level of heterogeneity was high (Tau² = 0.05; Chi² = 2.53, df = 1 (P = 0.11); I² = 
60%). The pooled mean difference for the level of depression at post-intervention was 
-0.18 (95% CI: -0.59, 0.23). This suggests that the level of depression was slightly lower 
in the controls compared to the intervention group but the difference was not 
significant (p=0.40) (Figure 12). 
 
A meta-analysis of data reporting the mean levels of depression at 6 months of 
follow-up 
 
Figure 13 Meta-analysis of data assessing the level of depression at 6 months of follow-
up. 
 
There was little evidence of heterogeneity among the studies (Tau² = 0.00; Chi² = 1.08, 
df = 2 (P = 0.58); I² = 0%). The pooled estimate comparing online CBT against the 
control group was -0.38 (95% CI: -1.09, 0.34), indicating that there was little or no 
evidence of a difference in the mean level of depression at 6 months of follow-up 
between the two groups (p=0.30) (Figure 13). 
2.3.5.3  Data synthesis and meta-analysis on the level of coping 
There was no statistically significant difference reported between groups on the total 
level of coping in two studies (sample n=373) that examined this outcome (Table 6) 
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(Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a; McCombie et al., 2016). 
Though, in one of the studies, the results varied for different components of the score 
at six months follow-up. For example, substance use decreased but venting increased 
more for completers in the intervention group compared to the control group, while 
religion decreased more in the last group (McCombie et al., 2016). 
 
Table 6 Results of studies reporting the level of coping 
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Note:  * Range: 2–10 (higher scores mean greater agreement); a - the number of completers, such as 




2.3.5.3.1 A meta-analysis of data on the levels of coping  
Of two studies reporting the level of coping, one reported total maladaptive and total 
adaptive scores (Mikocka-Walus et al., 2015), whereas another study reported the 
results for total maladaptive coping, but adaptive coping was presented as two 
components of this score: problem-focus and emotional-focus coping (McCombie et 
al., 2016). One study reported this outcome at three and six months of follow-up 
(McCombie et al., 2016) and other at six, 12 and 24 months of follow-up. Therefore, 
only maladaptive coping scores from both studies at six months were combined 
(Figure 14).  
 
Figure 14 Meta-analysis of maladaptive coping at 6 months of follow up. 
 
There were significant levels of heterogeneity (Tau² = 2.23; Chi² = 5,38, df = 1 (P = 
0.02); I² = 81%). Data from the study by McCombie et al., (2016) shows that the 
maladaptive score was worse in the control group, but this was based on the change 
from the baseline score only for completers and hence could be biased.  
 
The pooled estimate comparing online CBT against the control group was 0.38 (95% CI: 
-1.91, 2.67), indicating that there was little or no evidence of a difference in total 
maladaptive coping between the two groups (p=0.74) (Figure 14).   
2.3.5.4 Data synthesis and meta-analysis of the levels of stress 
There was no significant difference in the level of stress between control and 
intervention groups reported in four studies (n=669, of which adolescent n=101) 
examining this outcome (Table 7) (Bonnert et al., 2017; Ljotsson et al., 2011b; 
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Table 7 Results of studies reporting the levels of stress 
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Note: PSS-10 - perceived stress questionnaire; RSRRS - Revised Social Readjustment Rating Scale; * >300 high stress 150–299 
moderate stress <150 low stress; a- outcome measures with estimated means, SE (analysed intention to treat); b - the number of 
completers, such as data provided for completers only. 
2.3.5.4.1 A meta-analysis of data reporting the levels of stress 
Three studies assessed the level of stress, one at post-intervention (Ljotsson et al., 
2011b), one at three months (McCombie et al., 2016), three at six months (McCombie 
et al., 2016; Mikocka-Walus et al., 2015; Mikocka-Walus et al., 2016a; Ljotsson et al., 
2011b) and one at 12 and 24 months of follow-up (Mikocka-Walus et al., 2015; 
Mikocka-Walus et al., 2016a). Three studies reporting outcomes at 6 months could not 
be combined using the common effect measure due to the use of a different scale and 
a change score (McCombie et al., 2016). Therefore, two meta-analyses were 
performed, one where a different scale was used and raw data were available (Figure 
15), and one where the same scale was used, but a mixture of a raw and change score 
data was used (Figure 16). 
 
Figure 15 Meta-analysis of data reporting the level of stress at 6 months of follow-up 1. 
There was a moderate levels of statistical heterogeneity in the data on the level of 
stress (Tau² = 0.01; Chi² = 1.45, df = 1 (P = 0.23); I² = 31%) and the pooled standardised 
mean difference was 0.07 (95% CI: -0.22, 0.35, p=0.65). 
 
Study or Subgroup 
(Ljotsson et al., 2011b) 
(Mikocka-Walus et al., 2015) 
Total (95% CI) 
Heterogeneity: Tau² = 0.01; Chi² = 1.45, df = 1 (P = 0.23); I² = 31% 
Test for overall effect: Z = 0.46 (P = 0.65) 
Mean 
15.5 






















IV, Random, 95% CI 
-0.06 [-0.36, 0.24] 
0.23 [-0.14, 0.60] 
0.07 [-0.22, 0.35] 
Intervention Control Std. Mean Difference Std. Mean Difference 
IV, Random, 95% CI 
-2 -1 0 1 2 




Figure 16 Meta-analysis on the level of stress at 6 months of follow-up 2. 
 
There was little evidence of heterogeneity in the data on the level of stress (Tau² = 
0.00; Chi² = 0.20, df = 1 (P = 0.65); I² = 0%). The pooled mean difference was -0.16 (95% 
CI: -2.16, 1.85, p=0.88). 
 
Both meta-analyses showed little or no evidence of a difference between the 
intervention and control groups in the level of stress.   
2.3.5.5 Data synthesis and meta-analysis of the levels of HRQoL 
Of seven studies (n=619) that assessed HRQoL in IBS (Bonnert et al., 2017; Everitt et 
al., 2013; Hunt et al., 2009; Ljotsson et al., 2011a; Ljotsson et al., 2011b; Ljotsson et al., 
2010; Oerlemans et al., 2011) (Table 8), one study examined adolescent population 
(n=101) (Bonnert et al., 2017) and showed significant improvement in this outcome at 
post-intervention assessment. Amongst studies in adult populations, one study 
showed no difference in HRQoL at post-intervention assessment or 3 months follow-up 
(Everitt et al., 2013). Three studies reported a significant improvement in HRQoL in 
favour of online CBT at post-intervention assessment (Ljotsson et al., 2011b; Ljotsson 
et al., 2010; Ljotsson et al., 2011a). One study stated significant improvement in IBS-
QOL at post-intervention assessment but reported only an F statistic and p-value of 
<0.05 or the mean (SD) for completes only (Hunt et al., 2009).  
 
Two studies (n=373) that reported HRQoL in IBD showed no significant improvement 
on this outcome at any of the points of follow-up (McCombie et al., 2016; Mikocka-
Walus et al., 2015; Mikocka-Walus et al., 2016a). One study that measured this 
outcome using two scales did not find a significant difference between the 
intervention and control group on either of the scales (IBDQ and SF-12) at 12 weeks 
and 6 months follow up (Table 8) (McCombie et al., 2016). Other study showed that 
CBT improved HRQoL for patients with high scores on mental health subscales in a 
Study or Subgroup 
(Ljotsson et al., 2011b) 
(McCombie, 2016) 
Total (95% CI) 
Heterogeneity: Tau² = 0.00; Chi² = 0.20, df = 1 (P = 0.65); I² = 0% 
Test for overall effect: Z = 0.15 (P = 0.88) 
Mean 
  15.5 
  1.51 
SD 
  8.8 



















IV, Random, 95% CI 
-0.50 [-3.00, 2.00] 
0.46 [-2.89, 3.81] 
-0.16 [-2.16, 1.85] 
Intervention Control Mean Difference Mean Difference 
IV, Random, 95% CI 




subgroup analysis at six months follow-up, but the longer-term effects were difficult to 
assess given the high attrition rate (Mikocka-Walus et al., 2015; Mikocka-Walus et al., 
2016a). 
Table 8 Results of studies reporting the levels of HRQoL 
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Note: IBS–QOL - IBS Quality of Life Impairment; PedsQL - Paediatric Quality of Life Inventory; IBDQ - Inflammatory Bowel Disease 
Questionnaire; HRQOL (SF) - health-related quality of life short form; a - outcome measures with estimated means, SE (analysed 
intention to treat); b - the number of completers, such as data provided for completers only. 
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2.3.5.5.1 A meta-analysis of data on the levels of HRQoL 
 A meta-analysis of data on the levels of HRQoL at post-intervention assessment 
Six studies reported quality of life at post-intervention assessment and used the same 
scale (IBS-QOL) hence were combined in the meta-analysis (Figure 17). The result from 
two intervention groups: online CBT and online CBT plus support were combined 
(Table 8) in the study by Everitt et al. (2013).   
 
Figure 17 Meta-analysis on the level of IBS-QOL at post-intervention assessment. 
  
There was significant levels of heterogeneity (Tau² = 95.67; Chi² = 34.43, df = 5 (P < 
0.00001); I² = 85%). The results demonstrate an effect in favour of the intervention 
group but this differences was not-statistically significant (p=0.29). The pooled mean 
difference was 4.81 (95% CI: -4.03, 13.64). 
 
A meta-analysis of data on the levels of HRQoL at 3 months of follow-up 
Three studies reported HRQoL at 3 months of follow-up (Everitt et al., 2013; 
Oerlemans et al., 2011; McCombie et al., 2016). One of them uses change from the 
baseline score and different measure of outcome (McCombie et al., 2016) making 
possible to combine in the meta-analysis using a common measure of effect only two 
studies (Figure 18).   
 
Figure 18 Meta-analysis on the level of IBS-QOL at 3 months of follow-up. 
 
Study or Subgroup 
 
Everitt et al., 2013 
Oerlemans, 2011 
Subtotal (95% CI) 
Heterogeneity: Tau² = 7.79; Chi² = 1.32, df = 1 (P = 0.25); I² = 24% 

























IV, Random, 95% CI 
6.25 [0.71, 11.79] 
-1.75 [-14.21, 10.71] 
4.28 [-2.48, 11.04] 
Interventions Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-20 -10 0 10 20 
Favours [intervention] Favours [control] 
Study or Subgroup 
(Everitt et al., 2013) 
(Hunt et al., 2009) 
(Ljotsson et al., 2010) 
(Ljotsson et al., 2011a) 
(Ljotsson et al., 2011b) 
(Oerlemans, 2011) 
Total (95% CI) 
Heterogeneity: Tau² = 95.67; Chi² = 34.43, df = 5 (P < 0.00001); I² = 85% 





















































IV, Random, 95% CI 
0.18 [-4.35, 4.71] 
-27.00 [-45.25, -8.75] 
19.90 [10.92, 28.88] 
15.20 [4.91, 25.49] 
10.00 [4.47, 15.53] 
-1.02 [-13.04, 11.00] 
4.81 [-4.03, 13.64] 
Intervention Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-100 -50 0 50 100 
Favours [control] Favours [intervention] 
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There was low level of heterogeneity between the studies on IBS-QOL at three months 
of follow-up (Tau² = 7.79; Chi² = 1.32, df = 1 (P = 0.25); I² = 24%). A study by Everitt et 
al., (2013) carried bigger weight and had narrow CI, hence reflects the fact that the 
study has better accuracy than the other studies and it demonstrated the quality of life 
was better in the intervention group. However, this study had a discrepancy between 
the number of participants in the flowchart and the text.  
 
The result of the meta-analysis showed that there was little or no evidence of a 
difference in QoL between CBT and control group (4.28, 95% CI: -2.48, 11.04, p=0.21).  
 
A meta-analysis of data on the levels of HRQoL at 6 months of follow-up  
Two studies reported QoL at 6 months follow-up could not be combined, such as they 
used different scales (IBS-QOL and IBDQ) and provided a raw and change from the 
baseline score (McCombie et al., 2016; Ljotsson et al., 2011b) and two studies reported 
HRQoL using two subscales (SF-12 mental) and (SF-12 physical) at 6 months follow-up, 
hence two meta-analyses were performed to investigate online CBT effect on physical 
and mental HRQoL (Figure 19, Figure 20). 
 
Figure 19 Meta-analysis on HRQoL (mental) at 6 months of follow-up. 
 
There was little evidence of heterogeneity in the data on mental component of HRQoL 
(Tau² = 0.00; Chi² = 0.21, df = 1 (P = 0.65); I² = 0%).  
 
The meta-analysis showed little or no evidence of a difference between the 
intervention and control groups in the mean mental component score for HRQoL (0.73, 
95% CI:-2.35, 3.82, p=0.64) (Figure 19). 
 
Study or Subgroup 
 
McCombie, 2016 
Mikocka-Walus et al., 2015 
Subtotal (95% CI) 
Heterogeneity: Tau² = 0.00; Chi² = 0.21, df = 1 (P = 0.65); I² = 0% 

























IV, Random, 95% CI 
1.71 [-3.49, 6.91] 
0.20 [-3.64, 4.04] 
0.73 [-2.35, 3.82] 
Interventions Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-20 -10 0 10 20 




Figure 20 Meta-analysis on HRQoL (physical) at 6 months of follow-up. 
 
There was little evidence of heterogeneity on data for HRQoL (physical) (Tau² = 0.00; 
Chi² = 0.02, df = 1 (P = 0.90); I² = 0%). The meta-analysis showed little or no evidence of 
a difference between the intervention and control groups in the physical component 
score of HRQoL (-0.34, 95% CI: -3.06, 2.28, p=0.81) (Figure 20). 
2.3.5.6 Data synthesis and meta-analysis of the studies reporting the related 
outcomes 
Eight studies reported related outcomes (Table 9).  
Table 9 Results of studies reporting the related outcomes 
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McCombie, 2016 
Mikocka-Walus et al., 2015 
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Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.90); I² = 0% 

























IV, Random, 95% CI 
-0.15 [-4.15, 3.85] 
-0.50 [-4.20, 3.20] 
-0.34 [-3.06, 2.38] 
Interventions Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-20 -10 0 10 20 
Favours [intervention] Favours [control] 
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83% (n=39) good or excellent treatment; 
91% (n=43) good or excellent therapist's support; 
81% (n=38) satisfied or very satisfied with the overall intervention. 
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1.89 (1.44 - 2.33) 



































Note: a - the outcomes presented are adolescent-rated outcome measures; b- outcome measures with 
estimated means, SE (analysed intention to treat); TIC-P - Trimbos and Institute of Medical Technology 
Assessment Cost Questionnaire for Psychiatry; VSI - Visceral sensitivity index; ASI = Anxiety Sensitivity 
Index. CSI-24 - Children’s Somatisation Inventory- parents version; CSQ - Client Satisfaction Questionnaire; PEQ 
- Patient Enablement Questionnaire; IBS - BRQ - behavioural responses questionnaire; SGA of Relief - 
Subjects Global Assessment of Relief; CPSQ - The Consequences of Physical Sensations Questionnaire; 
SFQ - Social Functioning Questionnaire, EPQ - Eysenck Personality Questionnaire (Brief Version) for 
measuring neuroticism; PCS - Pain Catastrophizing Scale; CSFBD - The Cognitive Scale for Functional 
Bowel Disorders; *- patients were crossed over to active treatment; b - the number of completers, such 




2.3.5.6.1 A meta-analysis of the related outcomes data 
2.3.5.6.1.1 A meta-analysis of the cost-effectiveness data 
The cost-effectiveness at post-intervention was assessed in two studies (Ljotsson et al., 
2011a; Andersson et al., 2011). The random-effect model was used and SMD as a 
measure of effect in the meta-analysis. Three meta-analyses were performed on the 
total cost (include the cost of intervention), direct medical cost and direct non-medical 
cost (Figure 21, Figure 22, Figure 23). 
 
Figure 21 Meta-analysis on the total cost (include intervention) at post-intervention. 
 
 
Figure 22 Meta-analysis on direct medical cost at post-intervention. 
 
 
Figure 23 Meta-analysis on direct non-medical cost at post-intervention. 
 
There was little evidence of heterogeneity in all three of the meta-analysis. All three 
meta-analyses showed little or no evidence of a difference between the intervention 
and control groups in direct no-medical cost (p=0.93), total cost (include the cost of 
the intervention) (p=0.66) and direct medical cost (p=0.55). 
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(Andersson et al., 2011) 
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Heterogeneity: Chi² = 0.99, df = 1 (P = 0.32); I² = 0% 
Test for overall effect: Z = 0.09 (P = 0.93) 
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0.16 [-0.28, 0.60] 
-0.18 [-0.68, 0.33] 
0.01 [-0.31, 0.34] 
Intervention Control Std. Mean Difference Std. Mean Difference 
IV, Fixed, 95% CI 
-1 -0.5 0 0.5 1 
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Heterogeneity: Tau² = 0.00; Chi² = 0.06, df = 1 (P = 0.80); I² = 0% 
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IV, Random, 95% CI 
0.12 [-7.92, 8.16] 
-3.31 [-12.30, 5.68] 
-1.40 [-7.39, 4.59] 
Intervention Control Mean Difference Mean Difference 
IV, Random, 95% CI 
-100 -50 0 50 100 
Favours [intervention] Favours [control] 
(Andersson et al., 2011)
(Ljotsson et al., 2011a) 
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2.3.5.6.1.2 A meta-analysis of the visceral sensitivity data 
Three studies by the same author assessed visceral sensitivity at post-intervention 
assessment (Ljotsson et al., 2010; Ljotsson et al., 2011a; Ljotsson et al., 2011b) and 
used the same scale to measure this outcome.  
 
Figure 24 Meta-analysis of data reporting VSI at post-intervention assessment. 
 
There was a low level of heterogeneity (Tau² = 3.67; Chi² = 2.55, df = 2 (P = 0.28); I² = 
22%). The results demonstrate an effect in favour of the intervention group in VSI and 
this differences was statistically significant (p=0.0002). The pooled mean difference 
was -8.51 (95% CI: -12.99, -4.04) (Figure 24).  
2.3.5.6.1.3 A meta-analysis of the Sheehan Disability Scales data 
Two studies which examined the Sheehan Disability Scales at post-intervention 
assessment (Ljotsson et al., 2010; Ljotsson et al., 2011a) were included in the meta-
analysis (Figure 25).  
 
Figure 25 Meta-analysis of data of Sheehan Disability Scales at post-intervention. 
 
The evidence of heterogeneity was low (Tau² = 0.00; Chi² = 0.84, df = 1 (P = 0.36); I² = 
0%). Pooled mean difference (-2.78, 95% CI: -5.43, -0.12, p=0.04) showed that there 
were a statistically significant difference in favour of intervention. This means that 
people in the online CBT group experienced less symptom induced disability, 
compared to the control group. 
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Heterogeneity: Tau² = 0.00; Chi² = 0.84, df = 1 (P = 0.36); I² = 0% 
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IV, Random, 95% CI 
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-12.10 [-21.25, -2.95] 
-5.60 [-10.43, -0.77] 
-8.51 [-12.99, -4.04] 
Interventions Control Mean Difference Mean Difference 
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-20 -10 0 10 20 
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2.3.5.7  The long-term follow-up  
Only one author (Mikocka-Walus et al., 2016a) reported follow-up over 12 months, 
making meta-analysis impossible.  
 
This study shows that CBT did not significantly change disease activity (Table 4), mental 
health (Table 5), coping (Table 6) or quality of life (Table 8). At 24 months, there was a 
significant attrition rate (67% in the intervention group and 46 % in the control group 
were lost to follow-up). 
2.4 Discussion 
2.4.1 Principal Findings 
This is the first systematic review with a meta-analysis which has addressed the 
usefulness of online psychological interventions for mental and physical outcomes in 
gastrointestinal diseases. The review firstly demonstrates little evidence that online 
CBT improves IBS symptoms severity. However, four out of five studies that examined 
IBS symptoms severity showed statistical significance in favour of online CBT (Hunt et 
al., 2009; Ljotsson et al., 2010; Ljotsson et al., 2011a; Ljotsson et al., 2011b). One study 
(Everitt et al., 2013) (n=135), which carried the second biggest weight, showed findings 
in the opposite direction, making the overall difference not statistically significant. This 
study had a slight discrepancy between the number of participants in the text of the 
article and the CONSORT diagram. Another study reported data only for the 
completers (Hunt et al., 2009). A repeated meta-analysis without these two studies 
showed a significant improvement in IBS symptom severity at post-intervention. 
Therefore, future research is needed to clarify this result.   
 
Another systematic review which assessed the effectiveness of online CBT on IBS 
symptom severity showed no significant beneficial effect (Ford et al., 2014); this was 
based on two studies which were also included in the current systematic review 
(Ljotsson et al., 2010; Hunt et al., 2009). The previous review (Ford et al., 2014) 
showed that CBT, dynamic psychotherapy, hypnotherapy, and multicomponent 
psychological therapy, delivered F2F or using the telephone, were all more effective 
compared to control groups. Consequently, the mode of delivery appears to make a 
difference in the level of effectiveness of the intervention. The development of the 
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new or improved online CBT programs might enhance the effectiveness of the 
intervention.  
 
Regarding the disease activities in IBD, there was little or no evidence that online CBT 
affected this outcome, which is consistent with other systematic reviews (Gracie et al., 
2017; Timmer et al., 2011). The studies included in the systematic review Chapter 2 
recruited the unselected patients with IBD however one of these trials (Mikocka-Walus 
et al., 2015) also conducted a post-hoc analysis on a subpopulation of patients 
suggesting that CBT might be beneficial for patients at risk of suboptimal outcomes 
rather than the unselected IBD patients (Mikocka-Walus et al., 2015). Conducting an 
individual participant data meta-analysis could clarify if the interventions work across 
these subgroups in other studies but was not feasible in this review due to the lack of 
access to the raw data. Future studies should target these subgroups of patients to 
explore whether this result holds. 
 
Further, this review demonstrated that there was little or no evidence that online CBT 
is effective in improving the levels of anxiety and depression, stress, maladaptive 
coping, HRQoL, in patients with IBD and IBS. Also, there was little or no evidence of the 
cost-effectiveness of online CBT intervention. These results are contradictory with a 
recent systematic review by Gracie et al., (2017) which showed that depression scores 
and quality of life in IBD patients might slightly be improved in the short-term after 
psychological therapy intervention, particularly CBT and identify the efficacy gap 
between online and F2F psychotherapy modalities. This suggests that human contact 
might be necessary for psychotherapy to improve the outcomes. Combining online and 
F2F approaches have been found to increase the effectiveness and cost-effectiveness 
of psychological interventions and to reduce the attrition rates (Newman et al., 2011; 
Erbe et al., 2017). Therefore, the researchers should consider a combination of F2F and 
online intervention during the design of future trials.  
 
Of relevance, two previous systematic reviews on the effect of online interventions in 
gastroenterology (Knowles and Mikocka-Walus, 2014; Jackson et al., 2016) showed 
that online disease management improves a variety of disease outcomes such as 
medication adherence, disease activity, number of acute visits and healthcare costs, 
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among others. However, the findings from the current review show little or no 
evidence of the effectiveness of online psychotherapy on physical or mental health 
outcomes or cost-effectiveness. This may suggest that disease management could be 
more suited to online delivery than psychotherapy though more good quality studies 
are needed. 
 
Furthermore, findings from present review provide some preliminary evidence that 
online CBT may be an effective intervention for gastrointestinal symptom-specific 
anxiety as measured on the VSI scale and symptom induced disability as measured on 
the Sheehan Disability Scales. Both these findings came from the studies conducted by 
the same author (Ljotsson et al., 2010; Ljotsson et al., 2011a; Ljotsson et al., 2011b), 
hence the generalisability of the result could be questionable and the future studies 
should confirm this observation (Higgins et al., 2003).   
2.4.2 Limitations of the studies included in the review and recommendations for 
future studies 
There are several important issues identified in the previous studies which should be 
addressed by future research to improve the quality of evidence base around the 
efficacy of online psychotherapy in gastroenterological conditions. First, the review 
was mainly based on the comparisons at post-intervention, and long-term impact of 
online CBT is not known, with only one author reporting outcomes after 12 months of 
follow-up (Mikocka-Walus et al., 2016a). CBT aims to teach patients to be their own 
therapists to apply ideas and understanding of the principal of CBT after the 
intervention ends (Beck and Beck, 2011). To modify very firm dysfunctional beliefs and 
patterns of behaviour and maintain stabilisation, some patients might require over a 
year of therapy (Beck and Beck, 2011). A recent trial showed long-term clinical and 
cost-effectiveness of CBT in addition to usual care that includes antidepressants for 
certain group of people with depression who were unresponsive to drug therapy 
(Wiles et al., 2016). Long-term follow-up is necessary to understand the impact of 
online psychotherapy in GI disorders in the longer term. 
 
Further, participants in the control groups in most of the included studies were on a 
wait-list (Bonnert et al., 2017; Andersson et al., 2011; Ljotsson et al., 2010; Ljotsson et 
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al., 2011a; Hunt et al., 2009) and were crossed over to treatment after the assessment, 
when the intervention group completed the treatment (Hunt et al., 2009; Ljotsson et 
al., 2011a; Ljotsson et al., 2010; Bonnert et al., 2017; Andersson et al., 2011) or 
participants received multiple interventions (Everitt et al., 2013). These factors could 
affect the outcomes in the control groups due to the expectation of recovery. To limit 
this effect, standard care in the control groups should be chosen in future studies.   
 
Most studies were inconsistent with the reporting outcomes. One study had a 
discrepancy between the numbers of participants in the CONSORT diagram and the 
numbers provided in the text, and it was unclear what was the number of participants 
per arm for several reported outcomes (Everitt et al., 2013). We contacted the 
authors, but they could not access the trial data and clarify the numbers. One study 
used change scores rather than follow-up scores (McCombie et al., 2016). Two studies 
reported outcomes for completers of the online intervention programme only 
(McCombie et al., 2016; Hunt et al., 2009). Future studies should present the outcomes 
in the format facilitating meta-analysis (n, means, SD or mean difference with 
associated 95% confidence intervals).  
 
Sample sizes varied in the studies from 54 (Hunt et al., 2009) to 199 (McCombie et al., 
2016), with high dropout rates. The largest study had the highest attrition rate 
(McCombie et al., 2016). To address this issue, the researchers should focus on the 
reduction of attrition. The reduction of attrition could be achieved by introducing a 
follow-up booster session of online CBT. CBT with a booster session has been found to 
be more effective and more sustainable for mood and anxiety disorders than CBT 
interventions without a booster session (Gearing et al., 2013). Initiating partial contact 
with the psychologist can build the working alliance and hence encourage patients to 
comply with the online CBT programme. There is evidence that the working alliance 
between the therapist and the patients receiving online CBT for depression can be as 
good as in F2F psychotherapy (Preschl, Maercker and Wagner, 2011). Also, the dropout 
rate for patients with depression is significantly higher in CBT than in other 
psychotherapies (Cuijpers et al., 2008). Consistently, future trials of online 




Although all studies overall met the Cochrane Risk of Bias Tool for randomised 
controlled trials criteria for moderate risk of bias, one of them did not use allocation 
concealment and was thus considered to be at high risk of bias (McCombie et al., 
2016). An inadequately concealed allocation could be subject to exaggerated estimates 
of intervention effect (Higgins and Green, 2011). Future studies should use allocation 
concealment during randomisation. 
  
All studies were considered to have a high risk of performance and detection bias. It is 
often impossible to blind patients and the personnel in psychotherapy trials. 
Nevertheless, the knowledge of the intervention does not necessarily result in a low-
quality study (Higgins and Green, 2011). Some authors attempted to partially blind the 
participants (Mikocka-Walus et al., 2015; Ljotsson et al., 2011b) or the researchers who 
rated the scales to the symptom severity (Hunt et al., 2009) (Table 3). Future studies 
should use blinding of outcome assessors (the assessors could be masked to therapy), 
which is possible but rarely used in RCTs of psychological interventions (Grant et al., 
2013).  
2.4.3 Strengths and Limitations of the present review 
Strengths of this systematic review and meta-analysis lie in the use of rigorous 
methodology and following the protocol registered on PROSPERO. A comprehensive 
search strategy with a broad definition of the terms, a wide range of databases 
including the “grey” literature, with no language restriction was performed, and a 
formal critical appraisal tool was used. The screening of the titles and assessment of 
eligibility for inclusion was performed independently by two reviewers. A second 
reviewer checked the quality and risk of bias assessment.  
 
This review unavoidably has some limitations. There was significant heterogeneity 
between included studies in most of the meta-analyses, but the sources of this 
heterogeneity were not explored due to a small number of studies included. 
Furthermore, it was not possible to assess evidence of publication bias or to conduct 




Further, four out of all included studies were conducted in one country, Sweden 
(Bonnert et al., 2017; Ljotsson et al., 2011a; Ljotsson et al., 2010; Ljotsson et al., 2011b; 
Andersson et al., 2011) and three of them combined in the same meta-analysis 
(Ljotsson et al., 2010; Ljotsson et al., 2011b; Ljotsson, 2011), hence the generalisability 
of these results is unclear. 
 
Several studies recruited patients by self-referral (Ljotsson et al., 2011a; Andersson et 
al., 2011; Ljotsson et al., 2010; Ljotsson et al., 2011b; Hunt et al., 2009). Therefore, the 
results from these studies must be interpreted with caution, as the consequence of 
this recruitment method could be that the sample of participants was more willing to 
participate in this kind of intervention and were more responsive to it. 
 
Another limitation was the choice of the points of follow-up, at which the results of the 
outcomes could be combined in the meta-analysis. It has been decided that the data 
would be combined at post-intervention assessment, at three, six, 12 months follow-
up, as these were the most common assessment points in the included studies. 
However, the duration of the intervention varied greatly among the studies with the 
longest being a ten-week internet-delivered CBT course (Andersson et al., 2011; 
Ljotsson et al., 2010; Ljotsson et al., 2011b; Mikocka-Walus et al., 2015; Bonnert et al., 
2017; Ljotsson et al., 2011a) and the shortest a four-week (Oerlemans et al., 2011) 
therapy.  
 
To minimise language bias, we did not exclude studies published in languages other 
than English initially, with attempts to have them translated. However, during the 
screening process of titles and abstracts, none of the articles published in other 
languages was selected for the full-text assessment for eligibility. Retrieval bias in 
favour of studies published in English cannot be discounted due to the nature of the 
databases used and given that the search strategy was developed in English.  
2.4.4 Conclusions  
This review was conducted to examine the effect of online psychological interventions 
on physical and mental outcomes in GI diseases. Nine studies met inclusion criteria, 
and eight were included in the meta-analyses.   
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Despite the limitations of the primary studies, findings of the present systematic 
review suggest insufficient evidence of an association between online CBT and disease 
severity/activity, level of anxiety and depression, stress, maladaptive coping, HRQoL, 
and cost-effectiveness in patients with IBD and IBS. However, online psychotherapy 
was shown to improve gastrointestinal symptom-specific anxiety and lessen symptom 
induced disability significantly. These results may suggest that human contact might be 
necessary for CBT interventions to work. 
 
We were able to assess in the meta-analysis only a short-term CBT effect. Therefore, 
future studies should examine the long-term effectiveness of online therapies 
including interventions other than CBT. Also, the future meta-analysis would benefit 
from the use uniform instruments for measuring outcomes in primary studies, 
reporting of data in a format suitable for meta-analysis, employing larger sample sizes 
and using strategies to reduce high attrition levels and differential attrition. Future 
studies should focus on targeting the populations which are likely to benefit from 
psychological interventions, such as patients with a high baseline IBD activity, recently 
diagnosed, who are young and patients with comorbid psychological distress. A 
broader range of psychological interventions with booster sessions should be 
considered when planning future trials.  
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3 Chapter 3: Patients' and health professionals' views about the lived 
experience of people with IBD and comorbid anxiety and/or 
depression: a qualitative exploratory study.  
This chapter focuses on the identification and development of the appropriate theory 
phase of the intervention, which involves the conduct of the qualitative study. It 
reports the IBD patients' with comorbid anxiety and/or depression lived experience to 
identify challenges and gaps in the management of the disease in this population.  This 
chapter is methodologically linked to Chapter 4 which reports the views on the online 
psychological intervention from the same groups of participants.  
3.1.1 Background 
The chronic nature of IBD means that its symptoms will affect patients during most of 
their lives and, as a result, may jeopardise their QOL and mental health (WHO, 2003). 
 
The risk of developing depression and anxiety in patients with IBD is significantly 
higher than in the healthy population; and psychological factors contribute to 
worsening of the somatic symptoms of IBD (Mikocka-Walus et al., 2016b). It is also 
suggested that generalised anxiety disorders or depression could moderately increase 
the risk of surgery in patients with Crohn's disease (Ananthakrishnan et al., 2013). The 
largest study to date (n=2000) by Mikocka-Walus et al., (2016c), with a 9-year follow-
up, noted a significant relationship between anxiety/depression and disease activity 
over time in IBD (Mikocka-Walus et al., 2016c), thus indicating the need for 
psychological care in this population.  
 
In recent years, several qualitative studies have examined IBD patients’ lived 
experiences (Matini and Ogden, 2015; McMullan et al., 2017; Luo et al., 2018). These 
studies focused on the investigation of the patients' adaptation and resilience. A 
recent qualitative systematic review explored patients' experiences of living with IBD 
and found that "fatigue, incontinence and uncertainty about future, body image, and 
lack of information from healthcare professionals" formed the theme "living in 
isolation and exclusion" (Fourie et al., 2018). This study also highlighted that the 
patients felt that health professionals did not believe them, non specialists health 
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professionals had limited IBD knowledge and did not provide the information about 
the disease, which led to the lost of trust in health professionals and fear of 
unpredictable outcomes (Fourie et al., 2018).  
 
One recent qualitative study examined the experience of people with IBD and anxiety 
and low mood (Jordan et al., 2018). However, this study only focused on the patients' 
perspective. Hence, there is currently no data on both patients' and health 
professionals' views about the lived experience of IBD patients with comorbid anxiety 
and/or depression and if they are the same or different to those with IBD alone. 
Therefore, the present qualitative exploratory study looked to address this gap. The 
study of both patients’ and health providers’ perspectives is important as the delivery 
of adequate patient-centred care could best be achieved by understanding the views 
of both groups. The findings from the current study could help to identify any 
challenges and/or gaps in the management of IBD comorbid with mental illness.  
 
This study aims to explore and develop a detailed understanding of health 
professionals' and patients' perceptions, believes and assumptions regarding the lived 
experiences of patients with IBD and comorbid anxiety and/or depression and 
management of the disease. 
 
The study had the following question: 
What are the views of patients and health professionals on lived experience and 
management of IBD with comorbid anxiety and/or depression? 
3.1.2 Methods  
3.1.2.1 Design  
An exploratory qualitative design was used in the current study (Al-Busaidi, 2008). This 
design was chosen to explore the thoughts and feelings that might affect behaviour in 
those with IBD and comorbid anxiety and/or depression . The intention was to gather 
the feedback from the patients and health professionals, to explore their beliefs, 
analyse and understand phenomena in the natural settings and through the 
description to determine its meaning and develop concepts of what is IBD patients 
with comorbid anxiety and/or depression lived experience is. The perspective of both 
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patients and health professionals was necessary as health professionals provide care 
for these patients and have their own views of the different interventions available 
and are a source of information for patients on these interventions.  
 
Qualitative research is increasingly important within a health context (Al-Busaidi, 2008) 
as it gives insight into what factors could affect the implementation of new 
interventions and why and how patients and health professionals make decisions and 
respond (Sidhu, Jones and Stevenson, 2017). "Qualitative research fits well within the 
interpretative approach to knowledge, in which the main goal is to search for meaning 
and understanding..." (Greenhalgh, 2007, p. 66). Therefore, a general interpretive 
approach was adopted in the current study.  
 
Within the Medical Research Council (MRC) framework, as discussed in Chapter 1, this 
primary qualitative research fits within the identifying/developing appropriate theory 
stage of the framework (Craig et al., 2013). 
3.1.2.2 Participants 
3.1.2.2.1 Patients 
Inclusion Criteria: IBD patients over 18 years old who have comorbid anxiety and/or 
depression (subthreshold, mild or moderate), who access gastroenterology services in 
the hospitals of one of the regions in England included in the study.  
Exclusion Criteria: Individuals with learning or communication difficulties; those with 
severe anxiety and/or depression in whom it is thought that the interview may cause 
emotional distress; considered by their nurse or doctor not to be suitable to 
participate in the interview; do not adequately understand written or verbal 
information in English.  
3.1.2.2.2 Health professionals 
Inclusion Criteria: health professionals who work within the gastroenterology service 
team and have experience of working with IBD patients for at least two years. This 
length of experience was chosen so the health professional would be familiar with the 
patients’ lived experience, the challenges in managing IBD alongside anxiety and/or 
depression and the associated relevant health care provision for these patients.  
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Exclusion Criteria: health professionals with fewer than two years of experience of 
working with IBD patients. 
3.1.2.2.3 The strategy used for sampling  
Purposeful maximum variation sampling was used in this study (Patton, 1990). The 
strength of this sampling strategy is that "any common patterns that emerge from 
great variation are of particular interest and value in capturing the core experiences 
and central, shared aspects or impacts of a program" (Patton, 1990, p. 172). The 
diverse characteristics of the sample were chosen to maximise variation and were 
applied across participant variables: age, gender, disease duration and severity; and 
across health professionals’ length of working experience. In the current study, "a 
maximum variation sampling strategy would not be attempting to generalise findings 
to all people or all groups but would be looking for information that elucidates 
programmatic variation and significant common patterns within that variation" 
(Patton, 1990, p. 172). However, in practice, overarching purposeful sampling 
approaches are used to meet various interests, requirements and flexibility (Marshall, 
1996; Patton, 1990). Within this study, there was also an overarching purposeful 
sampling used as elements of a convenience sampling strategy alongside purposeful 
maximum variation sampling were used. Potential participants of various age, gender, 
disease activity and duration, with comorbid subthreshold, mild or moderate 
depression and/or anxiety were purposely selected from the database of three 
gastroenterology services in hospitals one region of England to ensure the richness of 
perspectives and to minimise the danger of altering the study to a single view. A 
similar purposive sampling strategy was implied to select various ages, lengths of 
experience and specialities of health professionals at these sites. The participants were 
purposely sampled across three different sites to make sure that the geographical 
variation among selected sites was represented in the study. 
 
The representation of gender variation in the sample was important as male and 
female patients have a different perception of QOL, IBD concerns specific to gender 




The maximum variation of the health professionals’ sample in the full range of 
characteristics such as gender, age, length of working experience, a wide range of 
health professionals' staff working with IBD patients (doctors, IBD nurses, research 
nurses, psychologist, and dietitian) was achieved. However, there were some 
limitations in the selection process of the patient participants as some were not willing 
to participate in the study. Therefore, there was also an element of a convenience 
sampling strategy used to obtain the patient numbers and simultaneously trying to 
ensure that the overall desired variation was achieved. 
 
Precise sample sizes for qualitative studies are usually impossible to specify prior to 
the study (Gentles et al., 2016). It was attempted to gain in-depth data which "from a 
small number of people can be very valuable, especially if the cases are information-
rich. Less depth from a larger number of people can be especially helpful in exploring a 
phenomenon and trying to document diversity or understand variation" (Patton, 1990, 
p. 184). Collecting and analysing data from a small sample would obtain: "(1) high-
quality, detailed descriptions of each case, which are useful for documenting 
uniqueness, and (2) important shared patterns that cut across cases and derive their 
significance from having emerged out of heterogeneity" (Patton, 1990, p. 172). 
Therefore, it was intended that the sample size for both groups would be determined 
by monitoring data saturation during the project. Data were collected until the point 
where data saturation was reached (that is, until no new themes, or the detail for 
existing themes was detected) and "where additional data collection contributes little 
or nothing new to the study" (Gentles et al., 2015, p. 1781). Although the sample size 
was guided by principles of data saturation, a pragmatic approach also was taken 
based on similar qualitative research within the field (Mikocka-Walus, 2013). A priori, it 
was expected that a minimum of 10 health professionals and a minimum of 10 patients 
would be recruited into the study.  
3.1.2.2.4 Patient and Public Involvement (PPI) 
A Patient and Public Involvement (PPI) representative was also interviewed in line with 
current best practice (National Institute for Health Research, 2014). PPI can greatly 
enhance the quality and appropriateness of the research and was considered 
important within this study (Brett et al., 2014). The PPI representative was a person 
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from the IBD patient panel at one of the participating hospitals. The PPI person was 
familiarised with the purpose of the study and the patient materials. The study 
procedures were discussed with the PPI person prior to the actual focus group to 
ensure that the burden placed on participants is justifiable and well explained. A 
practice interview was conducted with the PPI representative before undertaking the 
focus group, using the same topic guide intended to be used for the focus group. The 
PPI person was invited and took part in the focus group with other patients. The data 
gathered from the original interview with the PPI person was included in the analysis, 
and during the focus group, the PPI person contributed less to allow other participants 
to talk and share their views. PPI continued throughout this project by gaining 
feedback on the study conduct and input into the reporting and dissemination 
strategies.  
3.1.2.3 Method of Recruitment 
Both patients and health professionals were recruited across three different sites in 
one region of England, thus providing different perspectives and variation from these 
regions. 
3.1.2.3.1 Patients and the PPI person 
PPI person was contacted and recruited directly with the help and assistance of the 
mentors involved in the project. 
 
Eligible patients were identified by asking participating sites to identify IBD patients 
with comorbid depression and/or anxiety. Following this selection, the prospective 
participants were initially sent information letters from their treating doctor or nurse. 
During a hospital visit, the nurse or doctor discussed the research project with them. 
At the same time, some patients were initially approached during the IBD clinic and 
the information pack (the information sheet about the project, the research 
participant rights, the expression of interest form, the consent form, General Data 
Protection Regulation: Transparency Information, glossary, key demographics, illness 
characteristics form and contact details for more information) were distributed in 
person. The participants were given the opportunity to discuss the study with their 
family or friends. The patients who agreed to participate signed the consent form, 
which was sent to the primary researcher who then contacted them to agree on the 
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time and date for the focus group or interview. A stamped addressed envelope was 
provided with the consent form for ease. The health professionals from the 
gastroenterology service team were not aware which patients had agreed to 
participate in the research. However, in some cases when patients expressed an 
interest in the study and were willing to conduct the interview "on the spot", then the 
health professional would be aware and directed the patient to the interview room 
with the primary researcher.  
3.1.2.3.2 Health professionals  
Participating sites provided a list of eligible health professionals for those who had 
contact details (email or postal address) available. Consequently, the health 
professionals were contacted and recruited directly with the help and assistance of the 
mentors involved in the project. The prospective participants were initially approached 
by the collaborators at the hospital. The collaborators discussed the research project 
with the health professionals, and the information packs (the information sheet about 
the project, the research participant rights, the expression of interest form, the 
consent form, General Data Protection Regulation: Transparency Information and 
glossary) were distributed to them. The health professionals who agreed to participate 
signed the consent form, which was sent to the primary researcher who then 
contacted them to agree on the time and date for the interview. A stamped addressed 
envelope was provided with the consent form for ease. Some health professionals 
signed and scanned the consent forms and emailed them.  
3.1.2.4 Procedure for data collection 
Individual semi-structured interviews with open-ended questions were used for the 
health professional data collection so that the participants could "best voice their 
experiences unconstrained by any perspectives of the researcher or past research 
findings" (Creswell, 2015, p. 216). In addition, the interview with health professionals 
was preferred to the focus group from a practical point of view (i.e., busy schedule, 
availability at different times, possible power issues between nurses and doctors). 
 
Probing, prompting and summarising was used to help the flow of the interview 
(Holloway and Wheeler, 2010). A semi-structured one-to-one interview format with 
health professionals and a focus group format or interviews with IBD patients were 
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performed in English at a mutually convenient time in a private room at the hospital 
facilities or via the phone with health professionals.  
 
A focus group format was chosen to explore the patients' perception of the online 
psychological intervention programme. The focus group method is increasingly 
becoming accepted in health research, as it allows the exploration of complex 
behaviours and motivations and to collect the data quickly and cost-effectively 
(Holloway and Wheeler, 2010; Reed and Payton, 1997; Jayasekara, 2012). A focus 
group was preferred for the participant data collection method to stimulate memory 
and thoughts, facilitate and motivate discussion, leading to enhanced impulsive 
responses of participants and to explore the group’s dynamic (Jayasekara, 2012; 
Holloway and Wheeler, 2010). The participants' opinions emerging during the 
discussions in focus groups can bring the immediate evidence of similarities and 
differences in the experiences, compared to interviews were the comparability can be 
seen only in post hoc analysis (Morgan, 1997). During a focus group, participants are 
acting in response not only to the researchers' questions, but also to the other 
participants and the group dynamics, despite having similar experiences, opinions, and 
thoughts (Hesse-Biber and Leavy, 2011). Therefore, focus group interviews can be 
considered as moderated by group effects discussions (Taylor and Francis, 2013). 
Usually, the researcher would play the moderator role to influence the focus group 
dynamic and to stimulate the conversation flow and would in advance plan the topic 
guide for the discussion, which would be presented during the focus group (Hesse-
Biber and Leavy, 2011).  However, in the field of health sciences, focus groups tend to 
be less controlled and structured (Taylor and Francis, 2013). Therefore, in the current 
study, the primary researcher let the conversation in the focus group to flow. 
Simultaneously, to fulfil the research purpose the researcher took a moderator role 
and guided the conversation by asking the participants more specific questions and 
using prompts to encourage participants' involvement in the discussion. The procedure 
for conducting the focus groups followed 'Guidelines for Conducting a Focus Group' 
(Duke University, 2005). There is disagreement about the perfect number of 
participants in a focus group; however, it has been suggested that the group sizes 
should be between 4 and 12 persons (Holloway and Wheeler, 2010; Morse, 1994). 
Initially, the group of five people was chosen, for the participants to feel more 
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comfortable and to provide further opportunity for them to talk (Morse, 1994), with 
patients forming 2-3 focus groups to be run at three gastroenterology services in 
hospitals. However, there were difficulties in patient recruitment with only one focus 
group of three people recruited. To increase the recruitment, the research team 
offered an option of an individual interview to further participants. The relevant 
changes were made to the original patient recruitment pack (information sheet, the 
patient's consent form and invitation letter). The same topic guide was used for the 
interview as the focus group. These interviews were audiotaped, transcribed verbatim 
by the primary researcher and then, according to the Data Protection Act 1998, stored 
securely on the University of York servers. Data was collected until the point where 
information saturation was reached, that is until no new themes or the detail for 
existing themes could be detected (Creswell, 2015) and this determined the final 
sample size for participants (Kerr, Nixon and Wild, 2010). After the interviews with 12 
health professionals and 13 patients, the data reached saturation.   
3.1.2.5 Dissemination of findings 
All the participants were informed about the study results via email, as per their 
preference. A wider stakeholder network of organisations with interest in IBD, which 
includes the public, clinicians working in and outside the NHS, and charitable and 
commercial organisations involved in IBD and mental health were informed about the 
study result via newsletters. 
3.1.2.6 Study quality 
While arguably it is impossible for the settings to be totally unfamiliar or well known 
and "the researcher's insider-outsider status varies over the lifetime of a project" 
(Bourgeault, Dingwall and de Vries, 2010, p. 356), the researcher entered the settings 
as a "stranger" attempting to view the experience from the viewpoint of the 
participant to add validity to the qualitative research (Morse, 1994). The researcher 
gathered information using a triangulation strategy by encouraging patients to tell 
their story, using open questioning techniques, facilitating patients responses, picking 
up verbal and nonverbal cues, clarifying patients augmentation or ambiguous 
statements (Silverman, Kurtz and Draper, 2013; Miles and Gilbert, 2005; Patton, 2002), 
as well as writing the descriptive and reflective field notes (Creswell, 2015). A richer 
and balanced description of the phenomenon can be generated as a result of the use 
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of this strategy (Miles and Gilbert, 2005). The interviewer was a woman, a PhD 
student, who trained in medicine, public health and cognitive behaviour therapy (CBT). 
The participants had not met her prior to the start of the study, but they were aware 
that she was conducting the research as part of her PhD project. The primary 
researcher attempted to disregard her professional experience, affiliations in the 
research field, and methodological assumptions to reach the true understanding of the 
participants' perception (Bailey, 2008; Bourgeault et al., 2010; Ahern, 1999). It is 
inevitable that these influences could occur during the data collection, decision making 
on what important "findings" are, on the coding process and on how data should be 
analysed, but this was reflected through linking field notes and memos to the lines in 
the transcribed text (Bailey, 2008; Bourgeault et al., 2010; Ahern, 1999).  
 
The participants were invited to review the transcripts and comment on them, and the 
research team members cross-examined the process of the research to assure the 
trustworthiness of the study (Creswell, 2015). However, none of the participants 
expressed an interest in this. One health professional was asked to review the 
transcript of her interview, as there were technical difficulties with the recording of 
the interview, to make sure the presented information was accurate. The intention of 
the research was not to generalise the results but to ensure their transferability, which 
will be reached through a detailed description of the participants' perceptions 
(Creswell, 2015).   
3.1.2.7 Materials 
3.1.2.7.1 Topic guides  
After consultation with experts and literature review, an interview guide was 
developed to help focus the interview and still allow some flexibility (Miles and Gilbert, 
2005). For the interview and focus group topic guides see Appendix 11-12. This guide 
contained a list of open-ended questions, but if the participants deviated from the 
research topic or hesitated to speak, the researcher used short, helpful phrases and 
prompts to assist the steady flow of the interview (Taylor and Francis, 2013). The PPI 
person was able to offer input into the topic guide for the focus group to ensure it was 




It was anticipated that the focus group of the IBD patients would last up to 90 minutes 
and the in-person interviews would last between 25 and 45 minutes. The interview 
schedule was piloted with the PPI person and one health professional before the study 
commenced. The glossaries of terms to assist patients were distributed before the 
interview. The IBD patients who expressed an interest in taking part in future research-
related activities were invited to participate in the development of the intervention 
and the future feasibility trial.  
3.1.2.7.3 Health professionals 
A similar approach was applied to interviews with health professionals. It was 
anticipated that the in-person or phone interviews would last between 25 and 45 
minutes. All health professionals opted to undertake the interview over the telephone.  
3.1.2.8 Data Analysis  
Thematic analysis was used to analyse the interviews and focus group transcripts, to 
help move from broad qualitative data towards discovering patterns (Braun and 
Clarke, 2006). The method enables "systematically identifying, organising and offering 
insight into patterns of meaning (themes) across a data set" (Braun et al., 2019, p. 57). 
The method was chosen due to its flexible approach and accessibility and was driven 
by theoretical assumptions and the research questions  (Braun and Clarke, 2006). 
According to Braun and Clarke (2006), the thematic analysis should be carried out in six 
steps, which were followed in this study analysis:  
1. Familiarising yourself with your data 
2. Generating initial codes 
3. Searching for themes 
4. Reviewing themes 
5. Defining and naming themes 
6. Producing the report 
The field notes were read and revised, audio records were replayed, and preliminary 
reflection was written. The data were coded to help summarise its interpretation. The 
final primary codes were created by grouping the secondary and tertiary codes 
forming several levels of code within the primary codes (see codebook Appendix 21, 
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and concept maps Appendix 13, Appendix 14). All relevant codes were consolidated to 
form the themes. These themes were reassessed to see how they interrelated to each 
other and the whole data set. At this stage, the themes were split, combined with 
other themes or removed. Final themes were named, and an analytical description of 
the data written (Clarke and Braun, 2013). The analysis of the data was undertaken in 
two parts. At first, the health professionals’ and patients’ data were coded separately. 
The themes from both participant groups were closely aligned hence it was decided to 
combine them collectively with the differences and similarities discussed.  
 
After the data were coded, the themes emerged on the patient experience of living 
with IBD and anxiety and/or depression, according to the patients and health 
professionals. This data identified the perceived gaps in the management of the 
disease. NVivo was used to assist with the data analysis. The transcripts and analysis 
were checked and validated by other members of the supervisory team.  
3.1.2.9 Ethical Considerations  
The ethical approval for this study was obtained from the NHS Health Research 
Authority and the Department of Health Sciences Research Ethics Committee. All 
participants received written informed consent before they participated in the study. 
This research was conducted according to the requirements of the Declaration of 
Helsinki (World Medical Association, 2013). 
3.1.3 Results 
The data saturation was reached and determine the final sample size of 13 patients 
and 12 health professionals in this study. The focus group of three IBD patients lasted 
approximately 90 minutes. The in-person interviews with patients lasted between 25 
and 45 minutes. The interviews with the health professionals lasted between 20 and 
45 minutes.  
3.1.3.1 Demographics 
3.1.3.1.1 Patients demographics 
Patients’ ages ranged from 20 to 70 years old, with a median age of 45 years (Table 
10). Of the 13 patients included, nine had Crohn's disease and four had ulcerative 
colitis. Patients had different lengths since they were first diagnosed with some 1 to 2 
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years ago and others over 10 years ago, thus demonstrating the diversity in experience 
across the sample (Table 10). There was a relatively even split of genders in the sample 
with seven (54%) males and six (46%) females and all, except one, were Caucasian. Six 
participants were employed, two were unemployed, two were retired due to illness 
with an addition two who retired and there was one student (Table 10). A different 
number of patients were recruited from three different sites (six, five and two patients 
from the first, second and third site consequently) (Table 10).  
Table 10 Key demographic and illness characteristic of patient participants 
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3.1.3.1.2 Health professionals’ demographics 
Eight health professionals were female and four male. The age ranged from 32 to 54 
years old. The health professionals were consultant gastroenterologists, nurses, 
dietitians, or psychologists (Table 11). A different number of health professionals were 
recruited from three different sites (eight, three and one from the first, second and 
third site consequently) (Table 11). 
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Table 11 Key demographic characteristics of health professional participants 
Total number  12  










Age (years)  
 25–34    
 35–44    
 45–54    
 55≤   
Minimum age of participants  






















3.1.3.2 The experience of living with IBD and comorbid anxiety and/or 
depression 
The analysis identified that health professionals' and patients' responses to the 
experience of people living with IBD and comorbid anxiety and/or depression were 
distributed across three main themes: 1) bidirectional relationship between IBD and 
mental health, 2) the need for health care integration and 3) lack of awareness about 
the disease. The codebook in Appendix 21 provides the description of the reported 
codes and the frequency of their occurrence in both groups’ transcripts of the 
interviews. The concept maps 1 and 2 (see Appendix 13, Appendix 14) provide an 
overview of the codes and themes and their interrelationship. 
 
Regarding the experience of living with IBD and anxiety and/or depression, there were 
high levels of agreement between health professionals and patients observed. Three 
overarching themes were identified and demonstrated the complexity of this chronic 
long-term condition. The "bidirectional link between IBD and anxiety/or depression" 
theme indicated the importance of managing both the IBD and mental health 
simultaneously. Moreover, it indicated the importance of screening IBD patients for 
psychological health in line with the recent longitudinal follow-up study (Gracie et al., 
2018). The "lack of awareness about the disease" theme and "bidirectional link 
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between IBD and anxiety/or depression" signified the need for the "health care 
integration", the third identified theme, as a care model for these patients to 
overcome the challenges faced.  
3.1.3.2.1 Bidirectional relationship between IBD and mental health 
There was an agreement between patients' and health professionals’ views regarding 
the bidirectional link between IBD and mental health. The concept maps highlight 
several levels of the codes that formed this theme (Appendix 13); three primary codes 
were described here: IBD impacts on QOL, IBD impacts on mental health, and mental 
health impacts on IBD. 
 
All patients and health professionals agreed that IBD affected QOL. Mainly, IBD 
affected individuals' social and family life. Furthermore, participants thought that 
embarrassment with symptoms, being housebound, and having pain and fatigue that 
are difficult to manage also impacted on QOL. The patients recognised IBD’s influence 
on all aspects of their lives and the people around them, and thus influenced their 
QOL:  
"I think, it impacts hugely on the quality of life. […] because it places so many 
restrictions on you and on your family." (Patient 7, 67 years old, female). 
They also found that IBD symptoms were embarrassing and as a result, IBD influences 
their QOL and mental health: 
"I think […] nobody really knows how bad it is and because it's […] going to the 
toilet, and it's hard to talk about sometimes to people, like, at work, [...] you 
often find you go to the toilet, and they've not got solid walls, and it's 
embarrassing, and you know, it's things like that, that I had to deal with. You 
know, that’s what I find the hardest." (Patient 5, 56 years old, female). 
Both of these female patients had CD, and it has been suggested that female CD 
patients have a perception of the HRQoL worse than men (Saibeni et al., 2005). 
However, within this sample, males with CD also related similar impacts of IBD on QOL: 
"...when you have a flare […] it impacts your life because it is very restricting in 
both, work, family time, leisure time, it impacts every aspect in your life." 
(Patient 13, 32 years old, male).  
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Concurrently, some patients admitted that during remission they were able to live a 
reasonably normal life: 
"75% of the time I'm fine, but when I do have flare-ups and the problems, then 
it's very hard to get through the day."(Patient 11, 32 years old, male). 
Patients recognised that the diagnosis of IBD itself influenced their life. The reaction to 
the diagnosis differed among patients: denial accepted the diagnosis, hoped for a cure, 
traumatised by the news or became angry. One of the patients emphasised the 
importance of accepting the diagnosis:  
"It's not going to go away, better it stays part of me, but I don't want to define 
me." (Patient 1, 50 years old, male).  
Some patients thought that the IBD symptoms made them "housebound", which not 
only reduced their QOL and affected their mental health, but also, importantly reduced 
their ability to manage their disease. The patients were frightened to leave the house 
and were unable to attend their medical appointments. One patient said: 
"I don't leave the house for ages. [...] you so stressed to the point when [...] you 
don't want to leave in case you need to go, to the toilet. [...] it's horrible." 
(Patient 9, 20 years old, female).  
This indicated the need for flexibility in the management of the disease including 
remote management of the disease to reduce the need for the patients to attend clinic 
appointments, reduce the burden on patients and still allow the appropriate care and 
disease management of patients. 
  
Like patients, health professionals believed that IBD influenced patients' QOL as well as 
their mental health: 
"IBD is a chronic condition, so affects a person's QOL and mental health; people 
can become anxious or depressed." (Female, 43 years old). 
“I think it's about body image, the risk of stoma, medication, diarrhoea, 
urgency, potentially incontinent [...] people get very anxious. And if somebody 
has had an accident in front of, you know, colleagues at work, or the children in 
school, if you are a child or teenager that has a major impact on their mental 
health and can make people very depressed". (Male, 41 years old). 
However, the health professionals believed that the impact depended on the 
emotional resilience of the individual: 
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"I think, for some patients if IBD is managed well, it doesn't have a huge impact 
on patients. However, some patients with relatively moderate IBD symptoms, 
but they feel anxious and depressed." (Female, 43 years old). 
Both health professionals and patients believed that IBD influenced mental health. 
More specifically, IBD patients tended to become "anxious", "depressed", "stressed", 
have a sense of "being out of control" and had "fear and worry". One of the patients 
initially denied the presence of anxiety, then admitted to having it, but felt the IBD 
medication was the cause of it: 
"Yeah, like I say, I've never had anxiety regarding my IBD, but because of the 
drug that I am on for the IBD, [...] the symptoms are from this drug. This is what 
is giving me my anxiety. It is nothing to do with my actual IBD symptoms. It's to 
do with the fact that the drug inside me […] is giving me a side effect." (Patient 
11, 32 years old, male). 
Some of the health professionals also thought that the medication for IBD could 
influence mental wellbeing: 
"The other issue is we give a lot of steroids which can have a marked effect on 
people's mental health, causing, um..., exacerbating a mild depression, mania 
and other problems as well, psychosis [...]. So we can make people pretty 
unwell."(Male, 41 years old). 
Interestingly, some patients recognised themselves as being lucky about the support 
they received or in comparison to others, despite feeling unwell and having flares:  
"I was lucky; I had good support." (Patient 7, 67 years old, female). 
"I am lucky because I can play the game with my clients. [...] I work from home 
a lot so that I can manage it (Patient 3, 49 years old, male). 
Patients acknowledged different reasons for "being lucky", some, because of the 
support they had from the people around them, but some, because they compared 
themselves to others with a more severe course of the disease. The last statement 
above, reflected through the whole account, shows how important the experience of 
the others with IBD is to them. Thus, IBD patients with comorbid anxiety and/or 
depression are possibly seeking understanding and draw upon the experience of 
others with the same conditions.  They also talked about loneliness, which could be 
explained by the lack of awareness about the disease that came through in the other 
themes. Both health professionals and the patients agreed that anxiety and depression 
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influenced IBD. One of the health professionals said that mental health could affect the 
severity of the disease directly: 
"So psychological impact can affect directly the severity of the disease." (Male, 
54 years old). 
Patients often said that mental health, depression, in particular, led to the lack of 
motivation in treatment engagement for their IBD, and thus, created another factor 
that challenged the management of IBD in these patients. One person in the focus 
group said: 
"[...] when my depression was getting worse it's hasn't been for a long while, 
but when it's been very bad, you think what's the point of it all?" (Patient 2, 39 
years old, male). 
The other patients in this focus group agreed with this statement: 
"I'm just living with your phrase of what the point [...]. I cannot talk about a 
capital D, depression [...], but when I've been low, the motivation to try to make 
you better yeah, disappears." (Patient 1, 50 years old, male). 
"[...] I would think what I'm going to get up for, and [...] take the medication." 
(Patient 3, 49 years old, male). 
These comments suggest the need for health professionals to select the appropriate 
treatment (pharmacological or psychological) for this group of patients and to find 
ways to support them to engage with the treatment and this must be considered at 
the start of the treatment.    
 
Nevertheless, the majority of the health professionals and patients clearly and 
forcefully articulated the bidirectional link between IBD and anxiety and depression. 
The majority of patients said that one of the challenges in the management of the 
disease was mental health and its bidirectional relationship with IBD: 
"I think they are closely related, I think, one provokes the other. I think one can; 
I don't say that always does, but it's possible that the physical condition makes 
it more likely that you will also be mentally and emotionally, I think a little bit 
depressed." (Patient 6, 68 years old, female). 
"[...] that is a vicious circle." (Patient, 39 years old, male). 
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However, two patients said that this connection was only one way. One admitted that 
mental health made it difficult to manage IBD: 
"[...] my depression was worsening my Crohn's, not that my Crohn's [...] 
contributed to the depression." (Patient 7, 67 years old, female). 
Other said that IBD flare-ups were leading to a problem with mental health: 
 "It's the flare brings on anxiety and the low mood, not the other way round. I 
don't get another way round. [...] the trigger is IBD for the low mood." (Patient 
13, 32 years old, male). 
However, this patient admitted that after attending face to face psychological 
interventions they saw the improvement in how they felt, thus suggesting the 
bidirectional link.  
 
Regardless of speciality or hospital site, the health professionals, similar to the 
patients' views, identified the bidirectional relationship between IBD and mental 
health: 
"Because of the nature of the symptoms that it presents with and those 
symptoms then fuel further anxiety and low mood, which feed into the body 
and physical symptoms which create a vicious cycle between the physical 
symptoms and the emotional symptoms. So, I think, sometimes it's a bit of a 
chicken and an egg, to which one came first, but I think, either regardless which 
one came first it's a bidirectional relationship between the two.." (Female, 30 
years old). 
This link was not only seen as affecting a patient's ability to engage with clinicians and 
support services but also changing the adherence to medications and interventions, 
hospital readmissions and the ability to manage the disease: 
"You can have some very healthy patients who tolerate high degrees of 
disability from their disease and are not heavy resource users, and  the disease 
sorted out, and they’re still able to fulfil their life goals, against those who are 
more anxious […], and have a greater degree of impact, but less resilient and 
who has a smaller degree of symptoms actually causing their disease to have a 
great impact on their life. So, I think, there are both direct effects on the 
severity and also an indirect effect on the ability to deal with the same degree 
of disability." (Male, 54 years old). 
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Additionally, it was recognised that IBD symptoms could be over or underestimated in 
people with comorbid anxiety and/or depression, hence leading to inadequate 
treatment: 
"So, when somebody has anxiety and cannot control it, they would downplay 
their symptoms in order to avoid having an investigation from a 
gastroenterologist, such a colonoscopy. Similarly, but, you know, in a different 
way, if the patient is depressed and anxious and you’re using a pain score. So, if 
they are depressed and anxious and score more or highly on, "I feel ill", or "I 
have pain", they will score higher on that. Therefore, they have the potential to 
be overtreated [...] and then also lack of compliance with the treatment." 
(Male, 54 years old). 
Therefore, the treatment of mental health in this population appears to improve the 
management of the IBD itself.  
3.1.3.3 The lack of awareness about the disease 
"The lack of awareness about the disease" was reported as one of the challenges in 
managing IBD alongside anxiety and/or depression by many patients. The primary 
codes included in this theme were: "patients unaware of the psychological problem", 
"lack of awareness about mental health issue among health professionals", "look well 
outside and be rotten inside".  
Patients reported a lack of awareness among health professionals about mental health 
issues in patients with IBD:    
"[...] consultants perhaps need to be more aware that they not just dealing with 
a medical side of it, not just dealing with the surgical side, but there are mental 
health issues." (Patient 7, 67 years old, female). 
Despite health professionals admitting they did not actively assess patients for anxiety 
and/or depression, they were aware of the bidirectional link between anxiety and/or 
depression, as reported earlier, and in some cases patients would be referred for 
psychological help. Possibly, scarce resources and short appointment times with the 
gastroenterology team were culpable for this rather than lack of awareness about the 
mental health issues among health professionals. 
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Both health professionals and patients thought that sometimes IBD patients were not 
aware of the anxiety and depression or did not admit that it was present. Patients 
thought:    
"At first, you don't know you're suffering from depression. [...]. I thought it was 
me failing to cope with the illness." (Patient 7, 67 years old female). 
"[...] they're not really been truthful to themselves or don't want possibly admit 
certain elements of their persona or psychological health. That's not right." 
(Patient 3, 49 years old, male). 
Health professionals also confirmed: 
"A lot of them don't realise that they have it..." (Female, 53 years old). 
This connected to the other theme "need for the health care integration", where 
health professionals admitted that they were not actively asking patients about their 
mental health and were not trained to assess mental health and only relied on their 
personal judgment.  
 
Patients also highlighted a lack of awareness among the public, but health 
professionals did not raise this issue. One female patient with Crohn's disease said: 
"You look well on the outside, but you're absolutely feeling rotten on the inside 
[...]. I've lost quite lots of weight, and [...] I was so tired, but everybody thought I 
looked very well [...] you don't want to wear a budge [...] they don't see it as an 
illness, because you can't see it. If I had a pot on my arm, I'd be ok, because 
people can see that [...] you don't often get the consideration." (Patient 5, 56 
years old, female). 
"I think the quality of life is affected because people don't understand it. 
Because it's invisible. Therefore, people look at you and believe that you are fit 
and well and unfortunately you are not. You are not able to do some of the 
things that other people could do. So, peoples' expectation of you high and you 
can't deliver, because you can't deliver. [...]Because you cannot, it's not just 
about you, it's how other people perceive you. I often, if I had a really bad flare, 
I don't use the disabled toilets, unless I believe that I do not have choice but to 
do so, because I wouldn't. I think facilities need to be used how they should not 
just not take for granted. If I use the disabled toilet, the comments that I get or 
the looks that I get, or how people perceive me actually adds to my mental 
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anxiety because people don't understand that I look well but I am not" (Patient 
12, Female, 59 years old). 
3.1.3.3.1 The need for health care integration 
Health care integration was a combination of a few primary codes: "Cinderella 
services", "team of people should care for IBD with comorbid anxiety and depression", 
"holistic care", "both health professionals and patients should manage IBD with 
anxiety and/or depression", "research is good".  
 
The agreement between health professionals and patients view was observed 
regarding "Cinderella services", which included a lack of resources, the waiting list to 
access a psychologist, and limited psychological support. Many patients raised these 
problems. One patient said: 
"[...] mental wellbeing [...] they don't take it seriously. And all of the funds are 
being taken away from those things that you cannot see, those invisible 
illnesses that are not at the greatest risk. [...]. But the reality is, if you threw 
resources earlier [...] you would be able to divert those people on much earlier 
stage. [...] the nurse has 10 minutes appointment [...] for someone who has a 
chronic illness is ridicules. [...]. We expect to go to charities to find information 
now because there is not enough support in service. [..]. If I went to my GP and 
said I am now no longer able to cope, can I have counselling? There would be 
nine months waiting list, by which point, I would probably slit my wrists." 
(Patient 12, 59 years old, female). 
Like  patients, all health professionals commented on the shortage of psychologists, 
who should be part of the team in caring for people with IBD and comorbid anxiety 
and/or depression. The waiting list to see a psychologist impacted negatively on the 
patients’ experience and satisfaction with health care. It was suggested by health 
professionals that such "Cinderella services" prevented the IBD team from being able 
to treat patients appropriately: 
 "We have very limited psychological support at the hospital that we have to 
save for our in inverted commas for the worst patients if you like, which means 
that we don't overly promote it because we haven't got the resources to fulfil 
patients', you know, expectations and needs." (Female, 52 years old). 
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Additionally, health professionals believed that there was a major failure for IBD 
patients to appropriately link with mental health care services. The overstretched 
resources where an issue for all health professionals; however, it was evident that 
some hospitals had better psychological facilities for patients than others.  Despite 
having moderate waiting lists, some hospitals, had a specific gastro-psychology team 
to support these patients, while others, did not have a psychologist in the department 
or have links with the psychological services/departments. The health professionals 
pointed out the differences in availability of psychological support for patients at 
different locations: 
"We are very fortunate in [hospital location] that we have psychological 
facilities for patients, lots and lots of hospitals, the majority of the hospitals 
around the UK don't have that. So when I go to meetings and listen to other IBD 
colleagues, I always feel that we are lucky to have the services that we have. 
[…] Knowing what you can have and knowing what you are not delivering to 
patients, it's difficult sometimes, but then I feel for those people who have 
nothing at all." (Female, 52 years old). 
This might reflect the concept of the NHS postcode lottery, leading to differences in 
access, quality and availability of NHS treatment/services throughout the country. This 
also corresponded with the patients' opinion of an inability to get psychological 
support and long waiting lists to see a psychologist (in some cases being over 15-18 
months), with the longer waiting list in areas where health professionals indicated 
poor integration with psychological services/departments. 
 
Health professionals and patients agreed that the team of health professionals need to 
care for people with IBD and comorbid anxiety and/or depression. All health 
professionals indicated this: 
"I think to look after IBD patients; you need a complete team, you need your 
gastroenterologist, [...] you need the nurses to support them and the patients. I 
think you need GPs to be involved; you need the psychological support, um, 
available through whatever format that comes in, whether it be face to face 
whether it becomes over the Internet, whether it's via GP. I think we need all of 
it there, to work together, so everybody is working together to support patients, 
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and enable them to access the services where they actually want." (Female, age 
not indicated).   
More specifically, both patients and health professionals regarded the need for 
different skills from different specialities to provide holistic care. One health 
professional acknowledged that holistic care relies on the IBD nurse:  
"So, we probably have more time to spend on counselling, supporting patients 
than a gastroenterologist would and actually, you know, the training you get, 
the nurse gets, is very different to that of a gastroenterologist. So, you know 
holistic care is perhaps more a focus for a nurse, but certainly, you know 
everybody needs to have their expertise, you know, the gastroenterologist, the 
nurses specialist, the dietician, the pharmacist, psychologists, you know, we 
have different roles, haven't we." (Female 53 years old).   
However, some disagreement was observed in the discussion of holistic and integrated 
care. While health professionals felt that they provided holistic care for the patients, 
patients felt that, despite having supportive IBD nurses and gastroenterologists, they 
did not receive holistic care as part of their IBD management. Yet, the patients and 
health professionals acknowledged that the reason for this was poor funding and 
overstretched resources for the "invisible illness". Additionally, the health 
professionals and the patients highlighted the deficiencies in health care integration.  
 
Many patients acknowledged that they received fragmented care: 
"[...] a holistic approach to things [...] rather than everything in 
isolation"(Patient 2, 39 years old, male).  
Despite praising the IBD nurses for being supportive and a few patients, with a few 
being offered psychological help, the patients felt that there was no continuity of care 
or holistic care:   
"[...] a problem for IBD patient is fragmentation of treatment. [...]. I had to go to 
3 different hospitals. [...]. I have lots of different medications. [...]. I have been in 
the situation sometimes when they prescribe medication [...] then another 
consultant would tell me that it's not good and prescribe me something else." 
(Patient 12, 59 years old, female).  




"[...] not managing the mental wellbeing [...] is a false economy, total false 
economy. Because the reality is if we put  prevention  measures in place [...] and 
we put the support mechanisms in place, we would save ourselves so much 
money down the line in terms of NHS expense." (Patient 12, 59 years old, 
female).  
There were mixed responses about support from general practitioners (GPs), some 
believed that they do not get support from GPs for their IBD: 
"[...] he knows that I know more about IBD than he does because he is the 
generalist." (Patient 3, 49 years old, male). 
On the other hand, some patients said that they accessed psychological support from 
their GPs: 
"I spoke to my GP, and that was the first time any medic knew about it. And she 
was a huge support." (Patient 7, 67 years old, female). 
Some patients reported that they did not feel supported or trusted health 
professionals: 
"[...] having 30 years of illness that was never diagnosed and made me feel so 
bad. It means it affects my trust (Patient 12, 59 years old, female).  
"They are not as helpful as they should be. They just refer you off to somewhere 
else, and there is a waiting list of 28 weeks." (Patient 9, 20 years old, female). 
At the same time, this patient wanted to be supported by health professionals 
regarding their anxiety and depression. This suggested that the patient was 
disillusioned about the lack of support rather than being about trust. 
 
One of the patients expressed fear of being judged if they were open about 
psychological issues to the gastroenterology specialist and said that there was a 
gender difference in the care they received, admitting that they found female doctors 
were more sympathetic: 
"I doubt I could open so much to the male doctor [...] I can talk a lot easier to a 
female. [...].  I found them a lot more understanding to your views, [...] male [...] 
they are thinking you are weak men; you are not really." (Patient 8, 70 years 
old, male). 
Integrating health care could address these issues with routine screening for 




Most patients were not receiving any form of psychological support and were relying 
on family members and friends for support:   
"It's really been family and friends [...]. My husband; he gets a lot." (Patient 5, 
56 years old, female). 
However, patients would like to protect their family from their disease burden: 
"[...] it actually feels very lonely, and I feel the only person who can help is me. 
Because even close family members, you can describe it they cannot live it. [...] 
you don't want them to face some of the heartbreak that comes with it. You 
want to protect other people, and therefore your mental wellbeing has to take 
second place really." (Patient 12, 59 years old, female). 
Therefore, the patients still felt alone with the disease: 
 "It's a very lonely place" (Patient 13, 32 years old). 
"I'd like to talk to the people, but [...] some things are hard" (Patient 11, 32 
years old, male). 
Patients felt the need "get it off their chest": 
"[...] not everyone needs talking therapy, but if everyone has a chance at lease 
to talk about it." (Patient 1, 50 years old, male).  
The patients felt like they were alone with the disease and expressed interest in being 
involved more closely in the management of the disease alongside the health 
professionals. They thought that both patients and health professionals should work 
together and be involved in the management of IBD alongside anxiety and/or 
depression: 
"I always thought that there're two experts in the room when I go to an 
appointment. [...] I'm the expert in me, and they are the experts in the 
condition. So, I always kind of wanted that equality or taken responsibility." 
(Patient 1, 50 years old, male). 
This suggested that some patients were willing to be involved in self-directed 
interventions, where they could take responsibility for the management of their 
disease. However, some patients admitted that people with depression and anxiety 
were less likely to manage on their own: 
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"Obviously, if somebody in a really dark place with depression. They are less 
likely to manage everything." (Patient 3, 49 years old, male). 
"If I was in a place where psychologically I was less able,[...], then I'm going to 
need someone who kind of shake me and say you don't understand, but this is 
what you need. [...] because you wouldn't be able to do that working out." 
(Patient 1, 50 years old, male). 
These findings suggest the need for some support from health professionals and the 
need for precision medicine as each patient's needs are different. Therefore, the 
approach to the treatment and management of the disease should be individual. From 
a patient’s perspective:  
"Each IBD patient is different because the autoimmune disease would mean 
different things for different people." (Patient 7, 67 years old, female). 
"Their needs form medical professionals are all slightly different." (Patient 3, 49 
years old, male). 
The importance of integrated and tailored care for patients was reported by patients 
who for different reasons were unable to attend treatment at the hospital. A patient 
who suffers from IBD and social anxiety and depression refused psychological help that 
was offered as this required leaving the house and attending an appointment at the 
hospital: 
"I've been offered a counselling, [...], but I can't, I won't walk out of the house. If 
[...] you could have your counselling at home because you don't want to leave 
the house. [...] I said no because it's bad enough when you go for your review or 
your tablets or [...] right now, my hands are sweating because all I want to do is 
get back in the car and go home."." (Patient 10, 45 years old, female). 
This patient expressed a desire to have appointments at home or at the hospital but 
from a collaborative/integrative care standpoint being on the same date and at the 
same time rather than attending different departments at different times.  Further, a 
few patients had a fear of hospitals/doctors, which could prevent them from attending 
the appointments and receiving treatment: 
"I have a real phobia of doctors, a real phobia for hospitals. The minute I know 
I'm driving to the hospital, my heart will go ten to the dozen, because [...] 
having 30 years of illness that was never diagnosed and made me feel so bad, it 
means it affects my trust." (Patient 12, 59 years old, female). 
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One elderly patient did not want to take the medications prescribed for their 
depression: 
"Doctors that I saw gave me pills for my depression. I did that for about six 
months but then decided that makes you so wacky. And I, don't get me wrong, I 
was feeling well, but sort of spaced out. So, I decided to come off them." 
(Patient 8, 70 years old). 
This patient wanted access to a psychological intervention to tackle his depression and 
chose to access this privately rather than through the NHS. Some other patients also 
highlighted the cost involved in IBD management: 
"I had to retire on the ground that I can't longer work and I'm 59. I didn't choose 
that, but I pay for everything, I pay for my car parking, I pay for my 
prescriptions..." (Patient 12, 59 years old, female). 
This patient reported that having a team of people involved in the management of 
their care reduced costs as sometimes there was no agreement about prescriptions 
from different doctors in different departments and hospitals and that is could be 
avoided in an integrated care model.      
 
Contrary to the patients' view, the health professionals felt that they gave holistic 
support to patients in the form of reassurance for them and their family members, 
talking about the medication and answering their questions: 
"Right from the very beginning, once the patient has a diagnosis of 
inflammatory bowel disease then one of the IBD nurses will become involved in 
the patient's care, and psychological aspects are a part of the holistic care that 
we give, from management [of their] diseases to management of psychological 
aspects as well." (Female 52 years old). 
Some health professionals felt that holistic care was delivered by the team of people 
involved in the management of complicated IBD: 
"I see patients in the clinic, and I also support the IBD nurses in their clinics and 
the IBD MDT where [...] nurses, radiologists get together to discuss the 
management of patients with difficult or challenging IBD." (Male 49 years old). 
Many health professionals acknowledge good cooperation between departments and 
services. This point was supported by good referral procedures to the other 
department/services and GPs: 
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"I would send them to the psychologist in the hospital. Or, if there's a more 
serious problem, I may refer them to a GP for an assessment to see if they are 
depressed." (Female, 43 years old). 
Health professionals highlighted, that despite having different experiences with 
referring patients for psychological help, when they did access it, they had positive 
outcomes: 
"[...] when you see the patients before and after, we’re lucky that we can see 
that in the clinic and you definitely notice a vast improvement in the patients." 
(Female, 53 years old).   
At the same time, health professionals acknowledge that they do not have special 
training in mental health assessment. The recognition of the mental health problem 
and the referrals rely on the personal judgment of the IBD nurse or gastroenterologist: 
"I suppose that one of the challenges is making an assessment in the first place, 
but in terms of resources, the training that I had has been very, you know, 
learning training on the job kind of, but I have not done any formal training in 
my formal (speciality) education, but everything else was kind of learning 
through the years of experience." (Female, 52 years old). 
However, even though all health professionals reported a bidirectional link between 
IBD and anxiety/depression, they admitted not vigorously screening for mental health 
issues: 
"...we don't currently actively pursue patients looking for any signs of anxiety 
and depression." (Male, 54 years old). 
Many patients understood that gastroenterology teams were not trained to deal with 
mental health issues and felt they should recognise the problem and refer to a 
specialist: 
"[...] certainly, the gastroenterologist and specialist nurses are not equipped to 
support people with more severe psychological needs, and I don’t think they 
should be. I think what they need to be skilled at is [...] refer the person to the 
specialist’s help. So they need not to be afraid of the psychological risk of IBD" 
(Patient 1, 50 years old, male). 
As a result of the fragmented care received by IBD patients with anxiety and/or 
depression,  many patients found their way of coping with the disease. Some of these 
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coping strategies included: exercise, "pre-plan" and use distraction. These findings 
suggest that behavioural activation and goal setting were acceptable to patients. One 
of the patients said: 
"I read a lot, so I would immerse myself in something that I really love [...]. I 
would walk. [...]. It's a distraction. I take my mind off it." (Patient 6, 68 years 
old, female). 
One of the patients did not want any external help: 
"I'm not keen on outside interference unless that absolutely necessary. So if I 
thought my life..., yes I would go to the doctor, but if I just feel the kind of 
depression or anxiety where I know what it's caused by, you know, because I 
have a flare-up of the colitis that really isn't something that needs medical or 
psychological interference [...]. It's not something that I want to, have to involve 
a lot of other people with. And I can manage it easier myself, than having 
everybody making an issue of it [...]. I think it makes it worse. It emphasises it; it 
makes it more important. The more people you have talking about you: are you 
worrying, do you feel ok, do you feel anxious, and that makes you anxious. It's 
sometimes better to just look after it yourself." (Patient 6, 68 years old).  
Interestingly, the principal concern of this patient was loneliness, and this was the only 
patient who had no support from their family members.  
 
One patient thought that any kind of research was very important in the management 
of the disease: 
"[...] any research or anything that is going to make a difference is while 
worthwhile. [...] in terms of mental wellbeing not just for IBD [...]." (Patient 12, 
59 years old, female). 
This was supported by another patient who, after the interview, said that the reason 
for taking part in this study or any other research in the future was that it might help 
to manage IBD if not now then for the future generations. 
3.1.4 Discussion 
To the author’s knowledge, this is the first qualitative study exploring patients' and 
health professionals' views about patients' experiences of living with IBD and comorbid 
anxiety and/or depression.  
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The bidirectional relationship between IBD and mental health 
Throughout all the themes, the psychological experiences of those living with IBD and 
comorbid anxiety and/or depression were emphasised. Participants identified IBD’s 
negative influence on mental health and quality of life. They also acknowledged their 
need for psychological support. The bidirectional relationship between IBD and mental 
health theme highlighted the importance of addressing both conditions in 
combination. In previous studies, patients with IBD have been found to have reduced 
quality of life and a significant level of psychological co-morbidities, including anxiety 
and depression, particularly during active disease (Mikocka-Walus et al., 2016b; Devlen 
et al., 2014; Byrne et al., 2017). The level of anxiety and depression is often high in IBD 
patients, and both have an overwhelming impact on QOL but also on increased levels 
of complications and hospitalisation (Mikocka-Walus et al., 2016b; Navabi et al., 2018; 
Zhang et al., 2013).  
 
The need for health care integration  
The link between IBD and mental health services was a common concern among 
health professionals. It was noticeable that the collaboration between psychological 
and IBD services differs at different hospital sites included in this study. This was 
supported by patients’ experiences such as long waiting lists to access a psychologist 
and the lack of psychological resources available to them. Patients also felt that IBD 
nurses and gastroenterologists were not trained in delivering psychological help, but 
they should recognise the mental health problems in IBD patients and refer them to 
specialist services. This result is in line with the second European evidence-based 
Consensus on the diagnosis and management of Crohn's disease, which 
recommended: "training of gastroenterologists to integrate psychosocial factors in 
clinical practice" (Van Assche et al., 2010). Both health professionals and patients were 
aligned in their response and agreed that a team of people should care for people with 
IBD and comorbid anxiety and/or depression.  
 
The recent audits (first audit n=233, second n=228), to measure prevalence, patient 
participation, and potential benefits to mental health and/or quality of life of 
integrated psychological screening and intervention model, suggested that the 
integrated care model is more effective than the traditional biomedical model (Lores 
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et al., 2019). Thus, patients with IBD should be offered integrated biopsychosocial care 
which includes a combination of gastroenterological and psychological treatments in 
addition to dietary counselling and other health services as required (Van Assche et al., 
2013; Van Assche et al., 2010).  
 
In England, Improving Access to Psychological Therapies (IAPT) programme that offers 
psychological therapies for patients with anxiety or depression was implemented by 
the NHS in 2008 (Clark, 2011). The evidence from several studies suggested that there 
is a need to revise the method of operating of IAPT service and possibly tailoring 
available with IAPT programme psychological therapies to improve the outcomes 
(Scott, 2018; Perez et al., 2018). The recent report showed improved waiting times, 
referrals completion, recovery, reliable improvement and reliable recovery outcomes 
as the result of the IAPT use (NHS Digital, 2018). Despite this and despite of the 
proposed new integrated model of care for patients with a long term condition (LTC) 
(National Collaboration for Integrated Care and Support, 2013), it was stated that a 
majority of patients with common mental disorders symptoms were not receiving 
treatment, and an inequalities in the access to the treatment were present (McManus 
et al., 2016). This - with increasing demand for services - has led to increased waiting 
lists (BMA, 2018).  
 
These findings are in concordance with the findings from the present study which also 
determined a lack of resources, a long waiting list to access a psychologist, and limited 
psychological support. The evidence from recent studies demonstrated that scarce 
healthcare resource led to increased use of self-management in the treatment of the 
chronic conditions, and it showed the promising result in the management of anxiety, 
mood disorders (Shepardson, Tapio and Funderburk, 2017; Kidd et al., 2017) and IBD 
(Kennedy et al., 2004). However, there are only a limited number of self-management 
interventions available for IBD patients requiring new robust studies in the field  (Tran 
and Mulligan, 2018). Nevertheless, some patients with anxiety and depression, as 
demonstrated in the findings presented in this Chapter used a variety of self-
management strategies. This is consistent with the findings from recent qualitative 
research on self-management for mood and anxiety where patients used variety of 
self-management strategies (Villaggi et al., 2015). A personalised guided self-
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management treatment can reduce visits to primary care and hospitals as evidenced 
by the RCT where patients applied a treatment protocol developed by clinicians to 
manage an IBD relapse (Robinson et al., 2001). Interestingly, this study also showed 
that prior to the trial almost 25% of the patients attempted to treat relapses 
themselves unguided. Therefore, guided self-management may potentially make self-
treatment safer (Robinson et al., 2001). Furthermore, self-management could reduce 
the utilisation of the healthcare system (Barker et al., 2018), thus, possibly, could be 
considered in the care model of IBD patients with comorbid anxiety and/or depression.    
 
Presently, an integrated care model is recommended for all IBD patients (Mikocka-
Walus et al., 2012b). NICE also advise that IBD patients should be cared for by a 
multidisciplinary team of specialists with a maximum of four weeks for assessment by 
a specialist (NICE, 2019b). Unfortunately, this advice remains at the guidelines level 
and has not been applied in practice, as highlighted in the findings presented in this 
Chapter. 
 
Despite receiving some support from the gastroenterology team and in some cases 
from the GPs, most patients felt that the NHS let them down and they were left alone 
with the disease. They also recognised that they did not receive holistic care, the care 
they received was fragmented, and they were not involved in the management of the 
disease. These findings revealed the need for health care integration. This theme is 
broadly consistent with the result from a recent survey conducted in Scotland, where 
participants expressed the need for a holistic care approach in the management of IBD 
(Schoultz, Macaden and Watson, 2016).  
 
The NICE guidelines highlighted the importance of providing holistic, integrated care 
for IBD patients (NICE, 2019b). However, they predominantly focused on the 
management of the physical symptoms of IBD. These guidelines recommend support 
for psychological wellbeing in IBD. However, there is no detailed advice on the 
management of psychological co-morbidities in IBD. Similar to the result from the 
survey in Scotland, participants in the current study wanted, in addition to the IBD 
clinicians, integration of other specialists, including a psychologist, in their IBD care 
team, which would contribute to better management of the disease. Jordan et al. 
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(2018) also concluded that patients with IBD and anxiety and low mood wished for 
psychological support from a clinician specialised in the IBD knowledge, showing the 
need for the integration of care and better access to specialists as opposed to GP 
driven IBD care.  
 
Health professionals and patients expressed the lack of psychological resources 
available to patients with IBD and comorbid anxiety and/or depression as a common 
occurence. Inadequate government funding might explain such findings. There is a 
need for the health professionals to actively assess for mental health problems in IBD 
and inform patients about the high prevalence of anxiety and depression among IBD 
patients and if needed to refer for psychological intervention. Furthermore, the 
probability of patients with mental health issues to actively seek help is reduced due to 
the stigma associated with the providers of psychological and psychiatric services 
(Corrigan, Druss and Perlick, 2014), thus the establishment of an integrated health care 
model with psychological services attached to current IBD services increases the 
probability of patients feeling able to seek psychological help. However, some 
hospitals unambiguously had better psychological services than others. This was also 
articulated by health professionals. The patients had better psychological support with 
shorter waiting lists to the psychologist where gastroenterology department had a 
gastro-psychology service with a clinical psychologist specialising in gastrointestinal 
diseases in place. The debate about the geographical disparity in health is not new, 
and the term NHS postcode lottery increasingly used (Public Health England, 2017). 
The access to services and the quality of care are inconsistent across the country, and 
their availability and sufficiency depend on where people live (Care Quality 
Commission, 2018). 
 
Patients in the current study expressed a desire to be involved in the management of 
their disease collaboratively with health professionals and highlighted the supportive 
role of the family. Similarly to the current findings, the results of another recent study 
that examined patients’ views on lived experience with Crohn's disease also 
emphasised the need for the collaboration between patients and health professionals 
in the decisions about IBD treatment (Norton et al., 2012). The importance of the 
supportive family role for IBD patients was identified within the current study and has 
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been recognised by quality standards (NICE, 2019b). Furthermore, NICE also 
recommends, if possible, for health professionals to consider and encourage family’s 
and friends’ support and involvement in the treatment and care of IBD patients (NICE, 
2019b). It has been suggested that the principal concern of IBD patients and health 
professionals varies considerably as patients thought that health professionals did not 
believe them (Fourie et al., 2018). Moreover, from patients' view non specialists health 
professionals had limited IBD knowledge and could not provide the information about 
the disease (Fourie et al., 2018). This emphasised the importance of patients' and their 
family’s involvement in the IBD management and participation in self-directed 
interventions.  
 
The assessment and management of anxiety and depression were critical to both 
health professionals and patients, with both groups discussing the bidirectional 
relationship between mental health and IBD. The implementation of new strategies in 
the management of IBD with the integration of psychological services could improve 
the course of the disease and patients' QOL (Yanartas et al., 2016; Gracie et al., 2018). 
Consequently, the findings from the current study suggest the need for a new way of 
improving accessibility to psychological help which could improve patients' QOL and 
relieve the pressures from NHS services. The implementation of a new mode of 
delivery of the psychological intervention, as an online self-directed psychological 
intervention, into the management of IBD patients with comorbid anxiety and/or 
depression could ease the access to psychological help.  
  
The lack of awareness about the disease 
Overall, the findings indicate that mental problems in IBD patients are an under-
recognised health concern. Patients reported a lack of awareness of mental health 
issues among health professionals. Health professionals also admitted that they did 
not proactively look for signs of a psychological problem such as anxiety and 
depression in IBD patients. This could show the lack of awareness, but also perhaps, 
that health professionals would prefer not to find any psychological issues in IBD 
patients as they would have to refer patients for psychological help which is scarce. 
Increasing health professionals' awareness may improve the link between mental 
health and IBD treatment services though it will not change the problems with funding. 
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These findings add further weight to the conclusions from other studies suggesting the 
need to increase awareness about mental health in IBD among health professionals, 
introduce screening for these factors, and have a referral system to mental health 
services in place for further diagnostics and treatment (Faust et al., 2012; Mikocka-
Walus et al., 2016c; Mikocka-Walus et al., 2018). Enhancing knowledge and awareness 
about the mental health issues faced by IBD patients among health professionals and 
the establishment of routine screening for anxiety and depression in IBD clinics could 
improve patients' referral for psychological help and in turn, could improve the 
management of IBD (given the “bidirectional relationship” identified). However, failing 
to identify the mental health problem prevents people from obtaining help and access 
to the best available treatments (Corrigan et al., 2014). IBD patients' QOL could be 
improved by increasing awareness about the disease itself and the challenges faced by 
patients in the management of IBD among the public and health care professionals, by 
increasing understanding and improving provision of services (Bray et al., 2016).  
  
Patients felt the lack of knowledge about the disease among GPs and society. The lack 
of knowledge about IBD among non-specialist health professionals and public reduced 
patients’ ability to self-manage which has been reported in the other qualitative study 
(Cooper et al., 2010). The lack of awareness among non-specialist health professionals 
could lead to delays in diagnosis and thus in accessing care (Angelberger et al., 2009; 
Avedano, Lönnfors and Vermeire, 2014).  
3.1.5 Implications 
The findings from this study indicated a bidirectional relationship between IBD and 
mental health and the need for integrated care for IBD patients with comorbid anxiety 
and/or depression. The lack of psychological support was a significant challenge in the 
management of the disease. Patients and health professionals discussed the lack of 
psychological support for IBD patients and the lack of integrated care as a major 
concern for IBD patients with anxiety and/or depression. Thus, the findings indicate 
the need for the new provision of care for this population of patients which should be 




The lack of awareness about the disease suggests the need for implementation of 
activities designed to raise awareness about the disease among public and health 
professionals.    
3.1.5.1 Future research 
Future qualitative research could examine the concepts explored in this research in 
different geographical locations to examine the generalisability of the findings from 
the current study.  
3.1.5.2 Strengths and Limitations of the study 
The strength of this research lies in the data coding being conducted thoroughly and 
systematically. The research team members cross-examined the process of data 
collection and analysis to assure the credibility of the study. The study generated an in-
depth analysis of the patients’ and health professionals’ views about the patient's 
experiences of living with IBD and anxiety and/or depression not possible relying on 
quantitative only.  
 
This study has some potential limitations. First, the questions that were used for the 
interviews could have been improved by being more specifically related to the overall 
aims.  Some questions were not clear for the participants, hence required explanation 
from the researcher, which in turn could have influenced the response from the 
participant. It is possible that patients who did not require explanation understood the 
questions differently. On the other hand, there were other cross-questions and 
prompts used to verify the information answered by the participant.  
 
Some patients did not always answer the question with a specific focus on themselves 
but commented on their thoughts of other patients’ experiences and views, which 
might not reflect their own perspective.  
Another limitation of this study is that the anxiety and depression of a few IBD patients 
were managed well at the time of the interview. Hence, their answers could have been 
different if they had suffered from acute anxiety and depression currently.  
 
There were no difficulties in the process of recruiting health professionals to the study. 
However, the recruitment of the patients depended on the health professionals 
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involved and, hence, took longer than originally anticipated. The patients who 
expressed interest in participating in the interview were more likely a motivated group 
of patients, thus demonstrating an element of the convenience sampling. 
 
On the other hand, the study also recruited less motivated patients. One patient was 
observed to reject any form of outside help. They were satisfied with the management 
of psychological issues, which mostly consisted of distraction and were not motivated 
to seek outside help.  
 
The limitations of the qualitative research design should be considered. The study 
examined the population of patients and health professionals in hospitals in one region 
of England. The rich exploration from three different sites highlighted their different 
perspectives, but the study findings could be tested in different geographical areas to 
explore if the findings differ between locations.  
 
The study had some methodological limitations. The interview with patients took place 
in the hospital facilities, and some patients highlighted that they had a fear of hospitals 
and doctors. In other instances, patients had social anxiety and would prefer not to 
leave their home hence the interview had to be shortened to reduce the stress for 
patients. Although these patients provided very valuable data, future studies should 
consider a different place for the interviews, such as patients' home, cafe, or 
community buildings to reduce the stress on the participants. Therefore, they would 
be more engaged in the interviews and, perhaps, provide more in-depth data.  
3.1.5.3 Conclusions 
The current study gathered important data on the patients' and health professionals' 
views about the lived experience of patients with IBD and anxiety and/or depression. 
The themes of a bidirectional link between IBD and mental health, the need for 
integrated care for IBD patients with comorbid anxiety and/or depression, and the lack 
of awareness about the disease were identified. One of the main challenges that the 
patients faced was a lack of psychological support, thus, indicating the need for the 
implementation of a new, more accessible care model for this population where 
psychological care would be more easily available.  
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4 Chapter 4: Patients' and health professionals' views about online 
psychological interventions (PI) for inflammatory bowel disease 
(IBD): a qualitative exploratory study.  
Chapter 3 showed that there was an extensive unsatisfied need for psychological 
support in IBD patients with comorbid anxiety and/or depression who received 
standard IBD care. The lack of resources and funding for mental health support within 
the NHS warrants the development of online psychological programmes. This chapter 
looks at the patients' and health professionals’ views about online psychological 
interventions (PI), including their understanding of the intervention and willingness to 
utilise online PI. Furthermore, this chapter reports barriers and facilitators for the 
implementation of the programme. A prototype of an online intervention is also 
proposed in this chapter. This prototype is an early illustration of the online 
programme, providing recommendations and some visual representation of some of 
its elements that could be further developed and tested in future research outside this 
doctoral work.  
4.1 Introduction 
The importance of technology in the treatment of mental health and somatic disorders 
is increasingly recognised (Fairburn and Patel, 2017; Kloek et al., 2017; NIMH, 2019). 
One of the most developed online psychological therapies is Cognitive Behavioural 
Therapy (CBT). Online guided CBT has been found to be as effective as face-to-face 
(F2F) CBT for several mental disorders (Carlbring et al., 2018). CBT delivered over the 
telephone and online, with minimal clinician support, could significantly improve 
symptoms, QOL, coping and reduce distress for patients with IBS according to an RCT 
(n=558) (Everitt et al., 2019). Moreover, both of these modes of CBT delivery appear to 
be superior to treatment as usual (TAU), with the online intervention obviously being 
cheaper than telephone-delivered intervention in terms of quality-adjusted life-years 
(QALYs) (Everitt et al., 2019). Based on the evidence of the effectiveness of CBT in IBS 
and considering similar mechanisms of bidirectional interaction between the brain and 
the gut through the gut-brain-microbiota axis in IBD and IBS (Gracie et al., 2018; 
Martin et al., 2018), its effectiveness could be assumed in IBD. As a result, the use of 
the online PI programme could be an alternative to traditional psychotherapy for 
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selected subgroups of IBD patients and, perhaps, equally helpful as conventional 
psychotherapy (McCombie, 2016) while being cost-effective (McCrone et al., 2004; 
Nordgren et al., 2014). 
 
The government-funded initiative, Improving Access to Psychological Therapies (IAPT) 
for the treatment of depression and anxiety disorders in the UK (Clark, 2011), has 
improved access to the services and patient Disorders of brain-gut interaction (DBGI) 
recovery rate (Bastiampillai et al., 2019; Leigh and Flatt, 2015). However, in recent 
years, there has been an increase in the prevalence of common mental health 
disorders in the UK population (McManus et al., 2016), thus the need for more 
services. Online interventions could meet the increasing demand of patients for 
psychological support (Andersson et al., 2019). A recent small IAPT assessment survey 
showed no evidence of using online psychological interventions within the current 
offerings (Scott, 2018). However, patients' acceptability of online PI could not be 
explored within this study as only one out of the 90 patients was offered but declined 
online PI. Thus, there is a need to investigate the effectiveness and the acceptability of 
online delivered PI not just for the patients, but for the health professionals as well, 
which will help to inform current practice. 
 
According to a recent survey conducted in Australia (n=102), IBD patients seem to 
prefer online PI rather than face-to-face PI (McCombie, 2014). However, recent trials in 
the IBD context show that online psychotherapy is associated with high attrition which 
may result from the website format, therapy duration or lack of contact with a 
therapist (Mikocka-Walus, 2015; McCombie et al., 2016), but it is at present poorly 
understood. A systematic review (20 studies, 1418 participants) reported that guided 
internet-delivered CBT is possibly as effective as F2F CBT for some psychiatric and 
somatic disorders (Carlbring et al., 2018). Support from a clinician could enhance the 
treatment effects of online interventions for some mental health disorders, including 
depression and anxiety (Kenwright et al., 2005; Saddichha et al., 2014). Thus, guided 
online PI, with minimal clinician contact, could be considered as a therapeutic option 




To effectively implement the findings in a clinical environment, the effectiveness of 
psychological therapies should be evaluated in mixed-methods studies with a 
qualitative study nested within a randomised controlled trial (Midgley, Ansaldo and 
Target, 2014). However, there are no trials or qualitative studies conducted to date to 
evaluate psychotherapy in IBD patients with comorbid anxiety and/or depression.  
 
To empower patients and health professionals and increase the likelihood of the 
intervention implementation, the involvement of both of these groups as equal 
partners in the development (co-design) of the intervention is essential (Dawda and 
Knight, 2017).  
4.1.1 Identifying/developing theoretical evidence and the study rationale  
Psychological interventions are complex multicomponent interventions. Therefore, the 
development of an online intervention should follow the principles of the UK Medical 
Research Council (MRC) framework which guide development and evaluation of 
complex interventions (Figure 2) (Craig et al., 2013). The present qualitative study fits 
within the development phase suggested by the MRC framework (Craig et al., 2013). 
To effectively develop, evaluate and implement the potentially effective intervention, 
it is necessary to identify theoretical evidence, which informs the conduct of the 
qualitative study. The adaptation of the online intervention to the participants' needs 
with regards to the intervention content and design is likely to improve the 
acceptability of the intervention during the feasibility/piloting and implementation 
phases (Craig et al., 2013).  
 
To identify the theoretical evidence base, a comprehensive systematic review of the 
literature was performed and reported in Chapter 2 of this thesis. The findings from 
this systematic review showed insufficient evidence of an association between online 
CBT and most physical or mental health outcomes in IBD and IBS patients, except 
significantly improved gastrointestinal symptom-specific anxiety and lower symptoms 
induced disability (Hanlon et al., 2018). Furthermore, the findings from the review 
were based on the data from unselected populations (anyone with IBD) due to the lack 
of RCTs which would target patients who are likely to benefit from psychological 
interventions most, including those with poor mental health. 
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Recently, several studies have recommended examining the effectiveness of 
psychological interventions for the subgroups of IBD patients that are "in need" of 
psychological support (who have a high baseline IBD activity; have been recently 
diagnosed; are young; with comorbid psychological distress) and are more likely to 
benefit from the PI (Mikocka-Walus, 2015; Gracie et al., 2017; Timmer et al., 2011). 
However, no study to date has tested the effectiveness of the intervention for such 
populations. Consequently, the intention of this research was to develop a prototype 
online intervention for the IBD population with comorbid anxiety and/or depression, 
which could be tested in a future feasibility trial.  
 
To develop a theoretical understanding of the possible process of change, it was 
essential to supplement existing evidence and theory with new primary research. The 
conduct of the qualitative study is recommended for the development of the 
intervention for future evaluation, or evaluation of a previously developed and/or 
implemented intervention (Craig et al., 2013). Therefore, there was a need to perform 
a qualitative exploratory study involving interviews with the selected target group of 
patients with IBD and comorbid anxiety and/or depression and the health 
professionals involved in their care.  
Aim  
This study aimed to develop a prototype of an online PI for IBD patients with comorbid 
anxiety and/or depression. The intention was to develop an online intervention that 
could potentially (pending future testing) be delivered by more general medical staff 
who provide IBD care, such as IBD nurses, NHS junior mental health workers or an NHS 
psychologist to reduce the clinical load of psychologists and to be as cost-effective as 
possible to the NHS.  
 
The research questions were: 
1. What are the participants' views on PI? 
2. What are the barriers and facilitators associated with online PI for patients with IBD 
and anxiety/depression? 
3. How can an existing online psychological intervention be modified to meet patients’ 




The findings from the current study can help to adapt the existing "Tame Your Gut" 
online PI programme for patients with IBD developed in Australia to meet patients’ 
needs and as a result to potentially increase adherence, improve HRQOL and decrease 
the cost of care for IBD patients. 
4.2 Methods 
The full methods are presented in Chapter 3. This section presents only the 
information related to the online intervention.  
4.2.1 Materials  
The bidirectional link between IBD and anxiety and/or depression needed to be 
addressed in the adaptation of the intervention. The recent systematic review that 
examined the effectiveness of psychological therapy in disease activity, psychological 
comorbidity, and QOL  in IBD patients showed that a variety of PI were used for IBD 
patients (Gracie et al., 2017). However, only two of the included trials used an online 
mode of intervention delivery, and both used CBT (Mikocka-Walus, 2015; McCombie, 
2016). The systematic review (Hanlon et al., 2018), reported in Chapter 2, identified 
nine studies that examined the effectiveness of an online PI in gastrointestinal 
diseases, with two of the included RCTs focusing on IBD. These were the same studies 
listed in the previous systematic review on psychotherapy in IBD by Gracie et al. 
(2017). One of these studies used the "Tame Your Gut" psychological therapy program 
for people living with IBD in Australia (Mikocka-Walus, 2015), the second study used a 
modified (8-week) version of the original 10-week "Tame Your Gut" programme 
(McCombie, 2016). Apart from the programme developed in Australia, to date, no 
other online PI programs have been available for patients living with IBD. This online 
intervention was useful and well received by patients (Mikocka-Walus, 2015; 
McCombie, 2016). Therefore, this website was chosen to serve as an example to the 
participants of the present study with the plan to adapt this programme to the 
patients' needs and the UK environment. 
 
Before the interview, participants were asked to familiarise themselves with the "Tame 
Your Gut" website (TAME YOUR GUT, 2019). Participants could refer to the programme 
during the interview. This programme was used as an example for patients to 
comment on the  content and visual presentation. "Tame Your Gut" 
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(www.tameyourgut.com) is a 10-week, two hours per week program covering the 
following topics:  
✔ education about IBD and CBT 
✔ goal setting  
✔ relaxation training (stress and relaxation) 
✔ understanding our thinking (automatic thoughts and cognitive distortions) 
✔ emotional well-being (cognitive restructuring) 
✔ avoidance & IBD (exposure and overcoming avoidance) 
✔ coping strategies 
✔ taking responsibility (assertiveness training) 
✔ part of the tribe -social support (relationships and communication) 
✔ attention & distraction 
✔ maintaining the momentum (relapse prevention for mental health problems) 
The sessions include videos, audio and text materials. There are videos including a 
conversation between a therapist and a doctor about aetiology, symptoms and 
treatment of IBD. There is also a video with the dietician, who explains diet 
requirements for people with IBD. Some materials can be downloaded from the 
website and links to other relevant resources are provided. 
4.2.2 Prototype development 
The prototype (model) building facilitates the prediction of the interrelationships 
between different components of the intervention, the association between the 
intervention and outcomes, and can provide evidence on how the intervention 
proceeds (Campbell et al., 2000). The data from the developmental phase could be 
then used to develop a new online psychological intervention for IBD patients with 
comorbid anxiety and/or depression and design an appropriate trial to determine 
patient benefit.  
4.2.2.1 Prototype enhancement 
To enhance the prototype, a person-based approach to the development of digital 
health interventions was taken (Yardley et al., 2015). The person-based approach 
involves guiding principles, and qualitative research at all stages including design, 
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development, and trial/implementation of the intervention.  It is used to enhance and 
supplement the earlier discussed theory and evidence-based approaches suggested by 
the MRC framework (Craig et al., 2013; Yardley et al., 2015). Based on a person-based 
approach, guiding principles help guide through the intervention and make an outline 
of the essential aspects required to attain the intervention goals (Yardley et al., 2015). 
These principles were used in designing the current prototype. 
4.2.2.2 Initial development of the intervention prototype - participants 
interviews 
As the current intervention targets specific groups of patients, it is crucial to attain 
their views to be able to tailor the intervention to meet their requirements (NICE, 
2007). To increase the effectiveness of the interventions, there is a need to combine a 
wide range of evidence from individual, community and population levels (NICE, 2007). 
Themes identified from the interviews with patients and health professionals along 
with the theoretical evidence were used for the development of the prototype of the 
online psychological intervention adapted explicitly for the needs of IBD patients with 
anxiety and/or depression in the UK. The fluctuating nature of IBD and 
anxiety/depression symptoms became apparent from the patients' and health 
professionals' views (discussed in Chapter 3). The fluctuating characteristic of IBD has 
implications for designing an online PI, which patients could use as an ongoing tool 
when needed. The fact that IBD affects patients’ psychological functioning during 
remission in the absence of inflammation (Lix et al., 2008), also suggests the 
continuous need for the use of this type of intervention.  
4.3 Results 
In the present study, 13 IBD patients with comorbid anxiety and/or depression of 
various ages and mix of genders were interviewed. To further tailor the specific 
context in which the online intervention was to be applied, 12 health professionals, 
who for at least two years had cared for patients with IBD, were interviewed to 
establish their views on online PI for IBD patients’ with comorbid anxiety and/or 





4.3.1 Patients' and health professionals’ perspective on online PI 
Participants talked about their circumstances and described the factors which would 
encourage or stop them from engaging in the aspects of the online PI and how the 
existing "Tame Your Gut" programme could be adapted to their needs and 
requirements (see concept map Appendix 14). Patient responses regarding the ability 
to be involved in the self-directed online intervention were grouped into two major 
themes: 1) online psychological intervention is good, but not for everyone and 2) the 
existing online PI programme requires changes to the visual and contextual 
presentation.  
4.3.1.1 Online psychological intervention is good, but not for everyone  
All patients, except one, had positive attitudes towards the Internet, mobile apps and 
participation in an online PI. Patients were willing to participate and complete the 
programme irrespective of age and computer illiteracy which was suggested as a 
potential barrier by health professionals. However, the health professionals stated that 
they were uncertain about the patients' involvement, ability to facilitate and complete 
the self-directed online programme. The agreements and disagreements observed 
between practitioners and patients with regard to the participation in an online 
intervention are presented in Table 12. The major disagreements were about patients' 
participation in the programme and specific barriers for participation. Both groups 
agreed that the programme could increase the accessibility of psychological help and 
that the clinician-assisted version of the programme was preferred to the unassisted 
version.  
 
The health professionals concluded that the lack of human interaction, inability to 
tailor the intervention to the individual needs and the online format of the treatment 
would prevent patients from participation. Most patients agreed that tailoring the 
intervention to individual needs is essential. Moreover, both the health professionals 
and patients strongly agreed in their responses that personal interaction is important, 
and that the clinician-assisted self-directed online programme would encourage 




The health professionals thought that the computer illiterate and older patients were 
unlikely to be involved in a self-directed online PI programme. This differed to the 
patients' views. For those who were in their seventies (n=2) and did not use a 
computer, this was not a barrier. They expressed confidence in their motivation and 
personal commitments with the help of their family members and encouragement 
from health professionals. The differences in the views were also observed regarding 
participation in the programme for less well-educated individuals. Health professionals 
thought that this group of people would opt-out of participation in the programme, 
while patients suggested that people could watch the videos on the programme if they 
were not able to read. The patients and the health professionals were equally positive 
about the accessibility and flexibility of the programme. 
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Barriers Both groups 
• not tailored to the individual 
• personal interaction is important 
Patients 
• not improve the wellbeing 
• it could feed the peoples' isolation 
• "stigma attached to it"  
• no access to the Internet 
• negative attitude to the Internet and 
mobile apps 
• if doesn't work for me 
• feed loneliness 
• embarrassment, the stigma attached to 
mental health 
• do not need now 
• repeated reminders  
Health professionals  
• busy lifestyle  
• not admitting the problem  
• the older population would not use 
• computer illiterate, learning difficulties, 
not well educated 
• patients "might enjoy a sick role"  
"[...] now I would not, because I didn’t think I needed, but might have done in the 
past." (Patient 1, 50 years old, male).  
 
"Online is great, but every so often you should have a forum where you see people, 
where you see faces, and you see hearts. Because of the sad things for a lot of IBD 
sufferers, it's the loneliness. [...]." (Patient 12, 59 years old, female). 
 
"[...] some people just don't like admitting barely that they have got the problem and 
like to try to manage things with their head in the sand." (Female, health 
professional, 53 years old). 
 
"[...] some people are naturally obstructive and kind of enjoy the sick role, and I think 
they would be harder to engage." (Female, health professional, age not indicated). 
 
"There isn't a reason why I wouldn't do it. Why other people not do it? Might think it 
is some kind of stigma attached to it. But, personally I wouldn't think that." (Patient 
13, 32 years old, female). 
 
"I think, my consent about using for everybody, would be that it isn't flexible enough 







• lack of motivation  
Facilitators Both groups 
• positive attitude towards the Internet and 
mobile apps and participation in the online 
intervention 
• accessibility  
• flexibility  
• confidentiality  
• personal interaction (partial human contact) 
• tailoring intervention to individual needs  
• encouragement from health professionals 
• promotion of the programme to the patients 
by health professionals 
• family support 
• present the elements of the programme 
from a patient’s perspective 
• patients' testimonials  
• "knew expected outcomes" 
• the programme makes the difference to 
patients' wellbeing 
• keep patients' interest in the programme 
• repeated reminders  
Patients  
• suitable for people with social anxiety 
"I don't use a computer[...]. I find it difficult to use a computer. [...] my wife [...] is 
into computers for years. [...]. I would use it. [...], my wife will make that [laughing]. 
Yeah, I am sure, I would" (Patient 4, 70 years old, male). 
 
"I would, if the IBD nurse recommended it, that would be one incentive." (Patient 1, 
50 years old male). 
 
"[...] it allows me to choose the bits that I think would be the most helpful and for me 
to do it in my own time." (Patient 1, 50 years old, male). 
 
"[...] it may be accessible within their own time, they can do it in the evening, on the 
night, on the weekend, you know, they can dip in and out it, they could go back to 
it." (Female, health professionals, 32 years old). 
 
"... the chaps in my office for example where I work [...], the men were glued to the 
computers all the time, even in the lunch hours whereas the women took a break to 
talk to people about their various problems, the problems with their health, the 
problems with their children, the problems with their make up or whatever and I just 
wonder if males automatically turn to the Internet now and women may be less so 
and maybe that like be reflected in the website. And, I think, that men and women 
may handle the disease differently as well." (Patient 6, 68 years old, female). 







•  there is nothing else 
• gender difference 
Health professionals 
• younger, more savvy 
years old, female). 




• limited role of online PI  
• uncertainty about the patients' involvement 
and ability to facilitate and complete the 
self-directed online programme.  
• involvement in the self-directed 
programme - a mixed bag 
 
 
"I think it could be very useful. I think, similar to one I  have it used in IAPT 
[Improving Access to Psychological Therapies] services. I think, if you think about a 
stepped care model it would probably be used, maybe for the people with a milder 
and off psychological problems, who might be more motivated to access it and to 
drive themselves to complete it independent of a facilitator or a therapist [...] as a 
kind of a lower level intervention for people with milder problems, but [...] a more 
severe mental health [...] I would feel a bit more consent, directing people to that 
mode of intervention. I think there is a role for computerised therapies, but I do think 
that it is a limited role. [...].  I think my main message would be that it isn't for 
everyone, and it cannot be instead of having the availability of one to one, face to 
face psychotherapy if needed." (Female, health professionals, 30 years old). 
 
"I think it depends on the symptomatology and whether they think it's um, and 
whether they think it is an issue for them. So, I think it is probably about the patient's 
selection" (Male, health professionals, 49 years old). 
Understanding of talk 
therapy 
Both groups 
• a vague understanding of the talking 
therapy 
• the lack of knowledge  
"It's just talking through it. It's just talking if you've got any issues. [...]. I don't know 
how helpful it would be with IBD [...] I'd say more practical, doing a thing is better 
rather than talking." (Patient 9, 20 years old, female).  







49 years old, male).  
"It is a therapy that involves talking to someone through your thoughts and feelings 
to help you manage your problems by changing the way you think and behave, like 
CBT." (Female, health professionals, 43 years old). 
Wish to take control 
of their own 
treatment 
Patients  
• would like to take control of their own 
treatment.  
• would like to get health professionals 
support. 
"It's got to be the person's own responsibility" (Patient 2, 39 years old, male). 
 
"I would absolutely dearly love to take control of my own treatment. Do I have the 
ability? No. No, absolutely not." (Patient 12, 59 years old, female).  
 
"Well, I would, but I also like sound back and having specialists looking after me." 





• no experience 
• counselling,  
• CBT,  
• hypnotherapy;  
• had positive outcomes  
• all, except one, positive attitude  
 
Health professional  
• no experience 
• only one had experience with psychological 
intervention. 
"[...] seeing a psychologist certainly helps [...]. It did help me." (Patient 4, 70 years 
old, female). 
 
"My experience of CBT [...] was 20 years ago. And I'm still living benefit from the kind 
of changing my thinking. I never knew that I could think in a different way. That's 
what my CBT taught me."  (Patient 1, 50 years old, male). 
"My experience of it, I haven't used it personally as a user, but have used it as a staff 
member for working within... it gives access to psychological therapy service, so we 
use two computerised programmes for depression and anxiety in my role there, some 
experiences delivering, well assessing people of, on those, being a facilitator really to 







30 years old). 
Previous experience 
of using apps and 
Internet 
Patients 
• two patients had previous (one patient had 
a negative attitude and one positive 
experience of using Internet apps for 
depression)  
• none used the apps or the Internet for IBD 
management.  
Health professionals 
• no experience of using apps for IBD or 
mental health  
• one health professional used for the 
management of mental health. 
"The app [...] for the depression. Not for IBD, but for mental health. The calming 
things, they're really good." (Patient 9, 20 years old, female). 
 
"I did try a couple of Internet apps for stress. [...] but [...] I just started irritating, [...] 
on the Internet you are sitting there, and you breathe in, and you breathe out, at the 
end you feel like saying like shut up to the app." (Patient 6, 68 years old, female). 
 
"I do not really have any, at all really, apart from direct people to the websites for 
information, but not apps or anything like this. Not really." (Female health 
professionals, 52 years old).  
 
"I [...] have used it as a staff member [...] we use two computerised programmes for 
depression and anxiety. [...] being a facilitator really to supporting people who are 
using those programmes. [...] some people it provided greater flexibility, [...], my 
consent about using for everybody, would be that it isn't flexible enough to meet the 
individual needs of the user. [...] it takes away the therapeutic relationship, which is 
the facilitator for change for a lot of people." 
Expectation Patients  
• accept the condition 
• have information,  
• reassurance, 
• have a positive outlook, 
"I think that even just a short time that I've spent looking at it ["Tame Your Gut"], it 
makes me realise, I've got to be more positive about what I've got rather than 
focusing on the negatives of the IBD." "If you reduce the stress, I do believe, it would 








• improved QOL, 
• help flares through the management of 
stress 
• manage anxiety and stress 
"I would expect my mental outlook to change. It's the mental I have a problem with. 
[...] by doing this [the online psychological intervention]. I think this change my 




• the personal level was important  
• the preferred clinician-assisted online 
programme 
• the clinician-assisted programme should be 
an option 
 
"[...] one to one relationship with somebody [...] to me was really-really important" 
(Patient 7, 67 years old, female). 
 
"The ideal way to do it would be to have your first meeting with the clinician; then 
after that, it would be online. So, they [..] talk you a little bit through it and to lay out 
and tell you what the outcomes are. [...] if you meet somebody face to face, you 
might reinforce the importance of it and how helpful it can be [...]" (Patient 13, 32 
years old, male). 
 
"Either of them, [...], because text works as well." (Patient 10, 45 years old, female).  
 
"[...] my main consent about the computerised therapy [...], it takes away the 
therapeutic relationship, which is the facilitator for change for a lot of people." 
(Female health professionals, 30 years old). 
 
"[...] the clinician-assisted version would work a lot a lot better. [...] to be able to 
then talk about the content of what you were doing online [...] it could be at the 
beginning, after a month, yeah, the middle and the end, it could just be less frequent 
contact than what you would do in normal therapy. [...], it might help as much with 









"[...] some people like talking, it is the best way of resolving problems, and there are 
people who just like to get on with things [...]." (Female health professionals, 53 
years old).  
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4.3.1.2 The technical and visual presentation of the online programme 
A concordance was observed between the health professionals and patients regarding 
the technical aspects and visual presentation of the online programme (see Table 13). 
Most of the patients and health professionals were satisfied with the format and user-
friendliness of the existing programme, though some suggested the need for a mobile-
friendly version.  
 
The health professionals suggested that the intervention should have plain language (a 
couple of patients preferred the scientific language), bullet points, to be visually 
cleaner with less text, have introductory videos to each session, and use the videos 
with patients and health professionals, as well as offer activities to download. They 
proposed between three and ten sessions, of 15 min to 1-hour duration. This was to 
some extent in agreement with patients views, although they were more precise in 
their responses of what they wanted to be included in the online programme and, in 
particular, they wanted to see the other patients' experience, a patient forum, a and 
chat room. Patients also wanted to see the information about IBD itself, and various 
management strategies, including coping.  The findings from the qualitative study on 
patients' lived experience with IBD and anxiety and/or depression (Chapter 3) showed 
the patients themselves, without acknowledging it, were using some elements of 
behavioural activation (BA) such as exercising, reading, and other activities in everyday 
life to cope with the burden of the disease. Some patients and health professionals 
were not sure what should be included in the online programme. Thus, a psychologist 
with relevant consideration of the patients' preference should develop the context of 
the programme. 
 
All patient participants, except one, in the current study, expressed interest in taking 
part in the development of the online psychological intervention programme, 
indicating the likelihood of the intervention uptake. They agreed to comment on the 




Table 13 Changes to the technical and visual presentation of the online programme 




• positive feedback  
"I thought it was really good, very well laid out, nice format, nice ten weeks chunks. [...]. Yeah, make 
sense, there is nothing over too technical, I did understand." (Patient 13, 32 years old, male).  
 
"[...] consistency from week to week, so [...] the layout is the same. So, if I learn on week three that 
was a helpful [...] then I am more likely to go to week four to that same place so it’s about the 
consistency of appearance, so that I can learn as quickly as possible where to find where to look for 
the bits that would be helpful." (Patient 1, 50 years old, male).  
 
"...the format looks great, the way it was laid out, and there was a definite programme to follow, 
with different areas" (Female, 52 years old). 
Number and 
duration of the 
session  
Health professionals 
• 3-10 sessions  
• 15 minutes to the 1-hour 
duration  
• should not be longer than ten 
weeks  
Patients 
• 3-12 sessions  
• 15 minutes to 1-hour duration  
• should not be longer than ten 
weeks for most patients 
• allow some flexibility 
• be able to come back to the 
programme if needed 
• online support should be 
"I feel you should do it for as long as you needed. I don't think you should set. [...] you should do stuff 
as long as you need [...], you should be able to come back to it, if you need [...], because with anxiety 
you don't know how long it's last, yeah. I find that anxiety and depression phases. You just don't 
know." (Patient 9, 20 years old, female).  
 
"I need ongoing online support that you could dip in or dip out off." (Patient 12, 59 years old, female).  
 
"around about 6 to 8, some patients might need less, some patients might need more and something 
in short bursts, probably, I don't know, 15 minutes might be suitable for some people, other patients 
might find that they needed a bit more." (Female, 53 years old). 
 
"I cannot really say. I don't have a way of judging it."  (Male, 54 years old). 
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Primary codes Codes Quotations 
ongoing. 
Text, language  Both groups 
• text easy to read, 
understandable  
• to use less text  
• more bullet points 
• plain language 
• two patients would like to see 
more scientific language.  
"I thought it was easy, easy to understand. I also felt that somebody with IBD probably had a lot to do 
with developing of it, because they really think to understand how you felt. [...] different scenarios 
they really seem to understand it" (Patient 5, 56 years old, female).  
 
"The bullet points are probably handy because it's kind of breaks down to the chunks [...]" (Patient 13, 
32 years old, male).  
 
"It should be plain language" (Female, age not indicated). 
 
"it would seem quite overwhelming with long bits of text, so certainly text should be short 
paragraphs, maybe with bullet points to the top just so, or bullet point to the end, so once they read 
it, or before they read, so they know essentially what they need to get out of it. Sometimes bullet 
points do not have enough information." (Female, 32 years old). 
Pictures Both groups 
• happy with "stress-free" 
pictures on the website. 
"I didn't think of that. I didn't take any notes of that, didn't really noticed." (Patient 13, 32 years old, 
male). 
 
"No, I thought, they had what they needed to have. They had a different picture for each session and 
things like that. So, I thought it was about right, yeah." (Patient 5, 56 years old, female). 
Colour Both groups 
• happy with the website 
colours  
One patient 
• darker colours 
One health professional 
• less bright  
"darker colour. [...] blue or grey or black. It is the matter of to be able to see. [...] redo it." (Patient 8, 
70 years old, male).  
 
"I think it is too bright blue, should not be yellow or red for colour blind people." (Female, health 
professional, 43yeaes old). 
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Primary codes Codes Quotations 
• not yellow, red 
Video  Both groups 
• videos are important  
• to include videos with 
patients and health 
professionals  
• one video per session 
between 5 and 20 minutes  
• an introduction to the 
session's video. 
 
"[...] even its technology, it feels more personal. I think all session should have videos [...], it sets the 
tone, and it feels personal even it's probably not." (Patient 12, 59 years old, female). 
 
"[...] that is a very modern way of introducing topics." (Patient 1, 50 years old, male). 
 
"[...] a separate video for each topic, but even if it's instructions on how it could be even five bullet 
points [...] can be a quicker overview, and at the end, the summary again to reinforce it." (Patient 13, 
32 years old, male). 
 
"I might give people some introduction videos, and then I might let them choose from the range." 
(Male, 49 years old).  
Suggestion on 
what to include 
• anxiety and stress 
management 
• anger management 
• relaxation techniques 
• goal setting  
• coping strategy 
• the others' patients 
experience, testimonials  
• information about IBD and its 
treatment 
• programme tailoring and 
designed to navigate and 
signpost patients 
• not sure what should be 
"I am not a psychologist. I don't really know the full range of things that people would expect to be 
offered." (Patient 3, 49 years old, male). 
 
"[...] there should be like a chat, where you can have somebody on the other side." (Patient 10, 45 
years old, female). 
 
"if a system was set up whereby the possible questions you had and things were there to be 
answered" (Patient 7, 67 years old, female).  
 
"if my anxiety is very bad, I am on so many different medications, that actually makes my thought 
process difficult. So if I am anxious and stressed, I've got these other things going on as well, so it's 
difficult at that point to work out what I need. Because the fatigues hit, the low mood hits and 
everything hits. I almost feel it's like any programme needs to be a signposting programme that can 
do some other thinking for you." (Patient 12, 59 years old, female). 
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Primary codes Codes Quotations 
included in the online 
programme 
• work on mobile devices such 
as mobile phones and tablets 
• music 
• glossary 
• consistency in layout 
• clinician-assisted option 
recommendations 




 " [...] a credible medical site with information about IBD itself, the actual medical information about 
the physical condition, progress that they were making in research about the disease, a likelihood of 
them ever finding the way to really control or even cure it, changes in the treatment [...]" (Patient 5, 
68 years old, female). 
 
"[...] there should be like a chat, where you can have somebody on the other side." (Patient 10, 45 
years old, female). 
 
"if a system was set up whereby the possible questions you had and things were there to be 
answered" (Patient 7, 67 years old, female). 
 
"I was struggling to... if I would get out my laptop, it would be fine, but because I was doing it on my 
phone, I was having to make a sort of to make it bigger so that I could see, what it actually is said. 
Then, I was having to move the page across; it makes a bit harder to read." (Patient 5, 56 years old, 
female)." 
 




To the author’s knowledge, this is the first qualitative study exploring patients' and 
health professionals' views, attitudes and experiences of online psychological 
interventions for IBD. Based on the theory and evidence from this qualitative study, a 
prototype of the intervention was developed.  
4.4.1 Summary of the findings  
The responses from the participants in the current study indicated that they welcomed 
the format and user-friendliness of the existing "Tame Your Gut" programme. There 
were similarities in the responses from the health professionals and patients about the 
length and number of sessions, with the agreed duration between 15 minutes and 1-
hour and between 3 and 10 sessions. Most participants accepted the plain language 
and desired less but clearer text. This could be explained by the comorbid fatigue and 
the fact that patients with IBD and anxiety and/or depression are less able to process 
large amounts of information (Jamison, Sbrocco and Parris, 1989; van Langenberg et 
al., 2017; Rock et al., 2014), hence breaking it into sections and presenting as bullets 
point would be necessary for the programme. In addition, it was found that the videos 
were considered essential to the participants. They felt that the videos were more 
personalised than the text. Therefore, the implementation of the introductory videos 
that would refer directly to the participants could help with the lack of personal 
interaction during online sessions.  
 
In some cases, patients wished to take part in the online programme independently, 
for example, when the patient did not want to leave the house. However, even a 
patient with a social anxiety disorder preferred a clinician-assisted version if it was 
accessed in their home. Similarly, the combination of other forms of assistance could 
be considered, for example, Skype, telephone, email, text.  
 
Although some health professionals suggested that accessing the online programme 
would require a certain level of computer literacy and education, this was largely not 
supported by the results of the study. Patients of different ages, levels of education 
and computer literacy were interviewed and all of them understood the context of the 
existing programme and indicated that they would access the programme with the 
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help of a clinician or family member. Further, despite the difference in access to 
psychological services, there were no differences observed with regards to the 
patients' acceptance of online PI at different hospital facilities.  
 
Both health professionals and patients agreed that personal interaction was important. 
This finding is supported by the literature and also highlighted the importance of a 
therapeutic alliance between a patient and therapist for good treatment adherence 
and for some patients this alliance could be the facilitator for change (Barlow, 2014). 
The majority of participants in both groups recognised that encouragement from 
health professionals would increase compliance and completion of the online 
programme.  
 
The health professionals were unsure about whether patients' would agree to access 
an online PI and whether patients would complete the programme. Most patients 
expressed interest in the programme participation and were confident about its 
completion. Attitudes varied and were based on the patients’ and health professionals’ 
responses about the provision of holistic care, as discussed in Chapter 3. Health 
professionals believed, despite the lack of psychological resources and the long waiting 
list, that they provided adequate support for their patients. Contrary to the health 
professionals views patients reported feeling alone with their disease. This highlights 
the scale of the problem that patients face and something which health professionals 
may underestimate. Another reason for these varied viewpoints could be that all 
health professionals, except one, had no previous experience of using mobile apps or 
the Internet for IBD or mental health management. However, this was not seen as a 
barrier for patients. Only two patients had experience of using mobile apps for the 
management of mental health. One found the intervention very useful, while the other 
stopped using it and had a negative experience. However, another patient had a very 
strong negative attitude to any form of outside help irrespective of the mode of 
delivery. This person’s view added richness to the perspective of other participants in 
the study. It is important to acknowledge that the self-directed online PI might not be 
an appropriate tool for the management of depression and anxiety in some IBD 
patients such as patients with severe depression and anxiety, patients who reject any 
form of psychological help or support but, perhaps, offers help to others.  
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Contrary to the patients’ perception, the health professionals considered the lack of 
patients' motivation, computer illiteracy and older age as barriers to patient 
participation in the online programme. Although patients did not indicate them as 
barriers to self-directed treatment, they did express the need for support from family 
members or clinicians throughout the process. It is possible that some patients had an 
optimistic view of the online programme as a result of a very positive outcome of F2F 
therapy. Therefore, they hoped for the same outcomes, but without the unnecessarily 
waiting list. On the other hand, a previous study exploring patients' willingness to 
participate in an online PI programme concluded that patients preferred the online 
mode of delivery compared to F2F (McCombie, 2014). However, the study was 
conducted in New Zealand and it is unclear if the results would translate to the UK 
environment.   
 
The health professionals and patients indicated that the online programme could 
improve the accessibility to psychological support, avoiding a long waiting list. Therapy 
delivered online as part of IAPT services that provide evidence-based psychological 
therapies is already recommended in a stepped care model for people with anxiety 
disorders and depression (NICE, 2019a).  
 
Therefore, the findings suggest that a wide range of psychological treatments for IBD 
patients with anxiety and/or depression could be considered instead of classical F2F 
therapy. It is therefore essential to explore the possibility of self-directive online PIs. 
This mode of delivery could widen access to the therapies (Kessler et al., 2009). On the 
other hand, the high dropout rate in online interventions is often experienced. A meta-
analysis of data from 2,705 patients on self-guided online interventions for depression 
reported that such factors as a lower level of education, male gender and co-morbid 
anxiety significantly increased attrition risk (Karyotaki et al., 2015), although, it 
significantly decreases with age (Karyotaki et al., 2015). These factors suggest a 
necessity for some contact with the clinician to be considered during the 




4.4.2 Summary of the evidence from the previous literature in the context of the 
study's findings  
The participants' views and suggestions formed the basis for the prototype 
intervention. To provide evidence-based recommendations for any future online 
interventions, evidence from other studies was examined to assess whether the 
recommendations are feasible, effective and valid. If evidence in mental health and/or 
gastrointestinal diseases was lacking, then evidence from other fields were utilised.  
 
The most common patients' suggestions on what should be included in the 
intervention were anxiety and stress management, relaxation techniques, goal setting 
and coping strategies. These are part of the "Tame Your Gut" programme. This 
programme already demonstrated its effectiveness in improving the QOL of patients 
with IBD and was well received by patients in Australia and New Zealand (Mikocka-
Walus, 2015; McCombie, 2016). Thus, the author discussed only the features of the 
programme that the patients wished to change or features that were not already 
included in "Tame Your Gut" but suggested by patients.  
 
The clinician-assisted option of the PI 
The most commonly reported barrier to participation in an online PI programme was 
the lack of personal interaction. Therefore, many participants chose the clinician-
assisted option, which they thought would increase the ability to facilitate aspects of 
their own treatment, compliance and completion of the programme. The evidence 
from the literature also suggested that online psychotherapy, CBT in particular, seems 
to be effective when therapist-assisted, or with the addition of telephone support, or 
combined with F2F interventions (Kessler et al., 2009; Brabyn et al., 2016; Erbe et al., 
2017; Everitt et al., 2019; Grist et al., 2019). Guided online interventions were more 
acceptable and offered by GPs in primary care compared to unguided interventions 
according to a large (n=1044) survey (Breedvelt et al., 2019). Nevertheless, some 
participants thought that the clinician-assisted or exclusively self-directed programmes 







Patients and health professionals expressed concern about the online psychological 
intervention not being tailored and wished for this programme to meet each patient’s 
needs. “Tailored health promotion materials are any combination of information and 
behaviour change strategies intended to reach one specific person, based on 
characteristics unique to that person, related to the outcome of interest, and derived 
from an individual assessment” (Kreuter et al., 2000, p. 4). Tailoring engages various 
strategies directed on achieving more substantial outcomes (Hawkins et al., 2008). 
Hawkins et al. (2008) suggested that content matching, feedback and personalisation 
strategies help to attain the tailoring goals (Hawkins et al., 2008). Indeed, tailored 
online interventions appear to be more effective compared to non-tailored (Strecher, 
Shiffman and West, 2005; Lustria et al., 2013; De Cocker et al., 2016). 
 
All patients in the present study had pragmatic expectations from the completion of 
the programme. They hoped to improve their mental health and QOL, though some 
thought they could have better management of IBD through the management of 
mental health. These expectations led to patients' suggestions on the content and 
format of a future intervention. Some patients and health professionals were not sure 
what should be included in the online programme. Thus, the context of the 
programme should be developed by the psychologist with the consideration of 
patients' preferences. 
 
Number and duration of sessions 
There is no univocal opinion on the number and duration of the online PI sessions. The 
majority of studies in the systematic review (Chapter 2) suggested 10-week. However, 
a clear link between the length of the programme and the attrition rate was not 
observed. On the contrary, a 6-week intervention had a higher attrition rate than some 
10-week programmes (Hunt, 2009; Ljotsson, 2011). All participants in the current 
qualitative study agreed that the programme should not exceed 10 weeks and some 
suggested the need for ongoing access to the programme. The 8-week "Tame Your 
Gut" version of the programme was well-received by patients with IBD and it improved 
their QOL. Thus, an 8-week programme is recommended in the prototype of the 
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current intervention. Any briefer intervention would not comprise all the necessary 
components and topics. 
Videos 
The importance of videos was highlighted by the participants. Patients and health 
professionals found videos more personal than text. This is supported by the finding of 
online health interventions for other mental health disorders, where patients found 
that communication through videos had a more personal style (Ben-Zeev et al., 2018).  
 
The evidence from various online health interventions also showed that the 
information delivered through videos appeared to be more effective than the textual 
presentation of information, by improving patient engagement, concentration and 
interest (Lee, 2011; Alley et al., 2014; Soetens et al., 2014; Stanczyk et al., 2016). 
However, evidence from another trial suggested that for prevention of  weight gain, 
the video format of delivery was not superior to the text format, though it depended 
on the patient's preferences (Walthouwer et al., 2015). Patients particularly 
appreciated videos with a gastroenterologist in the "Tame Your Gut" programme, 
which provided information about IBD. Thus, the author recommends the inclusion of 
these videos with permission from the author or the creation of similar videos.  There 
is no evidence to suggest which video duration is best for this type of online 
intervention. Nevertheless, considering the time patients are prepared to dedicate to 
the intervention and their views about the videos presented in "Tame Your Gut", they 
should last between 5 and 20 minutes.  
 
The repeated reminders 
The participants' views about repeat reminders were divided. Nevertheless, provision 
of information, sending reminders, self-monitoring, reinforcement and other forms of 
further supervision/support could improve the effectiveness of the complex 
interventions for long-term conditions (Haynes, McKibbon and Kanani, 1996), thus 
were used during the prototype development. 
 
A mobile-friendly version of intervention  
The author also recommends having a mobile-friendly version of this intervention, to 
satisfy the participants' needs and thus increase the likelihood of engagement as 
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discussed earlier. A recent mixed methods study (n=129) showed that smartphone 
apps are effective in improving depression symptoms (Inkster, Sarda and Subramanian, 
2018). However, this study was observational and used pre-post quantitative analysis. 
 
Forum 
Patients wished to have some form of communication with other patients with similar 
conditions and clinicians in the format of a forum or chat room. A study in the IBS 
context found that an online support group of patients with similar diagnoses mainly 
focused on the interpretation of symptoms, disease management and on the 
interaction with clinicians (Coulson, 2005). Another recent study analysing 2,000 posts 
of online support for IBD patients during a two year period also found that the 
majority of patients were looking for information and emotional support (41.1% and 
36.1% respectively) (Britt, 2016). Network and esteem support (type of social support 
directed at improving peoples' believe in themselves) or encouragement were 
considered less important (14.2% and 14.3% respectively) (Britt, 2016). A qualitative 
study examining a community online social support also found that information about 
IBD was one of the major themes (Nehasil, 2015). This raises concerns as to whether 
patients were looking for answers about disease symptoms and management from 
other patients and the quality of responses they received. Patients could possibly be 
satisfied with the testimonials in the proposed intervention, which were highly valued 
by patients and health professionals in the present qualitative study, and the harmful 
information could be moderated in this format. It emerged from an ethnographic 
study of patients with cystic fibrosis that a forum was a useful tool not just to share 
information and emotions but to improve interactions with health professionals (Kirk, 
2016). The forum option could be considered and its feasibility tested in a future 
feasibility trial.   
4.4.3 Recommendations and real-world implementation 
Therefore, based on the findings from the present study and evidence from the 
previous literature in the context of the study's findings described in the section above, 
the following recommendations for the future interventions and how these 




Table 14 Recommendations 




 have consistency in the layout 
Number and 
duration of the 
session  
 8-week programme approximately of 1-hour duration  
 after the completion patients should be able to come back to 
the programme if needed, to have ongoing online support  
Text, language   reduce text by introducing bullet points with the link to more 
detailed text 
 use plain language with the link to the scientific resources, 
articles  
Pictures  have "stress-free" pictures on the website. 
Colour  use similar colour schemes to the "Tame Your Gut"  
Video   inclusion of videos into each session between 5 and 20 
minutes with an introduction video to each session as 
essential. 
 to include videos with health professionals and patients  
Suggestion on 
what to include 
 anxiety and stress management 
 anger management 
 relaxation techniques 
 goal setting  
 coping strategy 
 the others' patients experience, testimonials  
 information about IBD and its treatment 
 programme tailoring  
 mobile-friendly version 
 glossary 
 clinician-assisted option  
 chat/forum 
4.4.3.2 The real-world implementation of the PI  
4.4.3.2.1 Tailoring 
To tailor the current online intervention, patients will be required to complete a pre-
test before the start of the programme and at the end of it. The pre-test will contain 
questionnaires to measure the levels of distress and HRQOL. A short version of 
questionnaires is recommended to reduce the burden on patients as they reported 
that numerous questions put them off using interventions. After the completion of this 
online intervention programme, patient' outcomes could be assessed. Based on the 
results and depending on the chosen option (entirely self-directed or clinician-
assisted), patients could receive an individualised message with the patient's name to 
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complement them on the completion of part of the programme and suggesting the 
return to the programme, if needed, as they will have unlimited free access after 
completion. In the event of no improvement or worsening of the outcomes, patients 
will receive a telephone call from a clinician, in addition to the massage, to encourage 
attending a high-intensity therapy (step 3 of the stepped care model).      
 
Based on the answers to the questions during the pre-test, through tailored matrices, 
the programme design will allow participants to choose automatically from the 
database the appropriate response text using if-then principles (Dijkstra and De Vries, 
1999). Use of algorithms complicate the development of the online PI (Hawkins et al., 
2008).  Nevertheless, feedback technology appears to reduce symptom severity in 
patients with depression and anxiety at risk of poor response to treatment (Delgadillo 
et al., 2018) and was found to be effective in symptom reduction for patients with 
fibromyalgia (Collinge, Yarnold and Soltysik, 2013). 
 
The programme could be developed in collaboration with a programmer or using 
existing software for developing behavioural interventions, for instance, the LifeGuide 
Community Website (Williams, Yardley and Wills, 2013).  
 
To further tailor this online intervention, the following personalisation strategies might 
be used: identification, raising the expectation of customisation and contextualisation 
(Kelders et al., 2012). 
 Identification (patients' names will be appearing at the screen as he/she logs in 
to the programme; the patient name will be used at all forms of 
communication and feedback) (see Appendix 17-20).  
 Raising expectations of customisation (explicit declaration of tailoring, for 
instance, use of "welcome to YOUR online psychological intervention 
programme", "designed for YOU" (see Appendix 15-17). 
 
 Contextualisation (to increase enthusiasm for processing the information, 
attention and interest, the intervention will address both the IBD and mental 
health (anxiety and depression); this would be relevant to the patients' 
context). Furthermore, at the top of each website page there should be a bar, 
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which would show which percentage of the online intervention programme a 
patient had completed. Patients will also be able to participate in the forum to 
communicate with patients suffering from a similar condition as some of the 
participants highlighted the need for it in the interviews (see Appendix 19-20). 
 
Patients desired the intervention to be tailored to their level of anxiety and/or 
depression. However, as discussed above this online intervention is a low-intensity 
intervention (step 2 of the stepped care model) and patients referred to the 
intervention should have the same or similar levels of needs (sub-threshold depressive 
symptoms or mild to moderate depression and/or anxiety).  
 
Moreover, over the past decade, the efforts of many scientists have been directed at 
the development of the treatment protocols applicable across various mental illness 
diagnosis, without tailoring to the specific disorder, the so-called transdiagnostic 
treatment protocols (Sauer-Zavala et al., 2017). The idea is based on the principle that 
emotional disorders have common causal mechanisms (Sauer-Zavala et al., 2017). The 
recent evidence demonstrates the effectiveness of transdiagnostic treatments for 
reducing anxiety and depression (Norton and Barrera, 2012; Newby et al., 2015; 
Barlow et al., 2017). The transdiagnostic approach also showed greater usefulness 
compared to other approaches for patients with multiple comorbid anxiety, 
depression or other psychological distresses (Craske, 2012; Norton and Roberge, 
2017). Taking into account the high comorbidity rate of these psychological disorders, 
the transdiagnostic treatment offers a personalised approach during the selection of 
individual treatments (Craske, 2012; Brown et al., 2001).  
4.4.3.2.2 Adherence and behavioural outcomes 
Adherence to interventions during implementation in the health care settings and 
consequently, the intervention outcomes, is lower than during a trial (Beintner, Jacobi 
and Taylor, 2014). Therefore, it is essential to design the intervention programme that 
has a mechanism in place which maximises adherence by encouraging patients to 
engage with the intervention (Cugelman, Thelwall and Dawes, 2011). A recent 
systematic review that looked at the adherence concept in e-health concluded that the 
main measure of adherence is the actual use of technology and consists of the time 
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spent online, number of completed activities, and active interaction with the 
intervention, rather than completion of the whole programme (Sieverink, Kelders and 
van Gemert-Pijnen, 2017).  
 
Despite the varied responses about the repeated reminders in the present study, the 
reminders as well as the programme design that requires logging in should encourage 
the use of the programme and enable the providers to monitor participants. Provision 
of information, sending reminders, self-monitoring, reinforcement and other forms of 
further supervision/support could improve the effectiveness of complex interventions 
for long-term conditions (Haynes et al., 1996), thus were used during the model 
development. 
 
Open access websites have lower attrition, and higher dropout rates compared to the 
online interventions where participants enrolled in the intervention (Christensen, 
Griffiths and Farrer, 2009). Therefore, adherence to the intervention would be 
increased if the participants logged in to the programme and got repeat reminders 
(Christensen et al., 2009). The participants should receive an invitation letter to the 
programme (see an example in Appendix 15) and an automatic reminder email or a 
telephone text message (the patient's preferred option) at the beginning of each week 
(see an example in Appendix 16). 
 
Table 15 provides proposed steps of the patients care during participation in the 
programme. If the patient did not login to the programme during the subsequent two 
weeks, the health professional would make a follow-up telephone call to encourage 
the patient's participation. At the same time, the additional telephone support should 
be provided, or if there is a need and indication for more intensive care during this 
time, the person could step up in the stepped care model.  
 
The delivery of the programme would require some basic training for a clinician in the 
context in which it was to be implemented, and their minimal contact with the 





Table 15 Proposed steps to improve adherence to the intervention  
Step Time scale Action 
1 Before the start of the programme  An invitation letter to the programme 
with login details 
2 The beginning of each programme week  An automatic reminder email or a 
telephone text message 
3 Two weeks no log in A follow-up telephone call from the 
clinician to encourage and support 
4 If there is an indication for more intensive care during the phone call (step 3), 
person can be moved to more intensive care, face-to-face CBT.  
 
It has been found that as intervention length increases the dropout rate increases 
whereas the reverse was found with adherence (Christensen et al., 2009). The patients 
and health professionals’ views about the number and duration of the session in the 
current study varied. However, they agreed that it should allow for some flexibility but 
should not exceed ten sessions of between 15 minutes to 1-hour duration. Two 
previous studies that used ten and eight weeks of the "Tame Your Gut" programme 
had high dropout rates (Mikocka-Walus, 2015; McCombie, 2016). Therefore, the 
author aimed to develop the intervention to be as short as possible at the same time 
as making sure that it could achieve the expected outcomes. The eight weeks 
programme was considered optimal, as any shorter then it would not be able to 
deliver all the necessary topics.  
 
The design of the intervention can be enhanced by understanding the factors involved 
in achieving the desired behavioural outcomes. Fogg (2009) created a behaviour model 
where they showed how components such as ability, motivation, and triggers are 
cooperating in achieving the target behaviour (Figure 26). By addressing  main aspects 
of motivation such as patients' devotion to the goal and their ability to self-direct the 
intervention could increase adherence to the intervention (Swann et al., 2010). Highly 
motivated patients appear to benefit more from low-intensity interventions (Joice et 
al., 2011). Therefore, patients with a different level of motivation should maybe be 
dealt with differently (Swann et al., 2010). Health professionals involved in the delivery 
of such low-intensity interventions are crucial as adherence to the online interventions 
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highly depends on the encouragement of compliance from a clinician in addition to the 
specific technology tools used (Joice et al., 2011; Kelders et al., 2012). 
 
Figure 26 Three factors with subcomponents in the Fogg Behavior Model (Fogg, 2009). 
 
This can be applied to the current psychological interventions by altering the level of 
support for different patients and was supported by findings from the current 
qualitative study. For instance, motivated patients would have an option to enter an 
exclusively self-directed online programme themselves or have a clinician-assisted 
alternative. Less motivated patients could enter a clinician-assisted version and have a 
telephone or additional email support. However, it is essential for both this group of 
patients to be reassessed after the programme. This would encourage patients to 
comply with and complete the programme and assess the need for moving a step up 
to more intensive care if this programme did not achieve the objectives. 
4.4.3.2.3 Considering and maximising the likelihood of intervention uptake 
Stepped care model/embedding the intervention 
The National Institute for Health and Clinical Excellence (NICE) framework organises 
psychological therapy services for the treatment of some common mental health 
disorders in a structure of stepped care (Table 16) to archive the best patient-reported 
outcome measures (PROMS) with the least intrusive and most effective intervention 
(NICE, 2019a). If the initial intervention were found to be non beneficial to the patient, 




This stepped care model ensures that more patients can access the appropriate 
services as a part of the UK’s Improving Access to Psychological Therapies (IAPT) 
programme (NICE, 2019a). A stepped-care model appears to be more effective for the 
treatment of subthreshold depression and/or anxiety than usual care (van't Veer-
Tazelaar et al., 2009). This model also achieves more effective use of high-intensity 
intervention and is possibly cost-effective (Boyd, Baker and Reilly, 2019). 
 
Table 16 Stepped-care model: a combined summary for common mental health 
disorders 
Staff The focus of the intervention Nature of the intervention 




depressive symptoms or mild to 
moderate depression that has 
not responded to a low-
intensity intervention; initial 
presentation of moderate or 
severe depression; GAD with 
marked functional impairment 
or that has not responded to a 
low-intensity intervention; 
moderate to severe panic 
disorder; OCD with moderate or 
severe functional impairment; 
PTSD. 
Depression: CBT, IPT, behavioural 
activation, behavioural couples 
therapy, counselling*, short-term 
psychodynamic psychotherapy*, 
antidepressants, combined 
interventions, collaborative care**, 
self-help groups. 
GAD: CBT, applied relaxation, drug 
treatment, combined interventions, 
self-help groups. 
Panic disorder: CBT, antidepressants, 
self-help groups. 
OCD: CBT (including ERP), 
antidepressants, combined 
interventions and case management, 
self-help groups. 
PTSD: Trauma-focused CBT, EMDR, 
drug treatment. 
All disorders: Support groups, 
befriending, rehabilitation 
programmes, educational and 
employment support services; 
referral for further assessment and 
interventions. 




depressive symptoms or mild to 
moderate depression; GAD; 
mild to moderate panic 
disorder; mild to moderate 
OCD; PTSD (including people 
with mild to moderate PTSD) 
Depression: Individual facilitated self-
help, computerised CBT, structured 
physical activity, group-based peer 
support (self-help) programmes**, 
non-directive counselling delivered 
at home†, antidepressants, self-help 
groups. 
GAD and panic 
disorder: Individual non-
facilitated and facilitated self-
help, psychoeducational groups, 
self-help groups. 
OCD: Individual or group CBT 
(including ERP), self-help groups. 
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PTSD: Trauma-focused CBT or 
EMDR. 
All disorders: Support groups, 
educational and employment 
support services; referral for further 
assessment and interventions. 
Step 1: Primary care/IAPT 
service  
 
All disorders – known and 
suspected presentations of 
common mental health 
disorders. 
All disorders: Identification, 
assessment, psychoeducation, active 
monitoring; referral for further 
assessment and interventions. 
 
Step 2 of this care model is a low-intensity intervention for treating depression and 
anxiety disorders usually delivered by psychological well-being practitioners (PWPs) 
(NCCMH, 2019).  
 
Computerised and internet-delivered CBT is considered as a suitable treatment 
alternative and approved by IAPT at this step (NICE, 2019a). Therefore, the proposed 
intervention was considered as step 2 low-intensity intervention and could be used 
and integrated into the pathway for IAPT services. Therefore, online psychological 
intervention could be used in the first instance and in case of no response to this 
intervention, patients could be moved to a higher-intensity psychotherapy of step 3 
services. As these services provide a protocol-driven path, an implementation of the 
current intervention for IBD patients with comorbid anxiety and/or depression into 
IAPT would maximise the likelihood of the intervention uptake. However, this implies 
health professionals' awareness about the existence of an online programme.  
4.4.3.2.3.1 Collaborative care 
The online intervention can only be successfully implemented when it engages the 
collaboration between the targeted users, in the present case IBD patients with 
comorbid anxiety and/or depression, clinicians, researchers, software developers, and 
policy-makers (Pagliari, 2007) and the implementation of the collaborative care models 
for patients with depression emerge to be the most cost-effective (Joice et al., 2011). 
The codes and themes that came through patients and health professionals' data in 







To improve the implementation of the intervention in future and empower patients, 
their involvement in the evaluation phase of the intervention is essential (Craig et al., 
2013) and is desired by patients in this study.  
Health professionals' role 
At an early stage of the development of an intervention, it is vital to take into 
consideration who will deliver the intervention and in which settings. The complete 
version of the online psychological intervention is intended to be delivered by more 
general medical staff who provide IBD care, such as IBD nurses, NHS junior mental 
health workers, trained coaches (psychological wellbeing practitioners), social workers, 
professional counsellors, PWPs, but who would have access to psychological advice 
from a psychologist if and when required. The NHS psychologist also could refer 
patients to the programme to have minimal contact with patients instead of usual 
treatment involving regular face-to-face sessions that would reduce the workload of 
psychologists and could be cost-effective to the NHS.  
 
The finding from the current study demonstrated the importance for patients of the 
health professionals' encouragement. At the same time, they would like to take 
control of their own treatment with the clinicians' support. This can be facilitated with 
an improved relationship between health professionals and patients. Nurses play a 
crucial role in the encouragement of patients to be actively involved in their own 
treatment and make sure that patients benefit from safe, quality care (Norton et al., 
2012). 
 
The nurse-led services are fundamental for IBD care (Armuzzi et al., 2018; O'Connor et 
al., 2013) and a holistic approach to IBD care in the integrated care model involves a 
shift from essential to enhanced care by IBD nurses (Kemp et al., 2018). A recent 
systematic and meta-analysis of RCTs showed the effectiveness of the care delivered 
by nurse management of depression in a variety of long term health conditions, but 
the authors could not conclude on it's the cost-effectiveness (Ekers et al., 2013). 
However, several recent studies show nurse-led services, including telephone support, 
can significantly improve the quality of care and reduce the cost of care  (Bager, 2014; 
Squires, Boal and Naismith, 2016; Taylor et al., 2016; Correal et al., 2019). Patients in 
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the current study also highlighted the importance of support from IBD nurses. Thus, 
the current intervention could be designed to be delivered by nurses or NHS junior 
mental health workers, psychological wellbeing practitioners (PWPs), or NHS 
psychologist with limited human contact.  
 
However, in practice, non-specialist nurses or other health care practitioners could 
face some challenges during the delivery of the programme as shown in the study on 
delivering psychological intervention for patients with chronic fatigue 
syndrome/myalgic encephalomyelitis (Peters et al., 2011). The study concluded that 
being a beginner in delivering therapy, engaging patients, emotions, and the intricacy 
of the setting could lead to a possible strain between the therapist and patient (Peters 
et al., 2011). The negative impact that the intervention had on nurses could be 
overcome by regular supervision (Webster, Ekers and Chew-Graham, 2016). However, 
the proposed psychological intervention is aimed at IBD patients with subthreshold, 
mild or moderate depression and anxiety, hence determines the selection process 
prior engagement in the programme and referral of severe cases to the specialists 
before assigning to the programme. The online mode of delivery minimises the contact 
with the providers, thus reduce the emotional burden on them. From the evidence of 
the current qualitative study, it is predicted that for the implementation of the online 
interventions at least one nurse, PWP or psychotherapist is required per site. This 
assumption was based on the currently available services for this population. However, 
a feasible and acceptable number of health professionals delivering the intervention 
per a set number of patients could be defined in a future study. 
 
The current online psychological intervention could be delivered through various 
settings, including outpatient, hospital-based and therapeutic communities. The IBD 
patients with comorbid anxiety and/or depression can use the online psychological 
interventions in a wide range of locations: clinics, hospitals, homes and other facilities. 
The only requirement for the use of this intervention is access to the Internet. 
4.4.3.2.3.2 Confidentiality, security and ethical concerns about online interventions 
The internet assists implementation of the online interventions but, conversely, 
personal privacy could be breached during its use. Therefore, privacy and ethical 
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concerns have to be taken into account during the development of the intervention by 
following the e-Health Code of Ethics (e-Health Ethics, 2000). This assumes the 
patients, and the providers of the intervention are aware of the potential risks that 
could arise during the application of the online intervention (e-Health Ethics, 2000) and 
information about a possible breach of confidentiality should be given to patients 
(Manhal-Baugus, 2001).  
 
Online interventions bring some ethical advantages: they are more accessible and 
flexible, help to avoid the stigma, show psychologists' consideration of patients who 
cannot access services and their attempt to progress professionally by expanding 
expertise in the new format (Dever Fitzgerald et al., 2010). Despite security and 
confidentiality concerns, the majority of long-term condition patients have confidence 
in the online interventions and believe that these risks do not exceed gained returns 
(Hale and Kvedar, 2014). 
4.4.3.2.4 Determining measures for clinical outcomes 
A logic model (Figure 27) was adapted from the Better Care Fund (NHS England, 2015) 
and the draft of a logic model for integrating mental health into chronic disease 
prevention and health promotion. (Lando et al., 2006). It guides you through the 
process of design, development, evaluation and implementation of the intervention 
and helps with interpreting the result (NHS England, 2015). This model could be 
further modified during a feasibility trial. However, it is important to determine the 
outcomes at the beginning of the intervention development rather than 
"retrospectively fitting them to a predetermined and funded set of activities or 
interventions" (NHS England, 2015). 
 
System outcomes are reflected in the Impact section of Figure 27. Additionally, to the 
health and wellbeing outcomes, and the effective use of resources, system outcomes 
included improved experience in care (England, Butler and Gonzalez, 2015). Being a 
part of a stepped care model suggested online psychological intervention would be 
directed to achieving both, the system outcomes by improving access to psychological 
therapies and the personal outcomes for the patients as a result of using an online 





4.4.3.2.4.1 System outcomes 
Personal level outcomes 
At the personal level, the intervention should improve anxiety, depression and QOL. 
The disease activity and any other related outcomes could also be assessed. Suggested 
health outcomes and measures at a personal level as a result of participation in the 
current psychological intervention could be: 
 
1) Mental health outcomes 
Rates of anxiety and depression and/or mean levels of anxiety and depression 
Rates of anxiety, depression, level of stress and coping in patients assessed using 
validated screening scales such as the Hospital Anxiety and Depression Scale (HADS), 
the Patient Health Questionnaire (PHQ9), the State-Trait Anxiety Inventory (STAI), 
























































Improving health and 
well being outcomes 
Using recourses 
effectively (reducing 
in  waiting list and 
attendance of 
psychologist, 
reduction in hospital 
admission through 
improvement in the 
management of the 
disease) 
Improving experience 
of care (patients 
access to services 
Patient perceptions 
of care Consumer 
Assessment of 
Healthcare Providers 
and Services (CAHPS) 
instruments) 
Contextual and external factors: linkage between health care services (e.g., IBD and mental 




Generalised Anxiety Disorder Assessment (GAD-7), the Depression Anxiety Stress 
Scales (DASS), the Revised Social Readjustment Rating Scale (RSRRS), the IBD Stages of 
Change Coping Questionnaire (IBDSCCQ), the Perceived Stress Scale (PSS), the Brief 
COPE, the CORE /CORE – 10 (Clinical Outcomes in Routine Evaluation).  
 
2) HRQoL 
Health-related quality of life assessed using validated screening scales such as the (SF-
36) and IBDQ. Work and Social Adjustment Scale (WSAS) to measure of social 
functioning. 
 
3) Disease activity outcomes 
The remission rate in patients with IBD. 
Disease activity assessed using well-established scales or tests (the Crohn’s Disease 
Activity Index (CDAI) for those with CD or the Simple Clinical Colitis Activity Index 
(SCCAI) for those with UC, faecal calprotectin; blood parameters (C-reactive protein 
(CRP), Haemoglobin (Hb), platelet, White Cell Count (WCC), haematocrit).  
 
4) Any related outcomes  
(E.g. reduced time off work or school, sick leave, hospitalisation (frequency and 
length), pain, adverse events, adherence to the intervention programme, trial 
withdrawal and attrition during feasibility trial). A result of a recent study showed that 
9.3 % of 558 pooled participants reported some adverse events related to the online 
interventions for mental disorders (Rozental et al., 2015). Therefore, any adverse 
outcomes should be reported, as they could deteriorate patients' health and as a 
result reduce the cost-effectiveness of the intervention (Joice et al., 2011). 
Patients should be assessed at the last session to measure short term outcomes and at 
12 and 24 months after the intervention for long term outcomes.  
4.4.4 Implications 
The findings from this study indicate that IBD patients with comorbid anxiety and/or 
depression are open to the participation in self-directed online PI, suggesting its 
implementation in the current management of IBD. The intervention designed to meet 
the patient needs could be tested in future trials. If successful, online intervention 
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could be integrated into the management of IBD with comorbid anxiety and/or 
depression. The provision of online psychological help could be considered as part of 
the holistic care for this population. Furthermore, it could reduce long waiting lists to a 
psychologist and take the burden from the overstretched NHS resources and, 
potentially, reduce the cost of care.  
 
Patients and health professionals discussed the lack of psychological support for IBD 
patients and the lack of integrated care as a major concern for IBD patients with 
anxiety and/or depression (reported in Chapter 3). The integration of online 
intervention may fill this gap. Furthermore, the online mode of delivery could improve 
the accessibility of the intervention, as all participants considered this as a significant 
advantage of the programme. Additionally, as some participants reported that IBD 
symptoms and anxiety, including social anxiety, made them housebound, as a result, 
they missed the appointments. Therefore, the online mode of delivery intervention 
would increase the accessibility of help for this group of people, who would not be 
reached during conventional management of the disease, hence reducing inequality in 
care. 
 
It is estimated that the approximate annual NHS cost for UC was £3,084 per patient 
and £6,156 for CD, although, the cost could increase dramatically during relapses 
(Ghosh and Premchand, 2015). The cost-effectiveness of the online delivered 
interventions is debatable. The recently published study shows that the online 
delivered CBT for depression was as cost-effective as treatment as usual and had 
similar health outcomes (Holst et al., 2018). However, this study was conducted 
between 2010 and 2014 in Sweden, and its findings may not apply to the NHS settings 
in the UK. Furthermore, it is anticipated that the cost of usual care might have 
increased compared to an online intervention since the study was conducted. 
Therefore, the implementation of the programme and its cost-effectiveness should be 
explored in a future study.   
4.4.5 Strengths and limitations of the study 
The strength of this study have been discussed in Chapter 3. The methodological and 




Further, even though prior to the study, all participants received the recruitment pack 
with the glossary, the majority of participants did not read it. As a result, they had a 
vague understanding of the talk therapy term, and this might have influenced their 
answers.  As an example, one patient thought that talk therapy is "just talking", and 
wanted more "practical things", but after the explanation, they changed the 
perception. All participants were asked to familiarise themselves with the "Tame Your 
Gut" website prior to the interview/focus group. However, many participants did not 
do this. For these participants, the website was available during the interview. 
However, this could be considered to mirror usual practice, as patients in real life may 
decide on the participation in the programme in similar circumstances.   
 
Health professionals and patients received the link to the "Tame Your Gut" website 
and the glossary of terms prior to the interview. However, some patients were 
recruited during the IBD clinic and interviewed immediately after a short 
familiarisation with the study’s purpose, consent and a brief explanation of the 
terminology. These patients were able to access the website during the interview and 
navigate around it when answering the questions. Future studies could specify the 
time required for the participants' familiarisation with the online intervention. The 
patients who expressed interest in doing the interview instantly, possibly, were a more 
motivated group of patients and could have more positive attitudes toward an online 
PI. 
 
On the other hand, the study also recruited less motivated patients. One patient was 
observed to reject any form of outside help. They were satisfied with the management 
of psychological issues, which mostly consisted of distraction, were not motivated to 
seek outside help and had a negative attitude towards an online PI.  
 
The agreement between the health professionals and patients that the online 
programme can increase the accessibility of psychological help and that clinician-
assisted version of the programme was preferred increases the confidence of this 
study’s findings and the expectation for the implementation of the online programme 
into the management of the disease in this population of patients. 
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4.4.6 Future research 
To broaden the findings from this study, future research needs to consider designing 
better alternatives to the presently scarce psychological treatments. This prototype 
should be used in the development of the complete online programme and its efficacy 
tested in a future feasibility trial. 
 
The online psychological intervention should be tested in mixed-methods analysis to 
enhance effectiveness, feasibility and acceptability for the implementation in future. 
The mediators and moderators of intervention effectiveness and cost-effectiveness 
should also be explored. Furthermore, future research should determine if the self-
directed online PI directed on anxiety and depression is useful in the management of 
patients' IBD symptoms.  
4.5 Conclusions 
The current study gathered important data on the patients' and health professionals' 
perception (feasibility and acceptability) of an online PI programme for IBD. The 
findings suggested that patients, in general, had a positive attitude towards the online 
PI and were willing to participate in the programme. This differed from the health 
professionals’ views, as they were unsure about the patients' participation.  
 
The patients' and health professionals' comments about the existing "Tame Your Gut" 
programme formed a basis for the development of a prototype of an online PI for IBD 
patients with comorbid anxiety and/or depression. The inclusion of the online PI 
intervention could improve the accessibility to the psychological help and, as a result, 
enhance integrated care.  
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5 Discussion  
This chapter summarises the main findings of the present PhD project and their 
implications for research and practice, discussing study strengths and limitations, 
policy, clinical and research recommendations and providing the overall conclusion.   
5.1 Main findings 
This thesis made an original contribution to the research knowledge in three ways. 
Firstly, it demonstrated that there is insufficient evidence on the effectiveness of the 
online psychological therapy for mental and physical outcomes in gastrointestinal 
diseases, IBD and IBS specifically and the need to investigate it further. Secondly, the 
results of the qualitative study showed that there is a need for the integrated care for 
patients with IBD and comorbid anxiety and/or depression, particularly regarding the 
provision of psychological help. The findings also demonstrated that patients had a 
positive attitude towards online psychological intervention. Thirdly, based on 
theoretical evidence and patients' and health professionals' views, the project 
provided the recommendations (the prototype) for the online psychological 
intervention for patients with IBD and anxiety and/or depression. However, this 
prototype was explicitly developed for this population, and the generalisability of 
these recommendations for the other IBD patients "in need" (patients who have a high 
baseline IBD activity; have been recently diagnosed; are young; with comorbid 
psychological distress) requires further research. Moreover, a complete intervention 
would require further investigation of patients', health professionals' and stakeholders' 
views about the finished product in a new qualitative study to improve its 
implementation.  
 
This PhD project was informed by the MRC framework for designing complex 
interventions. The key findings of this thesis are discussed in line with the following 
specific aims: 
1. To gather theoretical evidence on the effectiveness of the online 
psychological therapy in gastrointestinal diseases.  
2. To investigate patients' with IBD and comorbid anxiety and/or depression 
and their service providers' views about the lived experiences of these patients. 
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3. To investigate participants' views about online psychological intervention 
and provide the recommendation for the online psychological intervention for 
patients with IBD and comorbid anxiety and/or depression.   
 
The use of online interventions in health, including the use of these interventions in 
mental health, has increased rapidly (Hill et al., 2017; Maples-Keller et al., 2017; Fodor 
et al., 2018). Several systematic reviews and meta-analyses have demonstrated that 
online psychotherapy is effective for treatment of anxiety and depression, convenient, 
flexible, confidential, acceptable, accessible, and more cost-effective compared to 
face-to-face therapy (Andrews et al., 2010; Richards and Richardson, 2012; Andrews 
and Williams, 2015; Musiat and Tarrier, 2014).  
 
The data on the effectiveness of online interventions in IBD are generally limited and 
thus to learn about its usefulness a decision was made to review the relevant literature 
in the context of gastrointestinal illness in general (i.e. including all gastrointestinal 
conditions and not just IBD). To the author’s knowledge, this was the first systematic 
review of its kind. The review showed that there is insufficient evidence to 
demonstrate the effectiveness of online CBT to manage mental and physical outcomes 
in gastrointestinal diseases, including IBS and IBD – data for only these two conditions 
were identified (Chapter 2).  
 
The previous systematic review on the effectiveness of psychotherapy in IBD, not 
limited to the online mode of delivery, showed that psychotherapies, CBT in particular, 
are effective in improving QOL and depression in patients with IBD (Gracie et al., 
2017). The authors of this review suggested investigating its effectiveness in patients 
with IBD and comorbid psychological distress, as this group is likely to benefit more 
from psychotherapy than the unselected patients with IBD included in the currently 
available trials (Gracie et al., 2017). 
 
A difference in the findings between Gracie et al. (2017) and the current review likely 
stems from the present review’s focus on online interventions. It is possible that for 
psychotherapy to work in this context, human contact is necessary – it is unclear for 
now what is the minimum amount of contact with a therapist for psychotherapy to be 
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effective. While online therapies offer clear advantages of time and cost savings, 
future interventions may need to examine hybrid models which involve both a 
therapist and online components. Furthermore, engagement in therapy, a high 
attrition rate and low adherence to treatment typical for the online interventions 
could potentially be improved by providing support of a clinician or technician (Musiat 
and Tarrier, 2014; Gilbody et al., 2017).  
 
The main message from the current systematic review was that the evidence on the 
usefulness of online psychological interventions in gastroenterology, and IBD 
specifically, is scarce. There is a need for more robust trials of psychotherapy in IBD, 
going beyond exclusively online solutions and with a particular focus on the selected 
subgroup of patients with IBD that are in need of psychotherapy such as those with 
anxiety and depression. 
 
The advantages of online interventions, the recommendations from the previous 
review (Gracie et al., 2017) and the studies of online psychological interventions in IBD 
identified during the current systematic review (Mikocka-Walus et al., 2015; Mikocka-
Walus et al., 2016a) confirmed the rationale for the present project: to develop a 
prototype of the programme for patients with IBD and comorbid anxiety and/or 
depression which could be tested in a future feasibility trial. Following the MRC 
framework, after the systematic review a qualitative exploratory study investigating 
patients' with IBD and comorbid anxiety and/or depression and their service providers' 
views about the lived experiences of these patients was performed (Chapter 3). To the 
author's knowledge, this was the first qualitative study of its kind. The basis for the 
selection of this group of patients was the recommendation from the previous 
systematic review (Gracie et al., 2017), as well as a high level of anxiety and depression 
comorbid with IBD and their impact on the disease management that was reported in 
previous research  (Mikocka-Walus et al., 2016b; Navabi et al., 2018).  
 
The participants' views about the lived experience were investigated to identify any 
gaps and difficulties in the management of the disease in this population and, as a 
result, increase understanding of how the provision of psychological services could be 
improved and to confirm the need for psychological interventions (Chapter 3).  
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The main message from this qualitative study was that patients with IBD and comorbid 
anxiety and/or depression do not get adequate psychological help. Because of the 
bidirectional links between IBD and mental health, there is a need to treat both at the 
same time (Chapter 3) (Gracie et al., 2018). There is a further need to increase 
awareness of IBD, a need for the implementation of the integrated model of care and 
more accessible psychological interventions into the routine management of patients 
with IBD and anxiety and/or depression. The online or partly online self-directed 
psychological intervention could be one such solution. 
 
This qualitative study also collected data on patients' and health professionals' views 
about future psychological interventions, which together with the theoretical 
evidence, lay the foundation for the modelling prototype of an online intervention for 
those with IBD and co-morbid anxiety/depression (Chapter 4). Only one online 
intervention for people with IBD called "Tame Your Gut" (TAME YOUR GUT, 2019) has 
been developed and tested to date (Mikocka-Walus, 2015; McCombie, 2016). 
Therefore, the "Tame Your Gut" programme was used as an example for the 
participants in this qualitative study to comment on the features of this intervention so 
it could be adapted to the patients' needs.   
 
The main message of this qualitative study was that self-directed online psychological 
interventions are accepted as an alternative to F2F therapy, an accessible option of 
delivering psychological help for patients with IBD and anxiety and/or depression, and 
are well-received by patients. The existing "Tame Your Gut" online psychological 
intervention for patients with IBD requires changes to adapt it to this population's 
needs and the UK environment (the intervention was originally designed in Australia). 
The proposed recommendations (discussed in detail in Chapter 4) could be 
implemented into the online intervention and its effectiveness evaluated in future 
trials. 
5.2 Implications for policy and practice 
The present work highlights the need for further trials on the effectiveness of online 
psychotherapy in IBD with comorbid anxiety/depression. It further showed a lack of 
awareness about the mental health comorbidity in IBD and IBD itself among the public 
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and non-specialist health professionals, GPs specifically, which in turn affects patients’ 
mental health and QOL. Data from another qualitative study showed that lack of 
awareness and knowledge about IBD among non-specialist health professionals and 
the public could reduce patients’ ability to self-manage (Cooper et al., 2010), which is 
an essential part of the integrated model of care.  The lack of public awareness and 
embarrassment could lead to the patients concealing their IBD diagnosis (Fourie et al., 
2018). Thus, the surrounding community might be unaware about the patients' IBD 
and, as a result, this could lead to discrimination at work or study due to frequent and 
extended sick leave (Avedano et al., 2014). The psychological wellbeing of patients 
could be improved by increasing awareness about the disease and developing support 
in the education sector and workplace. Consequently, by increasing awareness about 
the disease among health professionals and society, the improvement in the patients' 
QOL could be achieved (Bray et al., 2016). There is a clear need for the implementation 
of national and community level activities designed to raise awareness of IBD and 
mental health among patients, public and health professionals. These activities could 
include developing a resource guide for the health professionals on screening for signs 
of anxiety and depression, and on IBD symptoms for none IBD specialist health 
professionals; publication of articles in peer-reviewed journals and local newspapers; 
organising the workshops and interactive educational sessions for the patients and 
health professionals; development and distribution of newsletters and educational 
leaflets on the topic among patients and wider public; creating partnerships between 
media and the healthcare providers to increase awareness about IBD through radio 
and television; and a variety of campaigns (e.g. annual IBD walks) run by patient 
organisations such as Crohn’s & Colitis UK. The leading role in the increasing awareness 
of IBD belongs to scientific research, the results of which can subsequently be used to 
inform the above activities (Long et al., 2008). These activities showed their usefulness 
in raising disease awareness in other healthcare fields (Long et al., 2008; Ueland, 
Hornung and Greenwald, 2006; Zielinski et al., 2006; Bero et al., 1998). However, a 
passive distribution of the materials through papers, conferences and lectures may not 
be sufficient to change the behaviour of health professionals in decision making about 
the disease management compared to the interactive activities (Bero et al., 1998). 
Including more information about IBD and its mental health comorbidities in the 
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clinical curriculum for GPs could improve diagnostics and early treatment of the 
disease.  
 
Despite the fact that an integrated model of care with a multidisciplinary team of 
specialists is recommended for all IBD patients (Mikocka-Walus et al., 2012b; NICE, 
2019b), it is not implemented widely in practice and the findings of the current work 
indicated the need for integration of care to address anxiety and/or depression 
comorbid with IBD specifically. Lack of psychological support was commonly reported. 
Therefore, at the hospital trusts level, improving the provision of care is required, and 
at the national level, it is necessary for policymakers to take into consideration the 
barriers for its implementation and the mechanisms of overcoming these barriers. 
Development and introduction of an alternative provision of care such as self-
management online psychotherapy, may improve access to psychological help, reduce 
the long waiting lists to a psychologist and, potentially, reduce the cost of care under 
overstretched NHS resources.   
5.3 Strengths and limitations 
The main strength of this project was that it followed the development phase of the 
MRC framework for complex interventions. It was important to follow this framework 
as it has a phased approach which allows the researcher to determine to which stage 
the study belongs, to effectively plan and design the research, evaluate and implement 
the results (Campbell et al., 2000; Craig et al., 2013). The MRC framework had a 
significant impact on the research and is a valuable tool for the development, 
evaluation and implementation of the complex interventions (Campbell et al., 2000; 
Craig et al., 2013; Moore et al., 2014; De Silva et al., 2014). This framework has been 
applied effectively in the development of the complex interventions in other health 
fields (Furness et al., 2018; Bobrow et al., 2018; Lakshman et al., 2014). There are 
other frameworks for the development of the complex interventions available 
(Bartholomew et al., 2001; Glasgow, Vogt and Boles, 1999; Green and Kreuter, 1999; 
Pagliari, 2007), but they to some extent include stages of MRC framework what makes 




However, the project unavoidably has some limitations. The main drawback is that 
there was no experimental component to this project and the prototype has not been 
tested. Originally, there was an intention to develop the final product of the online 
intervention and conduct a feasibility trial to test its effectiveness. However, it was not 
feasible within the scope of this PhD project due to the delays in obtaining the 
research passport for the primary researcher, accessing the hospital sites and slow 
recruitment of patients to the qualitative study.  
 
The systematic review used a rigorous methodology with meta-analyses to increase 
the statistical power and followed the strict protocol registered on PROSPERO. 
Nevertheless, the findings of the systematic review were inconclusive due to the small 
number of studies, warranting new research on the subject. The sources of significant 
heterogeneity between included studies and the presence of publication bias also 
could not be investigated due to a small number of studies included in the meta-
analysis. There were also limitations in the individual studies such as short-term follow 
up, a high risk of performance and detection bias, inconsistency in the reporting 
outcomes. 
 
The strength of the qualitative study was applying triangulation principles, the coding 
of the data was conducted in a thorough and systematic way, and the process was 
cross-examined by the other research team members to increase the credibility and 
validity of the results. Moreover, this study was conducted across several hospital 
sites, which allowed for achieving richness and diversity of the data.  
 
Based on the theoretical evidence gathered prior to this qualitative study, the author 
focused on the selected population with IBD who had comorbid anxiety and/or 
depression. The gender variation was also crucial for this population to explore the 
difference in perceptions of online interventions. The evidence shows that there are 
gender differences in preferences between traditional and technology-assisted 
interventions (Kim, Choo and Ranney, 2014) and the acceptability of online 
psychological interventions (Campbell et al., 2015). No differences in the views 




The diverse ages of the participants were also essential to identify if their behaviour 
towards the Internet and technology differed. There are controversies with regards to 
the internet behaviours of the older population (Wagner, Hassanein and Head, 2010). 
Some evidence suggested the use of internet, e-mail or text messages is limited in 
older adults (over 65 years old) (Morrell, Mayhorn and Bennett, 2000; Gell et al., 
2013), particularly the use of online health interventions by those who likely to gain 
benefit from them (Gell et al., 2013), whereas other studies suggested that online 
interventions are effective in older adults (Choi, Kong and Jung, 2012). Furthermore, 
the uptake of online interventions by an older adult could be enhanced with 
encouragement, support and use of specially designed technology training for this 
population (Wagner et al., 2010; Vaportzis, Clausen and Gow, 2017). These findings 
correlated with the patients' view from the current study where old patients did not 
consider their age or knowledge of the technology as a barrier for participation in the 
programme but required support from family members or clinicians. 
 
The qualitative study also had some potential limitations. Its sample size was limited to 
a specific group of patients, patients with IBD and comorbid anxiety and/or depression 
in one region of England, and this limits its generalisability to other patients' with IBD 
in other regions. However, this was a purposely selected sample to develop the 
intervention prototype for this specific group of patients. The data collection was at 
the hospital facilities. However, putting patients in a less stressful environment during 
the interviews could, perhaps, engage them more in the conversation and provide 
more in-depth data.  
 
The majority of the participants did not familiarise themselves with the glossary or the 
"Tame Your Gut" programme prior interview. However, for these participants, the 
terminology was explained, and the website was available during the interviews. This 
was a pragmatic approach, which reflected the circumstances in which participants 
would make decisions about the online programme. The familiarisation time could be 
specified in future studies. Another limitation of this study was the inclusion of 
patients based on patient case notes and clinician’s evaluations. Specified levels of 





The limited number of online psychological interventions in gastrointestinal diseases, 
particularly IBD, identified in the systematic review, suggests the need for more robust 
trials to investigate its effectiveness. Future research should address the limitations of 
the existing studies by lengthening the follow-up period over 12 months, be consistent 
in presenting outcomes in the format facilitating meta-analysis (n, means, SD or mean 
difference with associated 95% confidence intervals), use allocation concealment 
during randomisation and use blinding of outcome assessors (the assessors could be 
masked to therapy).   
 
A high attrition level reported in the online interventions could be reduced by the 
introduction of the booster sessions, which also could help to maintain the effect of 
the psychotherapy (Beck and Beck, 2011; Gearing et al., 2013), thus should be 
considered during the design of the future interventions.  
 
The studies that met the inclusion criteria in the systematic review examined the 
effectiveness of CBT only. Thus, there is a need to test the effectiveness of other types 
of online interventions in gastrointestinal diseases. A systematic review by Gracie et al. 
(2017) confirmed CBT to be the most commonly used and most effective 
psychotherapy type in IBD to date (Gracie et al., 2017). However, other types of 
psychological therapy also were beneficial (Ford et al., 2014; Gracie et al., 2017) for 
QOL and reduction of depression in IBD (Gracie et al., 2017) and IBS (Ford et al., 2014), 
thus should be considered while designing future online interventions. One of the 
psychological interventions that could be considered is behavioural activation (BA), the 
effectiveness of which for depression is comparable to CBT (Jacobson et al., 1996; 
Richards et al., 2016). Moreover, BA was more cost-effective and could be delivered by 
NHS junior mental health workers not requiring specialised training in psychotherapies 
(Richards et al., 2016), which is fundamental due to the constrained resources in the 
NHS. Furthermore, the previous systematic reviews, not limited to the online mode of 
delivery, demonstrated the effectiveness of various psychological therapies delivered 
in-person or through telephone in IBS and IBD, including CBT (Ford et al., 2014; Gracie 
et al., 2017). The level of effectiveness of the intervention may depend on the mode of 
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its delivery, suggesting the need for designing online psychotherapy programs where 
the effectiveness can be enhanced by human contact which was considered during the 
development of the current prototype of the online intervention. However, a recent 
study showed that the combination of face-to-face with online intervention for anxiety 
and depression did not increase effectiveness, led to more treatment sessions and as a 
result was less cost-effective than the standard treatment (Kenter et al., 2015). 
However, these data came from an observational study and not an RCT thus could be 
subject to various types of bias for example selection bias. Furthermore, the study had 
online intervention in addition to the face-to-face, whereas future studies should 
develop online interventions as a substitute for face-to-face with limited human 
contact. 
 
The current systematic review can be updated in the future with the availability of 
more studies assessing online psychological interventions in gastrointestinal diseases, 
as it used a robust methodology and comprehensive search strategy. The most 
important recommendation resulting from the qualitative study is that the online 
psychological intervention should be co-designed by the patients, researches and 
other stakeholders to enhance effectiveness, feasibility and acceptability of its 
implementation.  
 
Moreover, future qualitative studies could examine patients’ and health professionals' 
views about online psychological interventions for patients with IBD and comorbid 
anxiety and or depression in different geographical locations of the UK to explore the 
generalisability of the findings from the current study. Furthermore, the view about 
online psychological interventions should be assessed for other subgroups of patients 
with IBD who are likely to benefit from psychological interventions: patients, who have 
been recently diagnosed, are young and have high baseline IBD activity (Gracie et al., 
2017; Mikocka-Walus, 2015). 
 
The recruitment process could be improved in future qualitative studies. The 
recruitment of patients in the current qualitative study depended on the collaborators’ 
level of involvement and interest in the study and was easier at some hospital sites 
than at others. The collaborators could not provide the data on how many patients 
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who had been approached were not interested in the study participation. Thus, the 
difficulties in the recruitment could be explained by either patients' low interest in the 
study or because collaborators were not approaching the potential patient's 
participants. Using more network contacts and opening the recruitment process at 
several sites simultaneously could increase recruitment. Furthermore, participants 
could be recruited online, for instance through Crohn's and Colitis UK website or the 
University where the researchers are based (recruiting the students and staff members 
with IBD). This would expand the area of recruitment, would require only the 
University ethical approval and would avoid unnecessary waiting time for the NHS 
ethical approval, obtaining the research passport and site access, however, may result 
in few recruits as IBD is not very common.  
 
Online psychological interventions should be tested in mixed-methods analyses 
(O'Cathain, Murphy and Nicholl, 2007; Campbell et al., 2000). Therefore, the feasibility 
trial on the effectiveness of the intervention that is developed based on the current 
prototype should be supported by new qualitative research. This could be done with 
the same patients and health professionals, as they agreed to comment on the finished 
intervention product, to see if the intervention met their requirements and needs. 
Engagement and work in partnership with health care providers, patients, PPI and 
policy-makers are becoming increasingly important in health care research (Banner et 
al., 2019; Graham et al., 2006). Some authors call this approach an experience-based 
co-design (Dawda and Knight, 2017). This methodology is based not only on patients' 
perceptions, attitudes, needs and views, but combines the user-centred orientation 
(experience base), also called a Design Thinking, and collaborative change process (co-
design) (Altman, Huang and Breland, 2018; Dawda and Knight, 2017). Consequently, 
patients and healthcare professionals work on improving the intervention as equal 
partners (co-designers) (Dawda and Knight, 2017). This would empower patients, 
public members, and stakeholders to become active participants in the development 
of the intervention that they will implement/use in the future.  
5.5 Conclusion 
The theoretical evidence from the broader literature and patients' and health 
professionals' comments about the existing "Tame Your Gut" programme formed a 
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basis for the development of a modelling prototype of an online PI for IBD patients 
with comorbid anxiety and/or depression. The intervention based on this prototype 
could be tested in a future trial. The productive collaborations between patients, 
stakeholders and researchers in co-designing of an online psychological intervention 
and its implementation into integrated care of patients with IBD and comorbid anxiety 
and/or depression, and other "in need" patients with IBD that are likely to benefit from 
psychological interventions, will be the key to broaden the knowledge in the field and 





Appendix 1 Search result  in Ovid MEDLINE(R) Epub Ahead of Print 
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to Present 
Searches Results 
exp Psychotherapy/ 173930 
exp Adaptation, Psychological/ 113018 
(psychotherap* or (behavior* adj2 therap*) or (behaviour* adj2 therap*) or cognitive 
therap* or psychological intervention* or psychological adaptation or systematic 
desensitiz* or systematic desensitis*).ti,ab. 
58369 
(Cognitive problem-solving skills training or characteranalyti* or character-analyti* or 
client-centered or client-centred or coherence therap* or contemplative therap* or 
conversational therap*).ti,ab. 
1242 
exp Problem Solving/ 22986 
Patient-Centered Care/ 14436 
(problem-solving adj2 training).ti,ab. 307 
((coping or cope or copes or coped) adj2 (skill* or behavior* or behaviours or 
train*)).ti,ab. 
4659 
(core energetic* or core process*).ti,ab. 492 
(dialectical behavio?r therap* or DBT).ti,ab. 2007 
(Dreamwork or Dyadic or DDP).ti,ab. 7092 
(expressive therap* or Desensiti* reprocessing or Desensiti* re-processing or 
Emotional Freedom Techni* or EFT or encounter group* or Experient* Dynamic or 
Existential therap* or exposure response prevent* therap* or (Eye Movement 
Desensitization adj2 Reprocessing) or EMDR).ti,ab. 
1224 
(goal setting or Gestalt* or Group Analy* or Milieu Therap* or milieutherap* or group-
based therap* or group-based treatment* or group-based intervention).ti,ab. 
11001 
(hakomi or holistic or holotropic or humanistic or human givens or hypnos* or 
hypnot* or hypno-therap*).ti,ab. 
37593 
(interaction therap* or interperson* therap* or inter-personal therap* or IPT).ti,ab. 2240 
(meditati* or mindfulness* or MBSR or morita therap*).ti,ab. 6824 
Mind-Body Therapies/ 782 
(body mind or mind-body therap* or Radix therap* or pulsing or body-oriented 
psychotherap* or IBP or postural integration or integrative body psychotherap* or 
Pesso Boyden system psychomotor or lifespan Integration or Rubenfeld synergy or 
Reichian).ti,ab. 
3716 
(multimodal* therap* or multi-modal* therap* or multi-theoreti* or 
multitheoreti*).ti,ab. 
4543 
(relaxation therapy or tai ji or therapeutic touch or yoga).ti,ab. 4121 
(object* relation* or objectrelation*).ti,ab. 1715 
Neurolinguistic programming/ 77 
(family constellation* or family therapy or family coping or family coping impairment 
or (family inventory adj (life events or changes)) or compromised family coping or 
parent education or (ineffective management adj3 therapeutic families regimen) or 




care or family care or altered family coping or critical care family needs inventory or 
psychoeducation or (adolescent coping orientation adj2 problem experiences) or 
feminist therap* or functional analytic or Freudian or family-based intervention* or 
internal family systems model or parent-child interact* or parent-training program* or 
peer support group*).ti,ab. 
(psychoanaly* or psycho-analyti* or psychodynamic or psycho-dynamic).ti,ab. 17205 
Counseling/ 32029 
(counsel?ing or directive counsel?ing or motivational interviewing or distance 
counsel?ing or (pastoral adj (care or counsel* or therap*))).ti,ab. 
77337 
reality therap*.ti,ab. 82 
(rebirthing or re-birthing or relationship counsel* or reprogram* or re-program* or 
breathwork).ti,ab. 
16760 
Psychotherapy, Rational-Emotive/ 189 





Self Care/ 28644 
(self care or self help or self relationship or sponsorship or self-manag* or selfmanag* 
or self-talk).ti,ab. 
33374 
(SHEN or social support* or social therap* or social care or social problem skills train* 
or psychoeducation or psychology social or social support).ti,ab. 
37287 
(spiritual therap* or prayer or holistic care or Sophia-analys).ti,ab. 2943 
(thought field therap* or transactional* or trans-actional* or transperson* or trans-
person* or twelve-step program* or vegetotherap* or vegeto-therap*).ti,ab. 
1968 
(relational-cultural or MCT or (multicultural adj (counsel?ing or therapy))).ti,ab. 4709 
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 
18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 
33 or 34 or 35 or 36 or 37 or 38 
592816 
exp Digestive System Diseases/ 1538482 
(digestive system diseases or biliary tract diseases or digestive system abnormalities 
or digestive system fistul* or gastrointestinal diseases or oesophag* diseases or 
esophag* diseases or oesophagit* or esophagit* or gastrit* or enterit* or 
gastroenterit* or intestinal diseases or colit* or enterocolit* or proctit* or 
proctocolit* or rectal diseases or IBD or inflammatory bowel diseases or Crohn disease 
or ulcerative colit* or diverticul* or achalasia cardiae or megaesophagus or 
megaoesophagus or achlorhydria or Barrett esophagus or Barrett oesophagus or 
deglutition disorder* or duodenogastric reflux or eructation or esophag* fistul* or 
esophag* motility disorder* or oesophag* motility disorder* or oesophag* diverticul* 
or oesophag* fistula or esophageal achalasia or oesophageal achalasia or gastric 
dilatation or reflux esophagitis or reflux oesophagitis or gastroesophag* reflux or 
gastro-esophageal reflux disease or gastro-oesophageal reflux disease or gastropares* 
or liver diseases or pancreatic diseases or postgastrectomy syndrom* or stomach 
diseases or stomach diverticul* or Zollinger-Ellison syndrome).ti,ab. 
220432 
(gastrit* adj2 (chronic superficial or chronic atrophic or atrophy or unspecified or 
antral or fundal or Helicobacter pylori associated or giant hypertrophic or 
granulomatous or alcoholic)).ti,ab. 
2687 
gastroptosis.ti,ab. 49 
(ulcer adj2 (peptic or duodenal or gastroduodenal or gastrojejunal or gastrocolic or 
gastrointestinal or jejunal or marginal or intestine or anus or rectum or gastric or 





(hourglass contraction adj stomach).ti,ab. 0 
hemorrhoid*.ti,ab. 3875 
proctalgia fugax.ti,ab. 112 
(psychogenic adj2 (diarrhoea or dyspepsia or intestinal disorders)).ti,ab. 1 
(neurogenic bowel or neurogenic bowel dysfunction).ti,ab. 207 
(liver diseases or liver cirrhosis or (drug-induced liver injury adj chronic) or fatty liver 
or liver failure or hepatitis chronic or liver cirrhosis or ((liver diseases or fatty liver or 
liver cirrhosis or hepatitis) adj2 alcoholic)).ti,ab. 
72102 
((chronic or alcoholic) adj pancreatitis).ti,ab. 13603 
(cholangitis or cholestasis or gallbladder diseases or postcholecystectomy 
syndrome).ti,ab. 
24882 
pancreatic steatorrhoea.ti,ab. 34 
postcholecystectomy syndrome.ti,ab. 330 
(spasm adj2 (sphincter adj3 Oddi)).ti,ab. 27 
(gallstone adj2 (disease or pancreatitis)).ti,ab. 3052 
(fistula adj2 ((rectum adj skin) or anal or rectal or anorectal or stomach or duodenum 
or gastrocolic or gastrojejunocolic)).ti,ab. 
1775 
enteroptosis.ti,ab. 12 
(dyspepsia adj2 (nervous or neurotic or psychogenic or heartburn)).ti,ab. 106 
(dyspepsia adj2 (nervous or neurotic or psychogenic or heartburn)).ti,ab. 106 
((dyskinesia adj esophagus) or (dyskinesia adj oesophagus) or corkscrew esophagus or 
corkscrew oesophagus or diffuse esophageal spasm or diffuse oesophageal spasm or 
(spasm adj esophagus) or (spasm adj oesophagus)).ti,ab. 
434 
(allergic adj2 (gastroenteritis or colitis)).ti,ab. 151 
(functional gastrointestinal disorder* or FGID*).ti,ab. 1641 
irritable bowel syndrome.ti,ab. 10325 
40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 
55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 
1628977 
exp Telecommunications/ 75705 
Internet/ 60255 
Computer Communication Networks/ 13144 
Text Messaging/ 1463 
(online or on-line or internet or telemedicine or telecommunication or computeri?ed 
or computer-assisted or (computer adj2 assisted)).ti,ab. 
221899 
website*.ti,ab. 18149 
(e-health or ehealth).ti,ab. 2866 
(etherap* or e-therapy).ti,ab. 361 
(electronic mail or electronic-mail or text messag*).ti,ab. 2957 
67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 337709 
39 and 66 and 76 387 
 
 
Appendix 2 Search result  in British Nursing Index ProQuest 
British Nursing Index ProQuest 19/02/2017 
201 
 
((SU.EXACT.EXPLODE("Computer Networks") OR SU.EXACT.EXPLODE("Technology In Health Care") OR 
SU.EXACT("Information Technology")) OR ab(("online" OR "on-line" OR "internet" OR "telemedicine" OR 
"telecommunication" OR "computeri?ed" OR "computer-assisted" OR ("computer" NEAR/2 "assisted")) 
OR ("website*") OR ("e-health" OR "health") OR ("etherap*" OR "e-therapy") OR ("electronic mail" OR 
"electronic-mail" OR "text messag*"))) AND (ab(ab(("digestive system diseases" OR "biliary tract 
diseases" OR "digestive system abnormalities" OR "digestive system fistul*" OR "gastrointestinal 
diseases" OR "oesophag* diseases" OR "esophag* diseases" OR "oesophagit*" OR "esophagit*" OR 
"gastrit*" OR "enterit*" OR "castroenterit*" OR "intestinal diseases" OR "colit*" OR "enterocolit*" OR 
"proctit*" OR "proctocolit*" OR "rectal diseases" OR "ibid" OR "inflammatory bowel diseases" OR "croon 
disease" OR "ulcerative colit*" OR "diverticul*" OR "achaenia cardiac" OR "oesophagus" OR 
"oesophagus" OR "achlorhydria" OR "Barrett esophagus" OR "Barrett oesophagus" OR "deglutition 
disorder*" OR "digastric reflux" OR "eructation" OR "esophag* fistul*" OR "esophag* motility disorder*" 
OR "oesophag* motility disorder*" OR "oesophag* diverticul*" OR "oesophag* fistula" OR "esophageal 
achaenia" OR "oesophageal achaenia" OR "gastric dilatation" OR "reflux esophagitis" OR "reflux 
oesophagitis" OR "castroesophag* reflux" OR "castro-esophageal reflux disease" OR "castro-
oesophageal reflux disease" OR "castropares*" OR "liver diseases" OR "pancreatic diseases" OR 
"postgastrectomy syndrom*" OR "stomach diseases" OR "stomach diverticul*" OR "bollinger-Ellison 
syndrome") OR ("gastrit*" PRE/2 ("chronic superficial" OR "chronic atrophic" OR "atrophy" OR 
"unspecified" OR "antral" OR "poundal" OR "Helicobacter pylori associated" OR "giant hypertrophic" OR 
"granulomatous" OR "alcoholic")) OR ("proptosis") OR ("ulcer" PRE/2 ("peptic" OR "duodenal" OR 
"astrodome" OR "jejunal" OR "astrocytic" OR "gastrointestinal" OR "jejunal " OR "marginal" OR 
"intestine" OR "anus" OR "rectum" OR "gastric" OR "stomach" OR "pylorus" OR "esophagus" OR 
"oesophagus")) OR ("pylorus") OR ("hourglass contraction" NEAR/4 "stomach") OR ("hemorrhoid*") OR 
("nostalgia fugal") OR ("psychogenic" PRE/2 ("diarrhoea" OR "dyspepsia" OR "intestinal disorders")) OR 
("neurogenic bowel" OR "neurogenic bowel dysfunction") OR ("liver diseases" OR "liver cirrhosis" OR 
("drug-induced liver injury" NEAR/1 "chronic") OR "fatty liver" OR "liver failure" OR "hepatitis chronic" 
OR "liver cirrhosis" OR (("liver diseases" OR "fatty liver" OR "liver cirrhosis" OR "hepatitis") PRE/2 
"alcoholic")) OR (("chronic" OR "alcoholic") NEAR/1 "pancreatitis") OR ("cholangitis" OR "homeostasis" 
OR "gallbladder diseases" OR "cholecystectomy syndrome") OR ("pancreatic steatorrhoea") OR 
("cholecystectomy syndrome") OR ("spasm" PRE/2 ("sphincter" PRE/3 "odds")) OR ("gallstone" NEAR/2 
("disease" OR "pancreatitis")) OR ("fistula" PRE/2 (("rectum" NEAR/1 "skin") OR "anal" OR "rectal" OR 
"anorectal" OR "stomach" OR "duodenum" OR "astrocytic" OR "castrojejunocolic")) OR 
("enterostomies") OR ("dyspepsia" PRE/2 ("nervous" OR "neurotic" OR "psychogenic" OR "heartburn")) 
OR (("dyskinesia" NEAR/1 "esophagus") OR ("dyskinesia" NEAR/1 "oesophagus") OR "corkscrew 
esophagus" OR "corkscrew oesophagus" OR "diffuse esophageal spasm" OR "diffuse oesophageal 
spasm" OR ("spasm" NEAR/1 "esophagus") OR ("spasm" NEAR/1 "oesophagus")) OR ("allergic" NEAR/2 
("gastroenteritis" OR "colitis")) OR ("functional gastrointestinal disorder*" OR "FGID*") OR ("irritable 
bowel syndrome") OR ("inflammatory bowel diseases"))) OR SU.EXACT.EXPLODE("Gastrointestinal 
System and Disorders")) AND ((SU.EXACT.EXPLODE("Psychotherapy") OR SU.EXACT.EXPLODE("Crisis 
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Intervention") OR SU.EXACT.EXPLODE("Alternative Therapies") OR SU.EXACT.EXPLODE("Creative 
Therapy") OR SU.EXACT.EXPLODE("Counselling") OR SU.EXACT("Self Care") OR SU.EXACT("Personal 
Care") OR SU.EXACT.EXPLODE("Patients : Education") OR SU.EXACT("Self Help Groups") OR 
SU.EXACT.EXPLODE("Biofeedback")) OR ab(("psychotherap*" OR ("behavior* NEAR/2 therap*") OR 
("behaviour* NEAR/2 therap*") OR "cognitive therap*" OR "psychological intervention*" OR 
"psychological adaptation" OR "systematic desensitiz*" OR "systematic desensitis*") OR ("cognitive 
problem-solving skills training" OR "characteranalyti*" OR "character-analyti*" OR "client-centered" OR 
"client-centred" OR "coherence therap*" OR "contemplative therap*" OR "conversational therap*") OR 
("problem-solving NEAR/2 training") OR (("coping" OR "cope" OR "copes" OR "coped") NEAR/2 ("skill*" 
OR "behavio?r*" OR "train*")) OR ("core energetic*" OR "core process*") OR ("dialectical behavio?r 
therap*" OR "debt") OR ("dreamworld" OR "Dyadic" OR "dip") OR ("expressive therap*" OR "Desensiti* 
reprocessing" OR "Desensiti* re-processing" OR "Emotional Freedom Techni*" OR "EFT" OR "encounter 
group*" OR "Experient* Dynamic" OR "Existential therap*" OR "exposure response prevent* therap*" 
OR ("Eye Movement Desensitization NEAR/2 Reprocessing") OR "emir") OR ("goal setting" OR "Gestalt*" 
OR "Group Analy*" OR "Milieu Therap*" OR "milieutherap*" OR "group-based therap*" OR "group-
based treatment*" OR "group-based intervention") OR ("hakim" OR "holistic" OR "aeolotropic" OR 
"humanistic" OR "human givens" OR "hypnos*" OR "hypnot*" OR "hypno-therap*") OR ("interaction 
therap*" OR "interperson* therap*" OR "inter-personal therap*" OR "apt") OR ("meditati*" OR 
"mindfulness*" OR "maer" OR "morita therap*") OR ("body mind" OR "mind-body therap*" OR "Radix 
therap*" OR "pulsing" OR "body-oriented psychotherap*" OR "imp" OR "postural integration" OR 
"integrative body psychotherap*" OR "gesso hoyden system psychomotor" OR "lifespan Integration" OR 
"rosenfeld synergy" OR "Reichian") OR ("multimodal* therap*" OR "multi-modal* therap*" OR "multi-
theoreti*" OR "multitheoreti*") OR ("relaxation therapy" OR "tai jib" OR "therapeutic touch" OR "yoga") 
OR ("object* relation*" OR "objectrelation*") OR ("family constellation*" OR "family therapy" OR 
"family coping" OR "family coping impairment" OR ("family inventory NEAR/1 " life events OR changes ") 
OR " compromised family coping " OR " parent education " OR (" ineffective management " NEAR/3 " 
therapeutic families regimen ") OR " family support " OR " family involvement " OR " family coping 
inventory " OR " family centered care " OR " family care " OR " altered family coping " OR " critical care 
family needs inventory " OR " coeducation " OR (" adolescent coping orientation " NEAR/2 " problem 
experiences ") OR " feminist therap* " OR " functional analytic " OR " Freudian " OR " family-based 
intervention* " OR " internal family systems model " OR " parent-child interact* " OR " parent-training 
program* " OR " peer support group* ") OR (" psychoanaly* " OR " psycho-analyti* " OR " 
psychodynamic " OR " psycho-dynamic ") OR (" counsel?ing " OR " directive counsel?ing " OR " 
motivational interviewing " OR " distance counsel?ing " OR (" pastoral " NEAR/1 (" care " OR " counsel* " 
OR " therap* "))) OR (" reality therap* ") OR (" rebirthing " OR " re-birthing " OR " relationship counsel* " 
OR " reprogram* " OR " re-program* " OR " breathwork ") OR (" rational emoti* " OR " Reiki " OR " rebs 
" OR " rational living therap* " OR " rut " OR " sensorimotor psychotherap* ") OR  (" acupuncture ") OR 
(" self care " OR " self help " OR " self relationship " OR " sponsorship " OR " self-manag* " OR " 
selfmanag* " OR " self-talk ") OR (" SHEN " OR " social support* " OR " social therap* " OR " social care " 
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OR " social problem skills train* " OR " coeducation " OR " psychology social " OR " social support ") OR 
(" spiritual therap* " OR " prayer " OR " holistic care " OR " Sophia-analyse ") OR (" thought field therap* 
" OR " transactional* " OR " trans-actional* " OR " transperson* " OR " trans-person* " OR " twelve-step 
program* " OR " vegetotherap* " OR " vegeto-therap* ") OR (" relational-cultural " OR " mot " OR (" 
multiculturaL NEAR/4 ("counsel?ing" OR "therapy")))))                                                                                             
116 
Appendix 3 Search result in CINAHL Plus 
CINAHL Plus search 19/02/2017 
Search 
Terms Search Options Actions 




S82 S70 OR S71 OR S72 OR S73 OR S74 OR S75 
OR S76 OR S77 OR S78 OR S79  




S81 S42 OR S43 OR S44 OR S45 OR S46 OR S47 
OR S48 OR S49 OR S50 OR S51 OR S52 OR 
S53 OR S54 OR S55 OR S56 OR S57 OR S58 
OR S59 OR S60 OR S61 OR S62 OR S63 OR 
S64 OR S65 OR S66 OR S67 OR S68 OR S69  




S80 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR 
S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR 
S14 OR S15 OR S16 OR S17 OR S18 OR S19 
OR S20 OR S21 OR S22 OR S23 OR S24 OR 
S25 OR S26 OR S27 OR S28 OR S29 OR S30 
OR S31 OR S32 OR S33 OR S34 OR S35 OR 
S36 OR S37 OR S38 OR S39 OR S40 OR S41  




S79 TI (electronic mail OR electronic-mail OR 
text messag*) OR AB (electronic mail OR 
electronic-mail OR text messag*)  




S78 TI (etherap* OR e-therapy) OR AB (etherap* 
OR e-therapy)  




S77 TI ( e-health OR ehealth ) OR AB ( e-health 
OR ehealth )  








S75 TI ( online OR on-line OR internet OR 
telemedicine OR telecommunication OR 
computeri#ed OR computer-assisted OR 
(computer N2 assisted) ) OR AB ( online OR 
on-line OR internet OR telemedicine OR 
telecommunication OR computeri#ed OR 
computer-assisted OR (computer N2 
assisted) )  
























S69 TI ( functional gastrointestinal disorder* OR 
FGID* ) OR AB ( functional gastrointestinal 
disorder* OR FGID* )  




S68 TI ( allergic N2 (gastroenteritis OR colitis) ) 
OR AB ( allergic N2 (gastroenteritis OR 
colitis) )  




S67 TI ( (dyskinesia N esophagus) OR (dyskinesia 
N oesophagus) OR corkscrew esophagus OR 
corkscrew oesophagus OR diffuse 
esophageal spasm OR diffuse oesophageal 
spasm OR (spasm N esophagus) OR (spasm 
N oesophagus) ) OR AB ( (dyskinesia N 
esophagus) OR (dyskinesia N oesophagus) 
OR corkscrew esophagus OR corkscrew 
oesophagus OR diffuse esophageal spasm 
OR diffuse oesophageal spasm OR (spasm N 
esophagus) OR (spasm N oesophagus) )  




S66 TI ( dyspepsia N2 (nervous OR neurotic OR 
psychogenic OR heartburn) ) OR AB ( 
dyspepsia N2 (nervous OR neurotic OR 
psychogenic OR heartburn) )  








S64 TI f#ecal# incontinence OR AB f#ecal# 
incontinence  




S63 TI ( fistula N3 ("rectum to skin" OR anal or 
rectal OR anorectal OR stomach OR 
duodenum OR gastrocolic OR 
gastrojejunocolic) ) OR AB ( fistula N3 
("rectum to skin" OR anal or rectal OR 
anorectal OR stomach OR duodenum OR 
gastrocolic OR gastrojejunocolic) )  




S62 TI ( functional N3 (diarrhoea OR (disorders N 
stomach) OR dyspepsia OR indigestion) ) OR 
AB ( functional N3 (diarrhoea OR (disorders 
N stomach) OR dyspepsia OR indigestion) )  




S61 TI ( gallstone N2 (disease OR pancreatitis) ) 
OR AB ( gallstone N2 (disease OR 
pancreatitis) )  




S60 TI spasm N2 "sphincter of Oddi") OR AB 
spasm N2 "sphincter of Oddi")  




S59 TI postcholecystectomy syndrome OR AB 
postcholecystectomy syndrome  






S58 TI pancreatic steatorrhoea OR AB pancreatic 
steatorrhoea  




S57 TI ( cholangitis OR cholestasis OR gallbladder 
diseases OR postcholecystectomy syndrome 
) OR AB ( cholangitis OR cholestasis OR 
gallbladder diseases OR 
postcholecystectomy syndrome )  




S56 TI ( (chronic OR alcoholic) N pancreatitis ) OR 
AB ( (chronic OR alcoholic) N pancreatitis )  




S55 TI (liver diseases OR liver cirrhosis OR (drug-
induced liver injury N chronic) OR fatty liver 
OR liver failure OR hepatitis chronic OR liver 
cirrhosis OR ((liver diseases OR fatty liver OR 
liver cirrhosis OR hepatitis) N2 alcoholic) ) 
OR AB ( liver diseases OR liver cirrhosis OR 
(drug-induced liver injury N chronic) OR fatty 
liver OR liver failure OR hepatitis chronic OR 
liver cirrhosis OR ((liver diseases OR fatty 
liver OR liver cirrhosis OR hepatitis) N2 
alcoholic))  




S54 TI ( neurogenic bowel OR neurogenic bowel 
dysfunction ) OR AB ( neurogenic bowel OR 
neurogenic bowel dysfunction )  




S53 TI ( psychogenic N2 (diarrhoea OR dyspepsia 
OR intestinal disorders) ) OR AB ( 
psychogenic N2 (diarrhoea OR dyspepsia OR 
intestinal disorders) )  
  (444) 
 
S52 TI ( psychogenic N2 (diarrhoea OR dyspepsia 
OR intestinal disorders) ) OR AB ( 
psychogenic N2 (diarrhoea OR dyspepsia OR 
intestinal disorders) )  












S49 TI hourglass contraction N stomach OR AB 
hourglass contraction N stomach  
  (3) 
 
S48 TI hourglass contraction N stomach OR AB 
hourglass contraction N stomach  








S46 TI ( ulcer N2 (peptic OR duodenal OR 
gastroduodenal OR gastrojejunal OR 
gastrocolic OR gastrointestinal OR jejunal OR 
marginal OR intestine OR anus OR rectum or 
gastric OR stomach OR pylorus or esophagus 
OR oesophagus) ) OR AB ( ulcer N2 (peptic 
OR duodenal OR gastroduodenal OR 
gastrojejunal OR gastrocolic OR 
gastrointestinal OR jejunal OR marginal OR 
intestine OR anus OR rectum or gastric OR 






stomach OR pylorus or esophagus OR 
oesophagus) )  




S44 TI ( gastrit* N2 (chronic superficial OR 
chronic atrophic OR atrophy OR unspecified 
OR antral OR fundal OR Helicobacter pylori 
associated OR giant hypertrophic OR 
granulomatous OR alcoholic) ) OR AB ( 
gastrit* N2 (chronic superficial OR chronic 
atrophic OR atrophy OR unspecified OR 
antral OR fundal OR Helicobacter pylori 
associated OR giant hypertrophic OR 
granulomatous OR alcoholic) )  




S43 TI ( digestive system diseases OR biliary tract 
diseases OR digestive system abnormalities 
OR digestive system fistul* OR 
gastrointestinal diseases OR oesophag* 
diseases OR esophag* diseases OR 
oesophagit* OR esophagit* OR gastrit* OR 
enterit* OR gastroenterit* OR intestinal 
diseases OR colit* OR enterocolit* OR 
proctit* OR proctocolit* OR rectal diseases 
OR IBD OR inflammatory bowel diseases OR 
Crohn disease OR ulcerative colit* OR 
diverticul* OR achalasia cardiae OR 
megaesophagus OR megaoesoph ... 








S41 TI (relational-cultural OR MCT OR 
(multicultural N (counsel#ing OR therapy)) 
OR AB (relational-cultural OR MCT OR 
(multicultural N (counsel#ing OR therapy)))  




S40 TI (thought field therap* OR transactional* 
OR trans-actional* OR transperson* OR 
trans-person* OR twelve-step program* OR 
vegetotherap* OR vegeto-therap*) OR AB 
(thought field therap* OR transactional* OR 
trans-actional* OR transperson* OR trans-
person* OR twelve-step program* OR 
vegetotherap* OR vegeto-therap*)  




S39 TI ( spiritual therap* OR prayer OR holistic 
care OR Sophia-analys ) OR AB ( spiritual 
therap* OR prayer OR holistic care OR 
Sophia-analys )  




S38 TI ( SHEN OR social support* OR social 
therap* OR social care OR social problem 
skills train* psychoeducation OR psychology 
social OR social support ) OR AB ( SHEN OR 
social support* OR social therap* OR social 
care OR social problem skills train* 
psychoeducation OR psychology social OR 
social support )  






S37 TI ( self care OR self help OR self relationship 
OR sponsorship OR self-manag* OR 
selfmanag* OR self-talk ) OR AB ( self care 
OR self help OR self relationship OR 
sponsorship OR self-manag* OR selfmanag* 
OR self-talk )  
















S33 TI ( rational emoti* OR Reiki or REBT OR 
rational living therap* OR RLT OR 
sensorimotor psychotherap* ) OR AB ( 
rational emoti* OR Reiki or REBT OR rational 
living therap* OR RLT OR sensorimotor 
psychotherap* )  




S32 TI ( rebirthing OR re-birthing OR relationship 
counsel* OR reprogram* OR re-program* 
OR breathwork ) OR AB ( rebirthing OR re-
birthing OR relationship counsel* OR 
reprogram* OR re-program* OR breathwork 
)  








S30 TI (counsel#ing OR directive counsel#ing OR 
motivational interviewing OR distance 
counsel#ng OR (pastoral N (care OR 
counsel* OR therap*))) OR AB (counsel#ing 
OR directive counsel#ing OR motivational 
interviewing OR distance counsel#ng OR 
(pastoral N (care OR counsel* OR therap*)))  








S28 TI ( psychoanaly* OR psycho-analyti* OR 
psychodynamic OR psycho-dynamic ) OR AB 
( psychoanaly* OR psycho-analyti* OR 
psychodynamic OR psycho-dynamic )  




S27 TI ( family constellation* OR family therapy 
OR family coping OR family coping 
impairment OR (family inventory N (life 
events OR changes)) OR compromised family 
coping OR parent education OR (ineffective 
management N3 therapeutic families 
regimen) OR family support OR family 
involvement OR family coping inventory OR 
family centered care OR family care OR 
altered family coping OR critical care family 
needs inventory OR psychoeducation OR 
(adolescent coping orientation N2 problem 
experiences) OR f ... 






S26 TI ( object* relation* OR objectrelation* ) 
OR AB ( object* relation* OR objectrelation* 
)  




S25 TI ( relaxation therapy OR tai ji OR 
therapeutic touch OR yoga ) OR AB ( 
relaxation therapy OR tai ji OR therapeutic 
touch OR yoga )  




S24 TI ( multimodal* therap* OR multi-modal* 
therap* OR multi-theoreti* OR 
multitheoreti* ) OR AB ( multimodal* 
therap* OR multi-modal* therap* OR multi-
theoreti* OR multitheoreti* )  




S23 TI ( body mind OR mind-body therap* OR 
Radix therap* OR pulsing OR body-oriented 
psychotherap* OR IBP OR postural 
integration OR integrative body 
psychotherap* OR Pesso Boyden system 
psychomotor OR lifespan Integration OR 
Rubenfeld synergy OR Reichian ) OR AB ( 
body mind OR mind-body therap* OR Radix 
therap* OR pulsing OR body-oriented 
psychotherap* OR IBP OR postural 
integration OR integrative body 
psychotherap* OR Pesso Boyden system 
psychomotor OR lifespan Integration OR 
Rubenfeld synergy OR  ... 








S21 TI ( meditati* OR mindfulness* OR MBSR OR 
morita therap* ) OR AB ( meditati* OR 
mindfulness* OR MBSR OR morita therap* )  




S20 TI (interaction therap* OR interperson* 
therap* or inter-personal therap* OR IPT) 
OR AB (interaction therap* OR interperson* 
therap* OR inter-personal therap* OR IPT)  




S19 TI (hakomi OR holistic or holotropic OR 
humanistic OR human givens OR hypnos* 
OR hypnot* OR hypno-therap*) OR AB 
(hakomi OR holistic OR holotropic or 
humanistic OR human givens OR hypnos* 
OR hypnot* OR hypno-therap*)  




S18 TI (goal setting OR gestalt* OR group analy* 
OR Milieu therap* OR milieutherap* OR 
group-based therap* OR group-based 
treatment* OR group-based intervention) 
OR AB (goal setting OR gestalt* OR group 
analy* OR Milieu therap* OR milieutherap* 
OR group-based therap* OR group-based 
treatment* OR group-based intervention)  




S17 TI ( expressive therap* or desensiti* 
reprocessing or desensiti* re-processing or 
emotional freedom techni* or EFT or 
encounter group* or experient* dynamic or 






existential therap* or exposure response 
prevent* therap* or ("eye movement 
desensitization and reprocessing") or EMDR 
) OR AB ( expressive therap* or desensiti* 
reprocessing or desensiti* re-processing or 
emotional freedom techni* or EFT or 
encounter group* or experient* dynamic or 
existential therap* or exposure response 
prevent* therap ... 
S16 TI (dreamwork or dyadic or DDP) OR AB 
(dreamwork or dyadic or DDP)  




S15 ( TI dialectical behavio#r therap* OR DBT ) 
OR ( AB dialectical behavio#r therap* OR 
DBT )  




S14 ( TI core energetic* OR core process* ) OR ( 
AB core energetic* OR core process* )  




S13 AB (coping OR cope OR copes OR coped) N2 
(skill* OR behavior* OR behaviours OR 
train*)  




S12 TI (coping OR cope OR copes OR coped) N2 
(skill* OR behavior* OR behaviours OR 
train*)  




























S5 AB cognitive problem-solving skills training 
OR characteranalyti* OR character-analyti* 
OR client-centered OR client-centred OR 
coherence therap* OR contemplative 
therap* OR conversational therap*  




S4 TI cognitive problem-solving skills training 
OR characteranalyti* OR character-analyti* 
OR client-centered OR client-centred OR 
coherence therap* OR contemplative 
therap* OR conversational therap*  




S3 AB psychotherap* OR (behavior* N2 
therap*) OR (behaviour* N2 therap*) OR 
cognitive therap* OR psychological 
intervention* OR psychological adaptation 
OR systematic desensitiz* OR systematic 
desensitis*  






S2 TI psychotherap* OR (behavior* N2 therap*) 
OR (behaviour* N2 therap*) OR cognitive 
therap* OR psychological intervention* OR 
psychological adaptation OR systematic 
desensitiz* OR systematic desensitis*  








Appendix 4 Search result in Cochrane 
Cochrane 
Search Name: GASTRO 
Date Run: 19/02/17  
Description:   
ID Search Hits 
#1 MeSH descriptor: [Psychotherapy] explode all trees 19988 
#2 MeSH descriptor: [Adaptation, Psychological] explode all trees 4684 
#3 (psychotherap* or (behavior* near/2 therap*) or (behaviour* near/2 therap*) or cognitive near 
therap* or "psychological intervention*" or "psychological adaptation" or systematic near 
desensiti?*):ti,ab 14078 
#4 "cognitive problem-solving skills training":ti,ab  2 
#5 ((characteranalyti* or character-analyti*) or client-centered or client-centred or (coherence 
near therap*) or (contemplative next therap*) or (conversational next therap*)):ti,ab  170 
#6 MeSH descriptor: [Problem Solving] explode all trees 1384 
#7 MeSH descriptor: [Patient-Centered Care] this term only 456 
#8 (problem-solving near/2 training):ti,ab  186 
#9 ((coping or cope or copes or coped) near/2 (skill* or behavio?r* or train*)):ti,ab  825 
#10 (core next energetic* or core next process*):ti,ab  4 
#11 (dialectical next behavio?r next therap* or DBT):ti,ab  157 
#12 (Dreamwork or Dyadic or DDP):ti,ab  577 
#13 (expressive next therap* or Desensiti* next reprocessing or Desensiti* next re-processing or 
Emotional next Freedom next Techni* or EFT or encounter next group* or Experient* next Dynamic or 
Existential next therap* or exposure near response near prevent* near therap* or (Eye next Movement 
next Desensitization near/2 Reprocessing) or EMDR):ti,ab  301 
#14 (goal near setting or Gestalt* or Group near Analy* or Milieu next Therap* or milieutherap* or 
group-based near therap* or group-based near treatment* or group-based near intervention):ti,ab 
 14353 
#15 (hakomi or holistic or holotropic or humanistic or human next givens or hypnos* or hypnot* or 
hypno-therap*):ti,ab  3575 
#16 (interaction next therap* or interperson* next therap* or inter-personal next therap* or 
IPT):ti,ab  494 
#17 (meditati* or mindfulness* or MBSR or morita next therap*):ti,ab  2101 
#18 MeSH descriptor: [Mind-Body Therapies] explode all trees 5361 
#19 (body next mind or mind-body next therap* or Radix next therap* or pulsing or body-oriented 
near psychotherap* or IBP or postural near integration or integrative next body next psychotherap* or 
Pesso next Boyden next system next psychomotor or lifespan near Integration or Rubenfeld next 
synergy or Reichian):ti,ab  230 
#20 (multimodal* near therap* or multi-modal* near therap* or multi-theoreti* or 
multitheoreti*):ti,ab  398 
#21 (relaxation near therapy or tai ji or therapeutic next touch or yoga):ti,ab  1882 
#22 (object* next relation* or objectrelation*):ti,ab  56 
#23 MeSH descriptor: [Neurolinguistic Programming] this term only 9 
#24 (family near constellation* or family next therapy or family next coping or "family coping 
impairment" or (family next inventory near (life next events or changes)) or compromised next family 
next coping or parent next education or ((ineffective next management) near/3 (therapeutic next 
families next regimen)) or family next support or family next involvement or family next coping next 
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inventory or family next centered next care or family next care or altered next family next coping or 
critical next care next family next needs next inventory or psychoeducation or ((adolescent next coping 
next orientation) near/2 (problem next experiences)) or feminist next therap* or functional next analytic 
or Freudian or family-based next intervention* or internal next family next systems model or parent-
child next interact* or parent-training near program* or peer next support next group*):ti,ab  2126 
#25 (psychoanaly* or psycho-analyti* or psychodynamic or psycho-dynamic):ti,ab  570 
#26 MeSH descriptor: [Counseling] this term only 3626 
#27 (counsel?ing or directive counsel?ing or motivational next interviewing or distance next 
counsel?ing or (pastoral near (care or counsel* or therap*))):ti,ab  3811 
#28 reality therap*:ti,ab  615 
#29 (rebirthing or re-birthing or relationship next counsel* or reprogram* or re-program* or 
breathwork):ti,ab  112 
#30 (rational next emoti* or Reiki or REBT or rational next living next therap* or RLT or 
sensorimotor near psychotherap*):ti,ab  165 
#31 MeSH descriptor: [Acupuncture] this term only 164 
#32 acupuncture:ti,ab  7809 
#33 MeSH descriptor: [Self Care] this term only 3661 
#34 (self next care or self next help or self next relationship or sponsorship or self-manag* or 
selfmanag* or self-talk):ti,ab  6756 
#35 (SHEN or social next support* or social next therap* or social next care or social next problem 
next skills next train* or psychoeducation or psychology near social or social next support):ti,ab  3712 
#36 (spiritual next therap* or prayer or holistic care or Sophia-analys):ti,ab  244 
#37 (thought next field next therap* or transactional* or trans-actional* or transperson* or trans-
person* or twelve-step near program* or vegetotherap* or vegeto-therap*):ti,ab  88 
#38 (relational-cultural or MCT or (multicultural near (counsel?ing or therapy))):ti,ab  588 
#39 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or 
#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or 
#31 or #32 or #33 or #34 or #35 or #36 or #37 or #38  74967 
#40 MeSH descriptor: [Digestive System Diseases] explode all trees 43191 
#41 (digestive next system next diseases or biliary next tract next diseases or digestive next system 
next abnormalities or digestive next system next fistul* or gastrointestinal next diseases or oesophag* 
next diseases or esophag* next diseases or oesophagit* or esophagit* or gastrit* or enterit* or 
gastroenterit* or intestinal next diseases or colit* or enterocolit* or proctit* or proctocolit* or rectal 
next diseases or IBD or inflammatory next bowel next diseases or Crohn next disease or ulcerative next 
colit* or diverticul* or achalasia near cardiae or megaesophagus or megaoesophagus or achlorhydria or 
Barrett near esophagus or Barrett near oesophagus or deglutition next disorder* or duodenogastric 
near reflux or eructation or esophag* fistul* or esophag* next motility next disorder* or oesophag* next 
motility next disorder* or oesophag* near diverticul* or oesophag* near fistula or esophageal near 
achalasia or oesophageal near achalasia or gastric near dilatation or reflux near esophagitis or reflux 
near oesophagitis or gastroesophag* near reflux or gastro-esophageal neat reflux next disease or gastro-
oesophageal next reflux next disease or gastropares* or liver near diseases or pancreatic near diseases 
or postgastrectomy next syndrom* or stomach near diseases or stomach near diverticul* or Zollinger-
Ellison near syndrome):ti,ab  10690 
#42 (gastrit* near/2 (chronic next superficial or chronic next atrophic or atrophy or unspecified or 
antral or fundal or Helicobacter next pylori next associated or giant near hypertrophic or granulomatous 
or alcoholic)):ti,ab  214 
#43 gastroptosis:ti,ab  13 
#44 (ulcer near/2 (peptic or duodenal or gastroduodenal or gastrojejunal or gastrocolic or 
gastrointestinal or jejunal or marginal or intestine or anus or rectum or gastric or stomach or pylorus or 
esophagus or oesophagus)):ti,ab  5004 
#45 pylorospasm:ti,ab  0 
#46 (hourglass next contraction near stomach):ti,ab  0 
#47 hemorrhoid*:ti,ab  625 
#48 proctalgia next fugax:ti,ab  2 
#49 (psychogenic near/2 (diarrhoea or dyspepsia or intestinal near disorders)):ti,ab  0 
#50 (neurogenic near bowel or neurogenic next bowel next dysfunction):ti,ab  21 
#51 (liver near diseases or liver near cirrhosis or (drug-induced next liver next injury near chronic) or 
fatty next liver or liver near failure or hepatitis near chronic or liver near cirrhosis or ((liver next diseases 
or fatty next liver or liver next cirrhosis or hepatitis) near/2 alcoholic)):ti,ab  9993 
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#52 ((chronic or alcoholic) near pancreatitis):ti,ab  476 
#53 (cholangitis or cholestasis or gallbladder near diseases or postcholecystectomy near 
syndrome):ti,ab  868 
#54 pancreatic near steatorrhoea:ti,ab  15 
#55 postcholecystectomy near syndrome:ti,ab  8 
#56 (spasm near/2 (sphincter near/3 Oddi)):ti,ab  5 
#57 (gallstone near/2 (disease or pancreatitis)):ti,ab  190 
#58 (fistula near/2 ((rectum near skin) or anal or rectal or anorectal or stomach or duodenum or 
gastrocolic or gastrojejunocolic)):ti,ab  87 
#59 (dyspepsia near/2 (nervous or neurotic or psychogenic or heartburn)):ti,ab  24 
#60 ((dyskinesia near esophagus) or (dyskinesia near oesophagus) or corkscrew near esophagus or 
corkscrew near oesophagus or diffuse next esophageal next spasm or diffuse next oesophageal next 
spasm or (spasm near esophagus) or (spasm near oesophagus)):ti,ab  12 
#61 (allergic near/2 (gastroenteritis or colitis)):ti,ab  9 
#62 (functional next gastrointestinal next disorder* or FGID*):ti,ab  140 
#63 irritable next bowel next syndrome:ti,ab  1809 
#64 inflammatory next bowel next diseases:ti,ab  139 
#65 #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 
or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64  58565 
#66 MeSH descriptor: [Telecommunications] explode all trees 4904 
#67 MeSH descriptor: [Internet] this term only 2832 
#68 MeSH descriptor: [Computer Communication Networks] this term only 73 
#69 MeSH descriptor: [Text Messaging] this term only 388 
#70 (online or on-line or internet or telemedicine or telecommunication or computeri?ed or 
computer-assisted or (computer near/2 assisted)):ti,ab  14933 
#71 website*:ti,ab  1656 
#72 (e-health or ehealth):ti,ab  250 
#73 (etherap* or e-therapy):ti,ab  80 
#74 (electronic near mail or electronic-mail or text near messag*):ti,ab  863 
#75 #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73 or #74  20837 
#76 #39 and #65 and #75  91 
 
Appendix 5 Search result in Health Management Information Consortium   
HMIC Health Management Information Consortium 1979 to November 2016  
(Run 19/02/2017) 
Searches                                                                                                                                                                    Results
1 exp psychotherapy/ 1875  
2 (psychotherap* or (behavior* adj2 therap*) or (behaviour* adj2 
therap*) or cognitive therap* or psychological intervention* or 
psychological adaptation or systematic desensitiz* or systematic 
desensitis*).ti,ab. 
1229  
3 (cognitive problem-solving skills training or characteranalyti* or 
character-analyti* or client-centered or client-centred or coherence 
therap* or contemplative therap* or conversational therap*).ti,ab. 
164  
4 exp Problem solving/ 225  
5 exp patient centred care/ 1234  
6 (problem-solving adj2 training).ti,ab. 10  
7 ((coping or cope or copes or coped) adj2 (skill* or behavior* or 
behaviours or train*)).ti,ab. 
137  
8 (core energetic* or core process*).ti,ab. 6  
9 (dialectical behavio?r therap* or DBT).ti,ab. 11  
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10 (Dreamwork or Dyadic or DDP).ti,ab. 42  
11 (expressive therap* or Desensiti* reprocessing or Desensiti* re-
processing or Emotional Freedom Techni* or EFT or encounter group* 
or Experient* Dynamic or Existential therap* or exposure response 
prevent* therap* or (Eye Movement Desensitization and Reprocessing) 
or EMDR).ti,ab. 
9  
12 (goal setting or Gestalt* or Group Analy* or Milieu Therap* or 
milieutherap* or group therap* or group-based therap* or group-
based treatment* or group-based intervention).ti,ab. 
327  
13 exp Hypnosis/ 14  
14 (hakomi or holistic or holotropic or humanistic or human givens or 
hypnos* or hypnot* or hypno-therap*).ti,ab. 
1303  
15 (interaction therap* or interperson* therap* or inter-personal therap* 
or IPT).ti,ab. 
23  
16 (meditati* or mindfulness* or MBSR or morita therap*).ti,ab. 79  
17 exp complementary medicine/ 1402  
18 (body mind or mind-body therap* or Radix therap* or pulsing or body-
oriented psychotherap* or IBP or postural integration or integrative 
body psychotherap* or Pesso Boyden system psychomotor or lifespan 
Integration or Rubenfeld synergy or Reichian).ti,ab. 
11  
19 (multimodal* therap* or multi-modal* therap* or multi-theoreti* or 
multitheoreti*).ti,ab. 
6  
20 exp Relaxation therapy/ 39  
21 (relaxation therapy or tai ji or therapeutic touch or yoga).ti,ab. 39  
22 (object* relation* or objectrelation*).ti,ab. 8  
23 exp Neurolinguistic programming/ 29  
24 (family constellation* or family therapy or family coping or family 
coping impairment or (family inventory adj (life events or changes)) or 
compromised family coping or parent education or (ineffective 
management adj3 therapeutic families regimen) or family support or 
family involvement or family coping inventory or family centered care 
or family care or altered family coping or critical care family needs 
inventory or psychoeducation or (adolescent coping orientation adj2 
problem experiences) or feminist therap* or functional analytic or 
Freudian or family-based intervention* or internal family systems 
model or parent-child interact* or parent-training program* or peer 
support group*).ti,ab. 
1107  
25 (psychoanaly* or psycho-analyti* or psychodynamic or psycho-
dynamic).ti,ab. 
180  
26 exp Counselling/ 1473  
27 (counsel?ing or directive counsel?ing or motivational interviewing or 
distance counsel?ing or (pastoral adj (care or counsel* or 
therap*))).ti,ab. 
2911  
28 reality therap*.ti,ab. 2  
29 (rebirthing or re-birthing or relationship counsel* or reprogram* or re-
program* or breathwork).ti,ab. 
10  
30 (rational emoti* or Reiki or REBT or rational living therap* or RLT or 
sensorimotor psychotherap*).ti,ab. 
13  
31 acupuncture.ti,ab. 170  
32 Self care/ 257  
33 (self care or self help or self relationship or sponsorship or self-manag* 2435  
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or selfmanag* or self-talk).ti,ab. 
34 (SHEN or social support* or social therap* or social care or social 
problem skills train* or psychoeducation or psychology social or social 
support).ti,ab. 
9414  
35 (spiritual therap* or prayer or holistic care or Sophia-analys).ti,ab. 194  
36 (thought field therap* or transactional* or trans-actional* or 
transperson* or trans-person* or twelve-step program* or 
vegetotherap* or vegeto-therap*).ti,ab. 
98  
37 (relational-cultural or MCT or (multicultural adj (counsel?ing or 
therapy))).ti,ab. 
4  
38 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 
15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 
or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 
22617  
39 exp Digestive System Diseases/ 2975  
40 (digestive system diseases or biliary tract diseases or digestive system 
abnormalities or digestive system fistul* or gastrointestinal diseases or 
oesophag* diseases or esophag* diseases or oesophagit* or esophagit* 
or gastrit* or enterit* or gastroenterit* or intestinal diseases or colit* 
or enterocolit* or proctit* or proctocolit* or rectal diseases or IBD or 
inflammatory bowel diseases or Crohn disease or ulcerative colit* or 
diverticul* or achalasia cardiae or megaesophagus or megaoesophagus 
or achlorhydria or Barrett esophagus or Barrett oesophagus or 
deglutition disorder* or duodenogastric reflux or eructation or 
esophag* fistul* or esophag* motility disorder* or oesophag* motility 
disorder* or oesophag* diverticul* or oesophag* fistula or esophageal 
achalasia or oesophageal achalasia or gastric dilatation or reflux 
esophagitis or reflux oesophagitis or gastroesophag* reflux or gastro-
esophageal reflux disease or gastro-oesophageal reflux disease or 
gastropares* or liver diseases or pancreatic diseases or 
postgastrectomy syndrom* or stomach diseases or stomach diverticul* 
or Zollinger-Ellison syndrome).ti,ab. 
266  
41 (gastrit* adj2 (chronic superficial or chronic atrophic or atrophy or 
unspecified or antral or fundal or Helicobacter pylori associated or 
giant hypertrophic or granulomatous or alcoholic)).ti,ab. 
0  
42 gastroptosis.ti,ab. 0  
43 (ulcer adj2 (peptic or duodenal or gastroduodenal or gastrojejunal or 
gastrocolic or gastrointestinal or jejunal or marginal or intestine or anus 
or rectum or gastric or stomach or pylorus or esophagus or 
oesophagus)).ti,ab. 
78  
44 pylorospasm.ti,ab. 0  
45 (hourglass contraction adj stomach).ti,ab. 0  
46 hemorrhoid*.ti,ab. 0  
47 proctalgia fugax.ti,ab. 0  
48 (psychogenic adj2 (diarrhoea or dyspepsia or intestinal disorders)).ti,ab. 0  
49 (neurogenic bowel or neurogenic bowel dysfunction).ti,ab. 0  
50 (liver diseases or liver cirrhosis or (drug-induced liver injury adj chronic) 
or fatty liver or liver failure or hepatitis chronic or liver cirrhosis or 
((liver diseases or fatty liver or liver cirrhosis or hepatitis) adj2 
alcoholic)).ti,ab. 
98  
51 ((chronic or alcoholic) adj pancreatitis).ti,ab. 8  





53 pancreatic steatorrhoea.ti,ab. 0  
54 postcholecystectomy syndrome.ti,ab. 0  
55 (spasm adj2 "sphincter of Oddi").ti,ab. 0  
56 (gallstone adj2 (disease or pancreatitis)).ti,ab. 8  
57 (functional adj3 (diarrhoea or (disorders adj stomach) or dyspepsia or 
indigestion)).ti,ab. 
2  
58 (fistula adj3 ("rectum to skin" or anal or rectal or anorectal or stomach 
or duodenum or gastrocolic or gastrojejunocolic)).ti,ab. 
0  
59 f?ecal? incontinence.ti,ab. 37  
60 enteroptosis.ti,ab. 0  
61 (dyspepsia adj2 (nervous or neurotic or psychogenic or 
heartburn)).ti,ab. 
1  
62 (dyspepsia adj2 (nervous or neurotic or psychogenic or 
heartburn)).ti,ab. 
1  
63 ((dyskinesia adj esophagus) or (dyskinesia adj oesophagus) or 
corkscrew esophagus or corkscrew oesophagus or diffuse esophageal 
spasm or diffuse oesophageal spasm or (spasm adj esophagus) or 
(spasm adj oesophagus)).ti,ab. 
0  
64 (allergic adj2 (gastroenteritis or colitis)).ti,ab. 0  
65 (functional gastrointestinal disorder* or FGID*).ti,ab. 3  
66 Inflammatory Bowel Diseases/ 0  
67 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 
or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 
64 or 65 or 66 
3210  
68 exp telecommunications/ 697  
69 exp internet/ 1295  
70 exp telemedicine/ 1248  
71 (online or on-line or internet or telemedicine or telecommunication or 
computeri?ed or computer-assisted or (computer adj2 assisted)).ti,ab. 
6026  
72 website*.ti,ab. 3637  
73 (e-health or ehealth).ti,ab. 229  
74 (etherap* or e-therapy).ti,ab. 0  
75 (electronic mail or electronic-mail or text messag*).ti,ab. 157  
76 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 10719  
77 38 and 67 and 76 2 
 
 
Appendix 6 Search result in PsycINFO 
PsycINFO 1806 to February Week 2 2017 (Run 19/02/2017) 
Searches Results 
exp Psychotherapy/ 197148 
(psychotherap* or (behavior* adj2 therap*) or (behaviour* adj2 therap*) or 
cognitive therap* or psychological intervention* or psychological adaptation or 
systematic desensitiz* or systematic desensitis*).ti,ab. 
130371 
(cognitive problem-solving skills training or characteranalyti* or character-analyti* 
or client-centered or client-centred or coherence therap* or contemplative 




exp problem solving/ 41735 
Client Centered Therapy/ 2897 
(problem-solving adj2 training).ti,ab. 853 
((coping or cope or copes or coped) adj2 (skill* or behavior* or behaviours or 
train*)).ti,ab. 
8566 
(core energetic* or core process*).ti,ab. 403 
(dialectical behavio?r therap* or DBT).ti,ab. 1510 
(dreamwork or dyadic or DDP).ti,ab. 11311 
(expressive therap* or desensiti* reprocessing or desensiti* re-processing or 
emotional freedom techni* or EFT or encounter group* or experient* dynamic or 
existential therap* or exposure response prevent* therap* or (eye movement 
desensitization adj3 reprocessing) or EMDR).ti,ab. 
3425 
(goal setting or gestalt* or group analy* or Milieu therap* or milieutherap* or 
group therap* or group-based therap* or group-based treatment* or group-based 
intervention).ti,ab. 
28885 
(hakomi or holistic or holotropic or humanistic or human givens or hypnos* or 
hypnot* or hypno-therap*).ti,ab. 
39760 
(interaction therap* or interperson* therap* or inter-personal therap* or 
IPT).ti,ab. 
1859 
(meditati* or mindfulness* or MBSR or morita therap*).ti,ab. 12973 
Mind body therapy/ 130 
(body mind or mind-body therap* or Radix therap* or pulsing or body-oriented 
psychotherap* or IBP or postural integration or integrative body psychotherap* or 
Pesso Boyden system psychomotor or lifespan Integration or Rubenfeld synergy or 
Reichian).ti,ab. 
1399 
(multimodal* therap* or multi-modal* therap* or multi-theoreti* or 
multitheoreti*).ti,ab. 
471 
(relaxation therapy or tai ji or therapeutic touch or yoga).ti,ab. 2661 
(object* relation* or objectrelation*).ti,ab. 8317 
Neurolinguistic programming/ 222 
(family constellation* or family therapy or family coping or family coping 
impairment or (family inventory adj (life events or changes)) or compromised 
family coping or parent education or (ineffective management adj3 therapeutic 
families regimen) or family support or family involvement or family coping 
inventory or family centered care or family care or altered family coping or critical 
care family needs inventory or psychoeducation or (adolescent coping orientation 
adj2 problem experiences) or feminist therap* or functional analytic or Freudian or 
family-based intervention* or internal family systems model or parent-child 
interact* or parent-training program* or peer support group*).ti,ab. 
41085 
(psychoanaly* or psycho-analyti* or psychodynamic or psycho-dynamic).ti,ab. 86908 
Counseling/ 21116 
(counsel?ing or directive counsel?ing or motivational interviewing or distance 
counsel?ing or (pastoral adj (care or counsel* or therap*))).ti,ab. 
75039 
reality therap*.ti,ab. 773 
(rebirthing or re-birthing or relationship counsel* or reprogram* or re-program* or 
breathwork).ti,ab. 
768 







Self Care/ 3868 
(self care or self help or self relationship or sponsorship or self-manag* or 
selfmanag* or self-talk).ti,ab. 
23453 
(SHEN or social support* or social therap* or social care or social problem skills 
train* or psychoeducation or psychology social or social support).ti,ab. 
46467 
(spiritual therap* or prayer or holistic care or Sophia-analys).ti,ab. 2901 
(thought field therap* or transactional* or trans-actional* or transperson* or 
trans-person* or twelve-step program* or vegetotherap* or vegeto-therap*).ti,ab. 
8863 
(relational-cultural or MCT or (multicultural adj (counsel?ing or therapy))).ti,ab. 1823 
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 
17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 
or 32 or 33 or 34 or 35 or 36 
543752 
exp digestive system disorders/ 11402 
(digestive system diseases or biliary tract diseases or digestive system 
abnormalities or digestive system fistul* or gastrointestinal diseases or oesophag* 
diseases or esophag* diseases or oesophagit* or esophagit* or gastrit* or enterit* 
or gastroenterit* or intestinal diseases or colit* or enterocolit* or proctit* or 
proctocolit* or rectal diseases or IBD or inflammatory bowel diseases or Crohn 
disease or ulcerative colit* or diverticul* or achalasia cardiae or megaesophagus or 
megaoesophagus or achlorhydria or Barrett esophagus or Barrett oesophagus or 
deglutition disorder* or duodenogastric reflux or eructation or esophag* fistul* or 
esophag* motility disorder* or oesophag* motility disorder* or oesophag* 
diverticul* or oesophag* fistula or esophageal achalasia or oesophageal achalasia 
or gastric dilatation or reflux esophagitis or reflux oesophagitis or gastroesophag* 
reflux or gastro-esophageal reflux disease or gastro-oesophageal reflux disease or 
gastropares* or liver diseases or pancreatic diseases or postgastrectomy syndrom* 
or stomach diseases or stomach diverticul* or Zollinger-Ellison syndrome).ti,ab. 
2309 
(gastrit* adj2 (chronic superficial or chronic atrophic or atrophy or unspecified or 
antral or fundal or Helicobacter pylori associated or giant hypertrophic or 
granulomatous or alcoholic)).ti,ab. 
6 
gastroptosis.ti,ab. 0 
(ulcer adj2 (peptic or duodenal or gastroduodenal or gastrojejunal or gastrocolic or 
gastrointestinal or jejunal or marginal or intestine or anus or rectum or gastric or 
stomach or pylorus or esophagus or oesophagus)).ti,ab. 
863 
pylorospasm.ti,ab. 3 
(hourglass contraction adj stomach).ti,ab. 0 
hemorrhoid*.ti,ab. 34 
proctalgia fugax.ti,ab. 4 
(psychogenic adj2 (diarrhoea or dyspepsia or intestinal disorders)).ti,ab. 0 
(neurogenic bowel or neurogenic bowel dysfunction).ti,ab. 8 
(liver diseases or liver cirrhosis or (drug-induced liver injury adj chronic) or fatty 
liver or liver failure or hepatitis chronic or liver cirrhosis or ((liver diseases or fatty 
liver or liver cirrhosis or hepatitis) adj2 alcoholic)).ti,ab. 
913 
((chronic or alcoholic) adj pancreatitis).ti,ab. 87 
(cholangitis or cholestasis or gallbladder diseases or postcholecystectomy 
syndrome).ti,ab. 
75 
pancreatic steatorrhoea.ti,ab. 0 
postcholecystectomy syndrome.ti,ab. 0 
(spasm adj2 (sphincter adj3 Oddi)).ti,ab. 0 
(gallstone adj2 (disease or pancreatitis)).ti,ab. 18 
(fistula adj2 ((rectum adj skin) or anal or rectal or anorectal or stomach or 10 
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duodenum or gastrocolic or gastrojejunocolic)).ti,ab. 
enteroptosis.ti,ab. 0 
(dyspepsia adj2 (nervous or neurotic or psychogenic or heartburn)).ti,ab. 12 
(dyspepsia adj2 (nervous or neurotic or psychogenic or heartburn)).ti,ab. 12 
((dyskinesia adj esophagus) or (dyskinesia adj oesophagus) or corkscrew esophagus 
or corkscrew oesophagus or diffuse esophageal spasm or diffuse oesophageal 
spasm or (spasm adj esophagus) or (spasm adj oesophagus)).ti,ab. 
2 
(allergic adj2 (gastroenteritis or colitis)).ti,ab. 0 
(functional gastrointestinal disorder* or FGID*).ti,ab. 194 
irritable bowel syndrome.ti,ab. 1258 
38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 
or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 
13767 
exp Telecommunications/ 15053 
Internet/ 26294 
Computer Mediated Communication/ 4937 
Text Messaging/ 430 
(online or on-line or internet or telemedicine or telecommunication or 
computeri?ed or computer-assisted or (computer adj2 assisted)).ti,ab. 
98899 
website*.ti,ab. 9265 
(e-health or ehealth).ti,ab. 837 
(electronic mail or electronic-mail or text messag*).ti,ab. 1842 
65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 124631 
37 and 64 and 73 56 
 
Appendix 7 Search result in PubMed 
PubMed 19/02/2017 
(("telecommunications"[MeSH Major Topic]) AND "digestive system diseases"[MeSH Major Topic]) AND 
"telecommunications"[MeSH Major Topic]  
Result 435 
 
Appendix 8 Search result in Embase 
Embase 1974 to 2017 February 17  (search run 19/02/2017) 
                       Searches                                                                               Results 
1 exp Psychotherapy/ 231545 
2 Psychoanalysis/ 34885 
3 Color therapy/ 106 
4 Crisis intervention/ 6236 
5 Horticultural therapy/ 59 
6 exp Adaptive behavior/ 53151 
7 (psychotherap* or (behavior* adj2 therap*) or (behaviour* adj2 therap*) 
or cognitive therap* or psychological intervention* or psychological 




8 (Cognitive problem-solving skills training or characteranalyti* or 
character-analyti* or client-centered or client-centred or coherence 
therap* or contemplative therap* or conversational therap*).ti,ab. 
1661 
9 exp Problem Solving/ 32957 
10 (problem-solving adj2 training).ti,ab. 436 
11 ((coping or cope or copes or coped) adj2 (skill* or behavior* or 
behaviours or train*)).ti,ab. 
6142 
12 (core energetic* or core process*).ti,ab. 549 
13 (dialectical behavio?r therap* or DBT).ti,ab. 2689 
14 (dreamwork or dyadic or DDP).ti,ab. 8407 
15 (expressive therap* or desensiti* reprocessing or desensiti* re-processing 
or emotional freedom techni* or EFT or encounter group* or experient* 
dynamic or existential therap* or exposure response prevent* therap* or 
(eye movement desensitization adj2 reprocessing) or EMDR).ti,ab. 
1858 
16 (goal setting or gestalt* or group analy* or Milieu therap* or 
milieutherap* or group-based therap* or group-based treatment* or 
group-based intervention).ti,ab. 
15555 
17 (hakomi or holistic or holotropic or humanistic or human givens or 
hypnos* or hypnot* or hypno-therap*).ti,ab. 
47083 
18 (interaction therap* or interperson* therap* or inter-personal therap* or 
IPT).ti,ab. 
2823 
19 (meditati* or mindfulness* or MBSR or morita therap*).ti,ab. 9083 
20 Alternative medicine/ 43480 
21 (body mind or mind-body therap* or Radix therap* or pulsing or body-
oriented psychotherap* or IBP or postural integration or integrative body 
psychotherap* or Pesso Boyden system psychomotor or lifespan 
Integration or Rubenfeld synergy or Reichian).ti,ab. 
4745 
22 (multimodal* therap* or multi-modal* therap* or multi-theoreti* or 
multitheoreti*).ti,ab. 
6463 
23 (relaxation therapy or tai ji or therapeutic touch or yoga).ti,ab. 5559 
24 (object* relation* or objectrelation*).ti,ab. 2470 
25 Kinesiotherapy/ 28294 
26 Psychophysiology/ 19708 
27 Meditation/ 6075 
28 (family constellation* or family therapy or family coping or family coping 
impairment or (family inventory adj (life events or changes)) or 
compromised family coping or parent education or (ineffective 
management adj3 therapeutic families regimen) or family support or 
family involvement or family coping inventory or family centered care or 
family care or altered family coping or critical care family needs inventory 
or psychoeducation or (adolescent coping orientation adj2 problem 
experiences) or feminist therap* or functional analytic or Freudian or 
family-based intervention* or internal family systems model or parent-
child interact* or parent-training program* or peer support group*).ti,ab. 
21749 
29 (psychoanaly* or psycho-analyti* or psychodynamic or psycho-
dynamic).ti,ab. 
25218 
30 Counseling/ 74219 
31 (counsel?ing or directive counsel?ing or motivational interviewing or 
distance counsel?ing or (pastoral adj (care or counsel* or therap*))).ti,ab. 
104544 
32 reality therap*.ti,ab. 136 
33 (rebirthing or re-birthing or relationship counsel* or reprogram* or re-22365 
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program* or breathwork).ti,ab. 
34 (rational emoti* or Reiki or REBT or rational living therap* or RLT or 
sensorimotor psychotherap*).ti,ab. 
864 
35 Acupuncture/ 36872 
36 acupuncture.ti,ab. 25964 
37 Self Care/ 45720 
38 (self care or self help or self relationship or sponsorship or self-manag* or 
selfmanag* or self-talk).ti,ab. 
43956 
39 (SHEN or social support* or social therap* or social care or social problem 
skills train* or psychoeducation or psychology social or social 
support).ti,ab. 
45847 
40 (spiritual therap* or prayer or holistic care or Sophia-analys).ti,ab. 3475 
41 (thought field therap* or transactional* or trans-actional* or 
transperson* or trans-person* or twelve-step program* or 
vegetotherap* or vegeto-therap*).ti,ab. 
2412 
42 (relational-cultural or MCT or (multicultural adj (counsel?ing or 
therapy))).ti,ab. 
7050 
43 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 
or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 
28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 
or 41 or 42 
782271 
44 exp digestive system disease/ 2730701 
45 (digestive system diseases or biliary tract diseases or digestive system 
abnormalities or digestive system fistul* or gastrointestinal diseases or 
oesophag* diseases or esophag* diseases or oesophagit* or esophagit* 
or gastrit* or enterit* or gastroenterit* or intestinal diseases or colit* or 
enterocolit* or proctit* or proctocolit* or rectal diseases or IBD or 
inflammatory bowel diseases or Crohn disease or ulcerative colit* or 
diverticul* or achalasia cardiae or megaesophagus or megaoesophagus or 
achlorhydria or Barrett esophagus or Barrett oesophagus or deglutition 
disorder* or duodenogastric reflux or eructation or esophag* fistul* or 
esophag* motility disorder* or oesophag* motility disorder* or 
oesophag* diverticul* or oesophag* fistula or esophageal achalasia or 
oesophageal achalasia or gastric dilatation or reflux esophagitis or reflux 
oesophagitis or gastroesophag* reflux or gastro-esophageal reflux 
disease or gastro-oesophageal reflux disease or gastropares* or liver 
diseases or pancreatic diseases or postgastrectomy syndrom* or stomach 
diseases or stomach diverticul* or Zollinger-Ellison syndrome).ti,ab. 
300016 
46 (gastrit* adj2 (chronic superficial or chronic atrophic or atrophy or 
unspecified or antral or fundal or Helicobacter pylori associated or giant 
hypertrophic or granulomatous or alcoholic)).ti,ab. 
3584 
47 gastroptosis.ti,ab. 41 
48 (ulcer adj2 (peptic or duodenal or gastroduodenal or gastrojejunal or 
gastrocolic or gastrointestinal or jejunal or marginal or intestine or anus 
or rectum or gastric or stomach or pylorus or esophagus or 
oesophagus)).ti,ab. 
49504 
49 pylorospasm.ti,ab. 116 
50 (hourglass contraction adj stomach).ti,ab. 0 
51 hemorrhoid*.ti,ab. 5236 
52 proctalgia fugax.ti,ab. 151 
53 (psychogenic adj2 (diarrhoea or dyspepsia or intestinal disorders)).ti,ab. 1 
54 (neurogenic bowel or neurogenic bowel dysfunction).ti,ab. 342 
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55 (liver diseases or liver cirrhosis or (drug-induced liver injury adj chronic) 
or fatty liver or liver failure or hepatitis chronic or liver cirrhosis or ((liver 
diseases or fatty liver or liver cirrhosis or hepatitis) adj2 alcoholic)).ti,ab. 
107715 
56 ((chronic or alcoholic) adj pancreatitis).ti,ab. 19440 
57 (cholangitis or cholestasis or gallbladder diseases or postcholecystectomy 
syndrome).ti,ab. 
34632 
58 pancreatic steatorrhoea.ti,ab. 39 
59 postcholecystectomy syndrome.ti,ab. 318 
60 (spasm adj2 (sphincter adj3 Oddi)).ti,ab. 34 
61 (gallstone adj2 (disease or pancreatitis)).ti,ab. 3981 
62 (fistula adj2 ((rectum adj skin) or anal or rectal or anorectal or stomach or 
duodenum or gastrocolic or gastrojejunocolic)).ti,ab. 
2502 
63 enteroptosis.ti,ab. 7 
64 (dyspepsia adj2 (nervous or neurotic or psychogenic or heartburn)).ti,ab. 182 
65 ((dyskinesia adj esophagus) or (dyskinesia adj oesophagus) or corkscrew 
esophagus or corkscrew oesophagus or diffuse esophageal spasm or 
diffuse oesophageal spasm or (spasm adj esophagus) or (spasm adj 
oesophagus)).ti,ab. 
605 
66 (allergic adj2 (gastroenteritis or colitis)).ti,ab. 197 
67 (functional gastrointestinal disorder* or FGID*).ti,ab. 2672 
68 irritable bowel syndrome.ti,ab. 15988 
69 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 
or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 
2779657 
70 Mass communication/ 13441 
71 Reminder System/ 2198 
72 Text messaging/ 2652 
73 Computer network/ 13511 
74 Telehealth/ 4063 
75 Telecommunication/ 31736 
76 Internet/ 96675 
77 (online or on-line or internet or telemedicine or telecommunication or 
computeri?ed or computer-assisted or (computer adj2 assisted)).ti,ab. 
282240 
78 website*.ti,ab. 25402 
79 (e-health or ehealth).ti,ab. 3168 
80 (etherap* or e-therapy).ti,ab. 429 
81 (electronic mail or electronic-mail or text messag*).ti,ab. 3568 
82 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 398934 
83 43 and 69 and 82 1206 
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        Appendix 10 PRISMA Checklist 
Section/topi
c  














TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and 
synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration 
number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what 
is already known.  
 
Objectives  4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
 




5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 




6 Specify study characteristics (e.g., PICOS, length of follow-
up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, 




7 Describe all information sources (e.g., databases with dates 
of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one 





9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 





10 Describe method of data extraction from reports (e.g., 
piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from 
investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias 
in individual 
studies  
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at 
the study or outcome level), and how this information is to 




13 State the principal summary measures (e.g., risk ratio, 




14 Describe the methods of handling data and combining 
results of studies, if done, including measures of consistency 





Appendix 11 Topic guide for the focus group 
Agenda and discussion topics for the focus group 
Duration of the session - 90 minutes 
Timetable 
1) 0-5 minutes: Seating positions and informed consent checks 
2) 5-10 minutes: Introduction points 
3) 10-40 minutes: Session one - Reviewing management of comorbid IBD and 
impact of IBD on wellbeing, quality of life 
Risk of bias 
across 
studies  
15 Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective 




16 Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating 





17 Give numbers of studies screened, assessed for eligibility, 
and included in the review, with reasons for exclusions at 





18 For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
 
Risk of bias 
within 
studies  
19 Present data on risk of bias of each study and, if available, 





20 For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally 




21 Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
 
Risk of bias 
across 
studies  
22 Present results of any assessment of risk of bias across 




23 Give results of additional analyses, if done (e.g., sensitivity or 






24 Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context 
of other evidence, and implications for future research.  
 
FUNDING  
Funding  27 Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 




4) 40-50 minutes: break for refreshments 
5) 50-80 minutes: Session two - Reviewing CBT role in management of IBD 
alongside depression and/or anxiety and exploring attitudes towards proposed 
online programme 
6) 80-90 minutes: Summarise session and thank participants 
1. Seating positions and informed consent checks 
2. Introduction points 
 Introduce the research and thanks for taking part 
 Remind the group that participation is voluntary and that they are free to 
leave at any time 
 Talk about the purpose of the focus group and how the information will be 
used 
 Set the ground rules for the group (only one person speaks at a time; give 
everyone equal chance to participate in the discussion; respect the opinions of 
others; do not put down or criticise others' comments; have the right to 
disagree during the discussion, respect the privacy of others in the group by 
not repeating what is discussed outside of the focus group) 
 Introduce the structure of the session 
 Introduce the discussion topics 
 Any questions? 
3. Session one - Reviewing management of comorbid IBD  
 Discuss the impact of IBD on QoL and wellbeing in general. Discuss that if 
wellbeing is affected for a long time, anxiety and depression may develop. 
Discuss challenges in managing IBD alongside depression and/or anxiety; how 
mental disorders impacts on IBD and IBD impacts on mental health? 
 Discuss who should have responsibility for the management of IBD in people 
with depression and/or anxiety (gastroenterologists, nurses, psychologists or 
patients should play a role in managing IBD alongside a mental disorder 
themselves?). Discuss the patient's ability and wish to take control of their own 
treatment. 
 Discuss medical, nursing or other care patients currently receive for their 
mental health (e.g. GP, mental health nurse, psychologist, and family, voluntary 
organisations, paid care) and which help was the most useful for management 
of IBD.  
4. Break 
5. Session two - Reviewing PIs role in the management of IBD alongside depression 
and/or anxiety and exploring attitudes towards proposed online programme  
 Discuss the role of talk therapy in managing IBD (a short explanation will be 
provided of what talk or talking or psychotherapy is). Discuss what is the role 
of talk therapy in IBD treatment and how could talk therapy help manage IBD 
and how it is relevant to them. 
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 Discuss what experience of using internet or mobile apps for IBD management 
or for mental health the patients have and their thoughts and feeling about 
the online talk therapy programme. 
 Discuss what should be included in this online programme; the lengths and 
how many of online session should be; should it be self-directed or delivered 
with their doctor/nurse/other health professionals assistance; how user-
friendly with regards to the content and format this programme is (format, 
colour, language, lay out; ease of use) and how this programme can be 
improved (i.e., should be added more videos, if so what length 5 -10 min, less 
text, more bullet points text). (Prior the focus group the participants will 
receive the link to the already developed online PI in Australia, as an example: 
http://www.tameyourgut.com/. This will be modified and adapted to the UK 
environment and participants need in the future feasibility trial). 
 Discuss their expectation from this programme (what outcomes they expect 
to change and what they would like to change); the reasons for using or not 
using this programme; their confidence that they will comply with and 
complete the online therapy; what will encourage patients to complete this 
programme? 
 Ask if there is anything else they would like to share that we haven’t 
discussed. 
6. Close session 
 
Appendix 12 Topic guide for the interview with health professionals 
 
1. Background information, role 
For gastroenterologist 
 Can you describe the role you play in supporting patients with IBD? 
 At what point do you tend to become involved in supporting patients with their 
IBD? (E.g. diagnosis, management, complications). 
 Are you involved in signposting patients, or referring them to other services for 
their IBD or mental health? If so, can you tell me about this? 
 If you noticed that an IBD patient suffers from anxiety and/or depression would you 
refer him/her to a mental health specialist or would you deal with this yourself? If 
yourself, how would you approach that? 
 What do patients think when you suggest referring them for psychological 
intervention? 
For psychologists 
 Can you describe the role you play in supporting patients with IBD to manage their 
mental health?  
 At what point do you tend to become involved in supporting patients with their 
mental health? (E.g. diagnosis, management, complications). 
 How patients accept their mental health disorder diagnosis? 
 Are you involved in signposting patients, or referring them to other services for 
their mental health? If so, can you tell me about this? 
For nurses 
 Can you describe the role you play in supporting patients with IBD? 
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 At what point do you tend to become involved in supporting patients with their 
IBD? (E.g. diagnosis, management, complications). 
 What do patients think when you suggest referring them for psychological 
intervention? 
2. IBD management 
 What do you think are the challenges to managing IBD with comorbid depression 
and/or anxiety? (Prompts – motivation, adherence, lack of psychological help). 
 How many practitioners should care for people with IBD and mental health disorder 
comorbidity? Is this right? 
 Do you think that patients have been helped by referral on to psychological 
services? 
 How do you think a mental disorder impacts on IBD? 
 Do you think that a mental health disorder impacts of a patient's ability to manage 
their IBD?  
 How do you think IBD impacts on mental health? 
 Do you think that IBD impacts on a patient's ability to manage their mental health? 
2. Psychological interventions and mode of delivery 
For gastroenterologist and nurses 
 Can you tell me, please, what is a talk therapy or psychotherapy? (Short 
explanation will be provided if a person has different understanding or does 
not know the meaning). 
 What is your experience of using internet or mobile apps for IBD management 
or for mental health? Explore attitudes and views on this. 
 How likely do you think IBD patients would agree to be involved in self-directed 
online programme?  
 How confident are you that IBD patients will comply with and complete the 
online programme? 
 How many sessions and of what duration should be included in an online 
psychotherapy programme? 
 Why would IBD patients use or not use this programme? 
 What will encourage patients to complete this programme? 
 What are your thoughts on providing exclusively online programme as 
compared to clinician-assisted programme? 
For psychologists 
 What is the role of psychotherapy or talk therapy in IBD management? 
 What is your experience of using internet or mobile apps for mental health 
management? Explore attitudes and views on this. 
 How confident are you that IBD patients will comply with and complete the 
online therapy? 
 How many sessions and of what duration should be included in an online 
psychotherapy programme? 
 Why would IBD patients use or not use this programme? 
 What will encourage patients to complete this programme? 
 What are your thoughts on providing exclusively online psychotherapy as 
compared to clinician or therapist-assisted psychotherapy? 
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3. Improving online psychological intervention programme 
 How user-friendly with regards to the content and format this programme is? 
What do you think should be included? (Prior the interview the participants will 
receive the link to the already developed online psychological intervention in 
Australia, as an example: http://www.tameyourgut.com/, which will be 
modified and adapted to the UK environment and participants need in the 
future feasibility trial). 
 How this programme can be improved? (Prompts –format, colour, language, 
and lay out, more information presented in short videos, rather than text, how 
many minutes maximum video should be to not lose patients interest). 
 Is there anything else you would like to share that we haven’t asked about? 
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Appendix 13 Concept map on patients' with IBD and anxiety and/or depression lived 
experiences   
 
Figure 28 Concept map on patients with IBD and comorbid anxiety and/or depression 
lived experiences 
 
Appendix 14 Concept map on patients' and health professionals' view about 
patients' participation in the online psychological intervention 
 
Figure 29 Concept map on patients' and health professionals' view about patients' 































Dear (name of the participant), 
Welcome to your online psychological intervention programme. 
During this programme, you can learn how to improve your mood, reduce stress 
and anxiety and thus a quality of life with the help of this short (8 weeks) online 
psychological intervention programme. Each week in the programme includes 2 
to 3 sessions, approximately one hour length. The programme includes videos, 
text materials and activities for you learning a specific skill to enable you to 
control and improve your mood and anxiety.  
You will learn to: 
 understand psychological interventions and learn specific skills for 
managing anxiety and low mood 
 learn how to use this knowledge in your own everyday lives to relieve the 
burden of negative emotions and IBD. 
After the completion of this programme you will have unlimited access to it, so it 
can be used when you need it. 
Your link to access the course is below, but before you get started we have some 
important summary information and tips to share.  
Programme length 
CBT for IBD people with anxiety/depression online programme will run for eight 
weeks. Each week, a new materials for that week's will be released. At the end of 
the eight weeks you will be able to go back to all of the course materials for 
unlimited time.   
Session lengths 
We encourage you to dedicate at least 1 hour per week for the programme. The 
interactive forum will be available for you all the time through with the other IBD 
patients who have similar symptoms and you will be able to sent a questions to 
the clinician. However, you might not get the response straight away, such as the 
member of our team will review questions on a weekly bases. If you have an 
urgent question contact your IBD nurse or GP. 
Get started 
Select one of the links below to start your course:  
I already have an online psychological programme account 
I have an account, but forgot my password 
I'm new -create an account 
We hope you enjoy and your programme will be useful! 
Kind Regards, 

































Dear (name of the participant), 
Welcome to Week (week number) of your online psychological intervention 
programme. 
Your personal link to access the programme is below. Here the summary of 
what will be covered this week. 
This Week 1 - Introduction to the programme 
Overview of the whole programme 
Goal setting  
Psychological help for IBD 
Recognising stress and symptom and dealing with stress 
Get started 
Select one of the links below to start your course.  
link to the programme: 
I already have an online psychological programme account 
I have an account, but forgot my password 
I'm new -create an account 
We hope you enjoy your programme! 
Kind Regards, 




Appendix 17 Example of personalisation on the screen and 
communication
Week 1  
Session 1 (Introduction) 
Exercise 1   
Welcome to the programme (text)       
Dear (name), 
We hope you find this 8-week course enjoyable and helpful. Here a brief information on 
what to expect: direct instruction lessons presented in text and video materials; 
worksheets, reflection questions and practice exercises. You will be able to post your 
questions and comments on the online Forum, if you wish. Forum is open to the 
participants of this online programme and the clinician. You will be able to download 
the course manual, and look for the resources in the library. 
You will be able to see the headings of each week exercise, but will not be able to access 
each following until previous is completed. After the completion of the course you will 
be able to access any session in any order without restriction. 
Please, engage yourself in the programme and let us know what you think in 
testimonials.  
Kind Regards, 
The online psychological intervention support team 
      







                                                                                                             NEXT 
 
Current progress % 
Hello (name) 10 % 
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Week 1  
Session 1 (Introduction) 
Exercise 2  
 Pre-test 
Before we get started, please complete this pre-test. After the completion of  
the programme course, we will ask you to take another  

























                                                                           
                                                                                 NEXT   
Current progress % 




Appendix 19 Example of consistency of appearance of the screen and presentation of 

















Week 1  
Week 2 
Session 1 
Exercise 1 (Introduction to 




Exercise 4 (Summary of the  
session)  
Session 2 (Introduction to the session) 
Session 4 ( ) 
Session 5 (Focus of Attention:  
Part 2 Anxiety about Anxiety) 
Session 6 (Avoidance & Safety  
Behaviours) 
Session 7 (Summary of the week 2, 






Week 8                                                                                          
 
 
                                                                                                     
 






                                                                           
                                                                                 NEXT   




Summary of the week 7 video.   
To review this week  
so far, we reviewed... 
 Overestimation of thread and 
underestimation of resources to 
cope 
 Focus of attention  
 Anxiety about anxiety 
 Avoidance 
 Safety behaviours 
 




For the best result, download the 
programme material 
Participate in all exercise, review sessions 
more than once if you need to, you can 
write down the important points of each 
session 
Read or review the extra materials 






 About the intervention Programme Library Useful links FAQ  Forum 

















Appendix 20 Example of consistency of appearance of the screen and presentation of 
text in bullet points 
  







Session 1 (Introduction) 
Session 2 () 
Exercise 1 
(Introduction to 
the session 5 
min video and 
text)  
Exercise 2 (8 min) 
Exercise 3 (10) 
Session 3 () 
Exercise 1 
(Introduction to 
the session 5 
min video and 
text)  
Exercise 2 (12min) 
Exercise 3 (5 min) 
Session 4 ( ) 
Session 5 () 
Session 6 (Summary of the week 7) 
Exercise 1 
(Summary of the 
week 7; 3 min 
video)  
Week 8                                                                                          
 
 
                                                                                                     
 
 
                                                                                                                       
                                                                                                                      NEXT                                                                          
 






 How would your life look different if 
you felt less anxious/depressed? 
 
 What would you be doing differently 
today, this week, this month, this 
year, if anxiety/depression weren't a 
problem in your life? 
 











About the intervention Programme Library Useful links FAQ  Forum 
Forum 




Appendix 21 Patients' and health professionals' views about online psychological 
interventions (PI) for inflammatory bowel disease (IBD) codebook 
Themes Primary 
codes 




Experience of living with IBD and comorbid anxiety and/or depression 
Bidirectional 
relationship 





 4 6 








 7 16 
frequent flyers  1 1 
IBD symptoms 
could be over or 
underestimating 
 2 2 




 5 7 
always at the 
back of your 
mind 




 2 2 
anxiety  16 40 









been lucky  4 5 
depression  18 44 









 2 3 
medications for 
mental health are 
not absorbing 
 1 1 
stress  7 13 
symptoms 
embarrassment, 
body image leads 
to depression 
and anxiety 
 5 10 
what's the point, 
lack of 
motivation 
 6 10 
younger more 
affected 
 2 2 
IBD impacts 
on QOL 
 8 11 
embarrassing 
subject 









housebound  6 13 
influence on 
social life, work, 
family 
 9 18 
no difference in 
remission 
 4 7 
pain and fatigues 
difficult to 
manage 
 5 14 
response to 
diagnose 




denial 3 4 































be expert in 
yourself 
 5 8 
people with 
depression and 
anxiety less likely 
to manage their 
own 
 5 6 
Cinderella 
services 
  18 40 
holistic care different patients 
need different 
care 
 2 2 
fear of hospitals, 
doctors 





 2 2 
false economy  2 4 
IBD more difficult 
to manage if you 
have anxiety and 
depression 
 6 7 
involvement in 
patients' support 
from diagnose to 
complications 












 12 19 
NHS let me down  
alone with 
disease, don't 
have a voice 
7 14 



































referral to GP, 
psychologist, IBD 
nurse 





























































refer to the 
specialist 
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head in the sand 





 8 15 
do not need now  3 4 
embarrassment, 
stigma attached 
to mental health 
 3 3 
enjoy the sick 
role 
 1 1 
feed loneliness  1 3 
if doesn't work 
for me 
 2 2 
lack of 
motivation 
 4 5 
negative attitude 
to the Internet 
and mobile apps 
 3 11 
no access to the 
Internet 
 1 1 
not tailored to 
the individual 










would not use 










personal level is 
important 
 22 70 
should be an 
option 








 4 7 
have positive 
outlook, QOL 





 1 1 
manage anxiety 
and stress 

















 14 26 
computer 
illiterate, but use 
with the spouse 
help 
 1 1 
encouragement  0 0 
 been tailored 2 3 








 family support 2 2 





 motivation 6 10 




























mobile apps and 
or participation 
in the online 
intervention 
 11 26 






social anxiety  1 1 
there is nothing 
else 
 4 5 
to find 
information 
 1 1 
younger, more 
savvy 









limited role of 
computerised 
therapies 
 4 6 
involvement in 
self-directed 
programme -  a 
mixed bag 











  21 40 
understandin
g of talk 
therapy 
  23 36 

















  0 0 
negative 
feedback 
 1 1 
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 3 3 
consistency in 
layout 
 1 2 
glossary  1 1 
information 
about disease 













 2 2 
music  1 1 




 6 14 
tailored 
intervention 
 7 18 
text, language  
avoid are you 
anxious or 
depressed, yes or 
no questions 
 2 3 
bullet points  15 21 
clear plan, less 
text 
 5 12 
plain language  15 17 
scientific 
language 




 1 2 












 7 14 
mobile friendly  1 1 
number and 
length of videos 
 24 53 
videos more 
useful then text 
or audio, are 
personalised 




 5 6 
when cannot 
listen be able to 
read 
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